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Carrier structurepecialised short reviews, here a general although not encyclopaedic survey of the
function, metabolic role, structure andmechanism of the ADP/ATP transport inmitochondria is presented. The
obvious need for an “old fashioned” review comes from the gateway role in metabolism of the ATP transfer
to the cytosol from mitochondria. Amidst the labours, 40 or more years ago, of unravelling the role of
mitochondrial compartments and of the two membranes, the sequence of steps of how ATP arrives in the
cytosol became amajor issue.When the dust settled, a picture emergedwhere ATP is exported across the inner
membrane in a 1:1 exchange against ADP and where the selection of ATP versus ADP is controlled by the high
membrane potential at the inner membrane, thus uplifting the free energy of ATP in the cytosol over the
mitochondrial matrix. Thus the disparate energy and redox states of the twomajor compartments are bridged
by twomembrane potential responsive carriers to enable their symbiosis in the eukaryotic cell. The advance to
the molecular level by studying the binding of nucleotides and inhibitors was facilitated by the high level of
carrier (AAC) binding sites in the mitochondrial membrane. A striking ﬂexibility of nucleotide binding
uncovered the reorientation of carrier sites between outer and inner face, assisted by the side speciﬁc high
afﬁnity inhibitors. The evidence of a single carrier site versus separate sites for substrate and inhibitors was
expounded. In an ideal setting principles of transport catalysis were elucidated. The isolation of intact AAC as a
ﬁrst for any transporter enabled the reconstitution of transport for unravelling, independently ofmitochondrial
complications, the factors controlling the ADP/ATP exchange. Electrical currents measured with the
reconstituted AAC demonstrated electrogenic translocation and charge shift of reorienting carrier sites.
Aberrant or vital para-functions of AAC in basal uncoupling and in the mitochondrial pore transition were
demonstrated in mitochondria and by patch clamp with reconstituted AAC. The ﬁrst amino acid sequence of
AAC and of any eukaryotic carrier furnished a 6-transmembrane helix folding model, and was the basis for
mapping the structure by access studies with various probes, and for demonstrating the strong conformation
changes demanded by the reorientation mechanism. Mutations served to elucidate the function of residues,
including the particular sensitivity of ATP versus ADP transport to deletion of critical positive charge in AAC.
After resisting for decades, at last the atomic crystal structure of the stabilised CAT–AAC complex emerged
supporting the predicted principle fold of the AAC but showing unexpected features relevant to mechanism.
Being a snapshot of an extreme abortive “c-state” the actual mechanism still remains a conjecture.
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In eukaryotic cells the ADP/ATP transport through the inner
mitochondrial membrane occupies a central metabolic role as a
critical step in the supply of ATP frommitochondria to the cytosol. Thetransport works as an ADP versus ATP exchange across the inner
mitochondrial membrane and is catalysed by the ADP/ATP carrier
(AAC). To cope with this role the AAC is equipped with several
outstanding features to be elucidated in this review. For this reason
the ADP/ATP transport and the underlying carrier have been a
Fig. 1. The ADP/ATP carrier as a gateway, inter-relating the phosphate transfer networks
in the two mitochondrial and the cytosolic compartments. The components in the
phosphate transfer network correspond to liver mitochondria. From [2].
1980 M. Klingenberg / Biochimica et Biophysica Acta 1778 (2008) 1978–2021paradigm not only for the mitochondrial carrier family but also for
understanding the mechanism of transport through biomembranes in
general. Among several reasons, there are at least two arguments to
support this stand of the AAC. First, the central role of the AAC in
oxidative metabolism requires high expression levels in most
eucaryotic cells, exceeding other transporters; second, the nature of
the transported substrates, being adenine nucleotides is outstanding
in their central and multiple roles in metabolism and regulation. In all
cells adenine nucleotide occurs at high concentrations for coping with
their universe of functions. Being large and highly charged substrates
their transport through biomembranes requires a carrier with highly
efﬁcient catalytic qualities.
In this review the salient developments of the ADP/ATP transport
and its carrier will be elaborated. Among the topics to be covered are
transport, regulation, carrier mechanism, structure/function relation-
ship, and the physiological implications. The important area of AAC
import into mitochondria, the regulation of expression, and the rare
clinical aberrations of AAC are not reviewed to keep the size of the
review manageable. Attention should be drawn to previous reviews
on the ADP/ATP transport system [1–9]. In addition, a number of
reviews on the mitochondrial carrier family include ADP/ATP trans-
port [1,10–15].
2. The early history
As the power stations of eukaryotic cells, mitochondria deliver
energy in the form of ATP to the cytosol. Although much effort was
devoted to elucidate the systemof oxidative phoshorylation, it remained
unclear up to the early 1960ies of how mitochondria receive substrates
for oxidation and how they ship ATP to the cytosol. For many, the latter
question seemed to be non-existent, holding that ADP and Pi are directly
converted to cytosolic ATP somewhere at the inner mitochondrial
membrane. The seemingly inconspicuous problemgainedﬁrst attention
when isolated mitochondria were found to contain high amounts of
adenine nucleotides [16–18] with an unclear role in oxidative
phosphorylation. Only after it was accepted that the inner membrane
presents an osmotic barrier, were the “bound” nucleotides form a
“soluble” pool within the matrix space, interacting with the ATP
synthase. In this “endogenous” pool of AMP, ADP and ATP, the degree
of phosphorylation could be varied by uncouplers, substrates and
oligomycin, indicating their participation in oxidative phosphorylation
[19–23]. Some of these nucleotides were thought to be tightly bound to
the ATP synthase and involved as intermediate receptors and donors in
the phosphate transfer to external ATP. More speciﬁcally it was asked,
whether these “bound” nucleotideswere on themainpathway involved
in the synthesis of external ATP or bypassed (see Chapter 5 “Micro-
compartmentation”). If yes, different views were expressed on how the
internally generated ATP was linked to the external ATP [22,24]. For
example a trans-phosphorylation (“mesomerase”) was proposed to
transfer γ-phosphate across the membrane from internal ATP to
external ADP [24]. Only by introducing rapid separation and quenching
techniques and by using 14C instead of 32P labelling, was the physical
transport of external 14C-ADP, etc. into mitochondria unequivocally
shown and the exchange against the endogenous counterparts
established [20,25,26]. Thus the recognition of an active endogenous
nucleotide pool and of a nucleotide transport was inter-dependent.
In this context the historical role of atractyloside (ATR) is to be
clariﬁed. Being known as an inhibitor of oxidative phosphorylation
[27,28], it was shown to prevent “binding” of ATP to mitochondria
[22,23,29–31]. ATR was concluded to bind and thus to block the ATP
synthesis site [30,32]. Only after the ADP/ATP transportwas established
[20,26], was ATR identiﬁed as an inhibitor of the transport, rather than
of ATP synthesis [26,33]. The ﬁrst “Bari-Meeting” in 1965 with its
fruitful discussions contributed to elucidate these problems and to
resolve the divergent views in the followingyears [34]. It is important to
stress this point since until today the central position of themitochondrial pool in ATP synthesis is occasionally not appreciated
by assuming a “micro-compartmentation” of ATP leading to unsub-
stantiated conclusions about the metabolic organisation of the ATP
export (see Chapter 5).
This early research was intertwined with the question of the
general compartmentation in mitochondria, the role of inner and
outer membranes. Using silicon layer ﬁltration, the differentiation of
total volume of ﬁltrated mitochondria or mitochondrial pellet
represented by the 3H2O space and the 14C-sucrose impermeable
matrix space [25,26,34] allowed to deﬁne the inner membrane as the
osmotic barrier, not freely permeable to solutes. The volume changes
of the matrix space visualised by electron microscopy in response to
variation of the external sucrose or KCl concentrations were in
agreement with the volumetric measurements [35]. The outer
osmotically inactive membrane in isolated mitochondria was shown
to be freely permeable to molecules with MW b4 kDa [35]. On this
background the gateway role of the AAC in phosphate transfer not
only from ATP synthase but also between the different phosphate
transferases known to exist in the matrix and intramembrane space
was illustrated in Fig. 1.
In the early 60ies the paradigm example for solute transport
through membranes was the glucose transport in erythrocytes [36,37].
The large internal space of erythrocytes permitted easy measurements
of kinetics whereas transport measurements in mitochondria were a
challenge due to the much smaller inner volume surrounded by a large
convoluted inner membrane surface, requiring higher time resolution
and micro scale analytical techniques. A further complication was the
rapid metabolic conversion of the transported substrates in mitochon-
dria. New micro-analytic anion exchange chromatography methods
permitted to deﬁne the endogenous nucleotide metabolism [21]. The
reﬁnement of the original centrifugal silicon layer ﬁltration technique
[38] enabled brief exposure to the labelled solutes, rapid separation
from themedium, extraction and ﬁxation of the phosphorylation status
by the bottom HClO4 layer [39]. Introduction of the inhibitor stop
method and the continuous development of semi and fully automated
rapid mixing, rapid sampling and stopping machines permitted
resolution of transport binding down to the 100 ms range [40,41].
3. The ADP/ATP transport
The terms ADP/ATP transport or ADP/ATP exchange will be
generally used, when the speciﬁcations, in what combination ATP
1981M. Klingenberg / Biochimica et Biophysica Acta 1778 (2008) 1978–2021and ADP are exchanged, are not relevant. Otherwise, the four ADPe–
ATPi etc exchange combinations are speciﬁed (see Chapter 5). The
underlying transporter is termed the ADP/ATP carrier (AAC). Other
terms used are “translocase”, which reﬂects the pioneering role of the
ADP/ATP transport in understanding carrier linked transport. Simi-
larly, the Escherichia coli lactose transporter was early called
“permease”. The popular term adenine nucleotide transporter (ANT)
is misleading since this term also implies transport of AMP which is
explicitly excluded by the AAC.
After the ﬁrst communications [20,25,26] on the discovery of the
ADP/ATP exchange and early conﬁrmatory work [33], a full
characterisation of the ADP/ATP transport in mitochondria was
given in two detailed key papers [42,43]. All these studies were
performed on rat liver mitochondria which were the classical
mitochondria for studying oxidative phosphorylation. First using
the centrifugal silicon layer ﬁltration technique [25,26,39], the ADP/
ATP transport across the inner mitochondrial membrane was
scrutinised by analysing the changes of endogenous pool composi-
tion on addition of 14C-ADP and 14C-ATP. The uptake and the release
of ATP, ADP, and AMPweremeasured formonitoring the speciﬁcity of
the inﬂux and of the efﬂux.
Basically the transport was established as a 1:1 exchange of added
ADP or ATP [26,42] with endogenous ADP and ATP in the mitochon-
drial matrix. AMP remained excluded from both uptake and efﬂux.
With further techniques the time course of the 1:1 exchange was
directly demonstrated by labelling the endogenous nucleotides
with 3H and the exogenous with 14C [2]. The example demonstrates
a simultaneous, approximately equal release and uptake (Fig. 2). In
experiments using 8-14C- and γ-32P-ATP, ATP is shown [42] to be taken
up as an intact molecule, thus refuting a proposed trans-phosphoryla-
tion of γ-P across the membrane to internal ADP [23]. The exchange
does not require Mg++ [42].To the contrary, added Mg++ was found to
partially inhibit exchange indicating that the free ADP and ATP are
transported. The inﬂuence on the exchange of uncoupling, of
manipulating the phophorylation level by arsenate, of ionophores
and oligomycin, was scrutinised for segregating the effects of the
nucleotide composition changes from the membrane potential, as
reviewed below.Fig. 2. The ADP/ATP exchange between external and endogenous adenine nucleotides of
mitochondria. The results demonstrate (a) the 1:1 exchange, (b) the endogenous pool as an
obligatory intermediate (no micro-compartmentation) and (c) the preference of ADPex–
ATPint exchange mode in the energised state of mitochondria. The exogenous nucleotides
are labelled with 3H, the endogenous nucleotides with 14C. The exchange is started by
addition of 3H-ADP to respiring and phosphorylating liver mitochondria. The decrease of
external 3H-ADP isparalleledby the immediate appearance inmitochondria of 3H-ADPand
after a delay it is phosphorylated to 3H-ATP. In exchange for 3H-ADP endogenous 14C-ATP is
immediately released, followed by a continuous 3H-ATP export. From [83].3.1. High substrate selectivity
Dealing with ATP and ADP places the ADP/ATP transport into a
special situation. The transported substrates are large, hydrophilic,
highly charged molecules, averse to low dielectric membrane
environment. In cells the ubiquitous ADP and ATP interact with
more proteins than any other ligand. Thus it is not surprising, that in
nature and in the laboratory more analogue compounds of ATP and
ADP are created than for any other substrate, providing a large arsenal
to explore the speciﬁcity of the transport. The ADP/ATP transport
exhibits unusually high selectivity [2,42,44], as compared to most ATP
utilising proteins, and also compared to other more recently identiﬁed
nucleotide transporters which are also members of the mitochondrial
carrier family [45–48]. Each part of nucleotide structure seems to be
recognised by the AAC. The metabolically important exclusion of AMP
shows that the phosphate moiety requires at least 2 phosphate
groups. It may seem paradox, that while the less charged AMP is
rejected; transport requires adenine nucleotides with their full charge
as ATP4− and ADP3−.
The ﬁnding that the prevailing Mg++ nucleotide complexes are not
transported [34,43] has important consequences, e.g. the concentra-
tion limitations by the much less abundant free ATP4− and ADP3− and
the electrophoretic exchange of ATP4− against ADP3. This contrasts to
the large universe of proteins involved in ATP hydrolysis or phosphate
transfer requiring Mg++. The underlying ADP/ATP carrier (AAC) is
distinguished by the absence [49] of the binding site motifs common
in ATP utilising phosphate transferring proteins, into which ﬁrst the
ADP/ATP carrier was mistakenly included [50]. Also other proteins
such as uncoupling proteins, in which the ATP or GTP (ADP or GDP
etc.) function as regulators rather than in phosphate transfer, have no
requirement for Mg++ or Ca++[51].
It was early concluded that the high speciﬁcity of oxidative
phosphorylation in mitochondria is conditioned by the transport [26]
rather than by ATP synthesis. At variance, assuming that in digitonin
particles the access to the ATP synthase does not require a transport, it
was suggested [44] that other factors controlled the speciﬁcity.
However, these results were critically reinvestigated and not
conﬁrmed [52]. Adenine nucleotide analogues with variations in the
phosphatemoiety such as replacing –O– in the P–O–P bridge by –NH–,
CH2– [2,42,44], or omission of –O– in phosphonate [53] are still
somewhat tolerated by the exchange. The phosphate groups must be
in the 5′ position [42] as judged from the inactivity of AMP-3′P and
ADP-3′P. d-ADP and d-ATP are transported at 10–15% the rates of their
ribose homologues. Concerning the basemoiety, a stringent speciﬁcity
for adenine is maintained, excluding most other bases [42]. Useful for
its ﬂuorescence are the close adenine analogues formycin -DP, -TP
which have 10% transport activity [2].
3.2. Transport of small solutes by the AAC
The AAC can also transport some small anionic solutes at much
lower rates, as shown with isolated mitochondria and reconstituted
AAC. Phospho-enolpyruvate (PEP) is transported in mitochondria
preferentially by the citrate carrier but there is also an ATR sensitive
PEP transport [54] with an activity of only a few % of ADP–ATP
transport. Pyrophosphate (PPi) transport by the AAC has been noted
[55] ﬁrst as a PPi driven AdN export from mitochondria which is
inhibited by ATR. In Ca++ loaded mitochondria PPi drives Ca++ out of
the mitochondria, which is again sensitive to CAT [56]. The effect is
much stronger in mitochondria from heart than liver. The PPi
transport was clearly characterised [57] as a 1:1 exchange of PPi
against ADP with AAC reconstituted vesicles. Depending on the in- or
outside location of PPi, the rates can reach about half of ADP/ATP
exchange. However the KM ~1mM is about 100 times higher than ADP
or ATP. PPi is generated during fatty acid (FA) activation and should be
imported in mitochondria only when ATP and ADP levels are low. It
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and ATP, which should be essential for the interaction with AAC.
Creatine phosphate (CrP) was shown [58] to be taken up in heart
mitochondria by a slow CAT sensitive process. With AAC proteolipo-
somes the CrP transport was characterised as an exchange against
ADP or ATP, however, at a 500 times lower rate than the ADP–ATP
exchange. The suggested close linkage of AAC to creatine kinase
(see Chapter 6) may facilitate CrP uptake in vivo.
3.3. Kinetics of ADP/ATP exchange
Maximum rates of ADP/ATP transport are of interest not only for
assessing the capacity of transport of the underlying carrier, but also
because of the possible rate limitation for the ATP supply in the
eukaryotic cells. Measurements of ADP/ATP exchange kinetics in
mitochondria can be experimentally difﬁcult since they depend on
the exchange with a limited endogenous adenine nucleotide pool.
Liver mitochondria are favourable because they contain less trans-
port sites in relation to the nucleotide pool size. Even at low
temperature the time interval from the addition of the labelled ADP
or ATP until equilibration is only up to 50 s, requiring high time
resolution techniques for measuring the initial rates. In fact, initial
rates, although important, are rarely measured in mitochondria.
Ideally the exchange follows a ﬁrst order reaction to equilibrium
between internal or external labelled nucleotides, and the absolute
rate has to be calculated on the basis of the exchangeable
endogenous pool size, i.e. the ADP and ATP content since AMP is
not exchanged [43]. The ADP and ATP content can vary widely in
different metabolic states of mitochondria. The ﬁrst order ratewill be
composed of the different exchange rates of endogenous ADP and
ATP. A major factor controlling these differences is the membrane
potential. Because of these problems it is not surprising that in the
literature data on the rates of the ADP/ATP transport in mitochondria
varied considerably.
In the ﬁrst reports time courses were poorly [26] or not resolved
[23,33,59]. Some artefacts lead to the conclusion of a two stage
exchange [59]. Rigorous measurements of the exchange kinetics were
performed with a time resolution of 1 s, using rapid pressure ﬁltration
or the inhibitor stop method [43]. This resolutionwas sufﬁcient for rat
liver mitochondria to measure initial kinetics at 2° where 90% to
equilibrium is reached at about 50 s. The kinetics were approximately
ﬁrst order related to the ADP+ATP pool. The time course was
homogenous and the reported oscillations [44] of the rate during
the time course were not observed. In heart mitochondria the size of
the endogenous pool related to the carrier (AAC) content is about 3
times smaller, requiring higher resolution by subsequent develop-
ments of new automated rapid mixing, sampling and quenching
apparatus with a time resolution down to 0.1 s [40,41], as well a rapid
ﬁltration technique [60]. This enabled measurement of kinetics of
exchange at higher temperatures, up to 27° in rat liver mitochondria
and up to 20° in rat heart and yeast mitochondria [40].
A detailed study of the temperature dependence of the exchange
rates in liver mitochondria shows that the rate increases steeply
between 0° and 14° about 30 fold from about 3 to 90 µMol/min/g
protein and from 15° to 27° only 3 fold. In the Arrhenius plot a
temperature break is at 14.5° where the activation energy decreases
from 34 kcal to 13.8 kcal. An extrapolation of the temperature
dependence allows estimation of the rates at 37°. The same
temperature break was observed with heart mitochondria. Measure-
ments down to −10° (using 10% glycol) showed no further tempera-
ture break, indicating that a phase transition of phospholipids is not
involved. Therefore an intrinsic conformation change of the carrier
protein may occur around 14°. The signiﬁcance of this activation
energy in the transport mechanismwill be elucidated below (Chapter
16.1). Initial rates measured at 22° of transport into heart mitochon-
dria [60] by a rapid ﬁltration technique were lower than thosepreviously reported [40] possibly caused by nucleotide leakage from
broken mitochondria deposited on the ﬁlter.
The strong temperature dependence of transport below 14° was
ﬁrst noted [61] by comparing the phosphorylation rates of endogen-
ous and exogenous ADP using a fast sampling technique. Below 14°
endogenous ATP is formed much faster than external ATP. As a result
low temperature has a similar effect as ATR on oxidative phosphor-
ylation. Also the hydrolysis of exogenous ATP stimulated by uncoupler
at low temperature was much slower than the endogenous rate. A
difference in phosphorylation rates of endogenous and exogenous
nucleotides at 0° was also noted in other studies [62]. These results
show that at lower temperatures oxidative phosphorylation is rate
limited by the transport. Similar temperature breaks reﬂecting ADP-
ATP transport are found [61] in Arrhenius plots of the ADP stimulated
respiration and in the oxidation rate of endogenous NADH+NAPDH on
addition of ADP.
Transport rates at 37° are extrapolated assuming “linear” con-
tinuation to 37° in the Arrhenius plots. These “maximum” rates are
obtained under conditions, where the exchangeable portion of
internal AdN (low AMP content) and the membrane potential is
high in order to optimally drive ADP uptake against ATP release (see
below) [40,43,63]. For calculating the turnover number, the content of
AAC sites in mitochondria was determined by binding of CAT (see
Chapter 7.3). Comparatively low turnover values are measured
characterising the AAC as a slow carrier. However in reconstituted
vesicles with optimal phospholipid composition, the AAC works at a 4
fold higher turnover [64,65]. These higher turnovers have been
observed not only with bovine heart AAC but also with reconstituted
AAC from Saccharomyces cerevisiae [66].
A special effortwasmade tomeasure the initial phase of theADP/ATP
exchange in the ms range [67]. Using a quench-ﬂow apparatus with
starting and stopping mixing chambers and an intervening reaction
tube, a time range between 20 and 400 ms was covered, using an
inhibitor stop with ATR. A biphasic time course with an initial rapid
uptake between 25 and 100mswas observed and identiﬁed as a quench
delay. Its size depended among other factors on the ADP concentration
andon the timebetweenADPandATR addition, indicatingadelaydue to
the competitive removal of ADP by ATR. No time delay was observed
in the de-energised state (valinomycin, FCCP), where the AAC tends
to assume the c-state, showing that the reorientation from them- to the
c-state is the major rate limiting step for the ATR access and thus
responsible for the quench delay. As evident from mitochondrial
contraction recordings [68] and from NEM interaction [2,69,70] (see
Chapter 8.6), in the energised state on addition of ADP, the AAC is
converted mostly to the m-state. In accordance with this model
involving the carrier reorientation steps, thequenchdelaywas computer
simulated with m- to c-state transition turnover time of 50 s−1.
Another kinetic parameter burdened with variability is the KM.
Widely different values are reported, partially explained by experi-
mental problems. For example leakage of endogenous nucleotide
gives a higher true concentration than the added concentration, an
error most serious at low concentrations. As a result a too low KM is
determined unless the concentration is corrected for the leakage
[71,72]. The error can be minimized with the back exchange method,
which allows usingmore dilutemitochondria producing a low leakage
concentration [43]. The KM depends on the energy state of
mitochondria inﬂuencing the phosphorylation state of the endogen-
ous adenine nucleotide (AdN) pool and the membrane potential. A
biphasic relationship of V on the ADP or ATP concentration,
corresponding to two KM is obtained in V versus V/S, or 1/V versus
1/S plots [43]. In another work a non-linear relation is also observed
[71], but two reports found only a linear relation [72,73]. The rate
measurements were often based only on a single time point [71,73].
Evaluating rates obtained from the full time course, for ADP two
KM varying by a factor of about 10 are obtained: in the “energised”
state KM=3/27 µM, in the “de-energised” KM=0.8/11 µM, [2]. The two
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varying with ADP or ATP and the energy states. These KM values are at
variancewith those reported by Duyckaerts et al. [72] in energised/de-
energised states: KM (ADP) 1–2 µM, KM (ATP)=140 and 1 µM, or by
Barbour and Chan [71]: KM (ADP)=2–4 and 20–30 μM, KM (ATP)=
100–120 and 6–DEL id="del79" orig="- ">10 µM.
In reconstituted vesicles the variables affecting the kinetics and
thus the KM can be better controlled [64,65]. A wealth of
information is obtained by segregating the exchange modes (ADPe
against ADPi, ADPe against ATPi, etc). The concentration dependence
is linear with a single KM and the KM values do not show the large
increase on “energisation” as observed in mitochondria. With
Δψ=180 mV the KM for ATP increases only 1.5–2 fold. Most
interesting are studies of the competition between ADP and ATP,
which can best be performed with reconstituted vesicles where
inside and outside the concentration of ADP and ATP can be freely
adjusted in a “competitive” ADPe+ATPe against ADPi+ATPi exchange
mode, indicating the strong preference for ADP under the inﬂuence
of Δψ (see below).
3.4. Kinetic models of transport mechanism
In two studies of the kinetics criteria were applied for differentiat-
ing between single sites (ping-pong) or dual sites (sequential or
simultaneous) mechanisms. For this purpose, in addition to the
external also the internal concentrations of ADP and ATP were
changed by inhibiting oxidative phosphorylation to varying degrees
[71,72]. In 1/V versus 1/S plots the lines intersected with the ordinate
in accordance with a sequential mechanism. A non-linear biphasic
relation was found which varied with the endogenous nucleotide
composition. This was interpreted as a cooperation between two
binding sites, for example the two binding sites in an AAC homodimer
[71]. A ternary complex of AACwith both exchanging substrates had to
be postulated in the transport cycle and both groups proposed that the
release of the substrate from the AAC at the matrix side requires
binding of endogenous ADP or ATP destined for export. Originally
deduced from kinetic work on the aspartate–glutamate exchange in
mitochondria [74], this variant of the sequential mechanism avoids
the simultaneous existence of an outer and inner facing binding site,
and is more compatible with other data of inhibitor binding to be
elucidated below. However the evaluation of the experimental data
may be ﬂawed in several respects. Duyckaerts et al. [72] accounted
only for the endogenous ADP and ignored that ATP is also released.
Moreover, they assumed that the ADP–Mg complex is the endogenous
exchanging substrate contrary to evidence that only the free ADP and
ATP are transported. Further, the leakage of endogenous nucleotides
will skew the concentration dependence so that the KM are under-
estimated. Barbour and Chan [71] were aware of this error but did not
correct for the leakage of ADP.
It should be mentioned, that kinetic studies in reconstituted
vesicles with other mitochondrial carriers such as the glutamate–
aspartate carrier also seemed to support the sequential (simulta-
neous) mechanism [75,76]. However, there is a suspicion that low
“concentrations” in the µM range inside the vesicles andmitochondria
are kinetically not meaningful since in the small matrix space only a
few, down to one or less molecules are present. Notably in all cases the
apparent KM for internal substrate are measured in the mM range
contrasting to the µM range of the external KM, which at face value
would indicate that the inner side of the carrier exhibits a much lower
afﬁnity than the external side. However, in vesicles part of the carrier
molecules are in a reversed conﬁguration, so that one would have to
conclude that the membrane conﬁguration rather than the different
faces of the carrier determine the afﬁnity. A more rational explanation
seems to be that in the “µM” range the low number of molecules
present in the vesicles does not permit to deﬁne a kinetically relevant
concentration.3.5. The ADP–ATP exchange in submitochondrial particles
To investigate transport characteristics from the m-side of the
inner membrane, sonic particles from BHM (SMP) [73,77,78] were
loaded with 3H-ADP or 3H-ATP for measuring simultaneously uptake
and release [78]. The kinetics were followed by a rapid ﬁltration or the
BKA stop method. A 1 to 1 exchange between the endogenous 3H and
external 14C was demonstrated. The rates were 10 times lower than in
mitochondria [73,78], indicating that only part of the sonic particles
are tight and inside-out. ATR and CAT did not or only partially inhibit
the exchange unless added prior to sonication. BKA completely
inhibited exchange, without showing a time delay and a pH
dependence as in mitochondria. The temperature dependence
measured between 0° and 35° showed a steep increase up to 25°
with an activation energy of 24 kcal [78]. The rates were only weakly
inﬂuenced by energisation [78], but a strong inﬂuence on the KM of
ATP uptake was reported [73]. The selectivity for substrates was still
higher in SMP than in mitochondria, with exchange rates of dADP,
dATP, AMPPNP, AMPPCP amounting to only 2 to 3% of mitochondria.
The enhanced speciﬁcity reﬂects the different conﬁguration of the
binding site at the m-side in line with the single site reorienting
mechanism (see below). SMP were also used to demonstrate the
electrogenicity of the ATP–ADP exchange [79] as reviewed below. In
an early report on ATP transport in SMP by Shertzer and Racker [80]
the rates were actually 35 times lower than in mitochondria, although
equal rates are claimed.
4. Energy control
4.1. Energy dependent shift of ADP versus ATP transport in mitochondria
Some aspects of the inﬂuence of the mitochondrial energy state on
the ADP/ATP exchange were reviewed above, such the phosphoryla-
tion state of the endogenous pool on the KM. Here we will concentrate
on the differentiation between ADP and ATP transport, the important
consequence for the control of the ADP–ATP exchange, and the force
and mechanism involved. Basically the ADP/ATP exchange is not
energy dependent. It proceeds with high activity when the mitochon-
dria are completely depolarised by uncouplers [42,43] and ADP and
ATP are transported in both directions at nearly equal rates. Since in
this state the carrier purely acts as a facilitator, the exchange should be
symmetric in both directions. In mitochondria energisation shifts ADP
and ATP transport rates in opposite manner such that the ratios
VADP→/VATP→ of the inﬂux increases and VADP←/VATP← of the efﬂux
decreases [42,81]. This effect is most dramatic, when, similarly to in
vivo conditions, ADP and ATP are offered simultaneously at varying
proportions. ADP uptake is preferred to such an extent, that equal
uptake rates are obtained only when the mixture is skewed to 8% ADP
and 92% ATP [81,82].
In the energised state internal ATP is the preferred exchange
partner as deduced [42,81] from varying the endogenous ATP content
by alternating incubations with Pi and oligomycin, signalling that
energy drives efﬂux of ATP in preference to ADP. With advanced
sampling techniques [40] individual uptake and release rates were
simultaneously measured, directly showing that in the energised state
ATP is released preferably toADP but in the uncoupled stateADP leaves
the mitochondria more rapidly than ATP [81,83], although equal rates
should be expected, just as observed for the uptake. This can be
explained by considering that in the mitochondria the nucleotides are
present mostly as the Mg++ complexes which are not transported and
thus the concentration of free ATP is decreased about 10 times more
than of ADP because of the stronger Mg++ binding constant. After
correction of this effect the ratio of the efﬂux rates in the uncoupled
state is VATP←/VADP←≈1 and in the energised state ≈20 [81].
By promoting uptake of ADP and release of ATP, the transport is
modulated such that itwould cooperatewithoxidative phosphorylation.
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(D=ADP, T=ATP) where De−Ti are the productive, Te−Di counter-
productive, and De−Di, Te−Ti neutral modes. The combinations must be
regarded as statistically independent whether the AAC operates in a
ping-pong or sequential mechanism. As shown in Fig. 3A in the
energised state the productive mode reaches nearly 60% and surpasses
the counter-productive mode 15 fold. The partitioning of the capacity
among these modes represents the most important regulation of the
AAC. It was earlier recognised that the principal force for this regulation
is the membrane potential Δψ. Since the exchange uses the “free”
nucleotides without Mg++, ATP4− and ADP3− appeared to be the
transported species and as a result the De−Ti and Ti−De modes are
electrically imbalanced. The difference of one negative charge is the
anchor for Δψ driving the exchange De−Ti. The ﬁnal proof of correlating
Δψ with the electrically imbalanced transport came from the recon-
stituted system [64,65,84] as reviewed below. Here the single exchange
modes could be segregated or combined and various Δψ imposed at
will. Fig. 3B shows the dramatic shift of the modes by Δψ. At
“physiological” +180 mV the De−Ti mode share amounts to more than
60% whereas at −120 mV the opposite mode pattern is seen.
The conclusion of the electrical nature of the ADP/ATP exchange
was not immediately accepted, partially, as it would upset the
textbook P/O ratios. Mitchell and Moyle believed to have shown [85]
that the exchange is neutral, corresponding to ADP3−↔ATPH3−, with a
parallel H+ release, or that it is neutralised by Ca++ co-transport [86].
Kemp and Out suggested an energy dependant conformation change
which differentiates between ADP and ATP [87]. Vignais et al.
assumed [88] that the energy transduction to the ATP synthesis
also drives the ATP export, implying a localised release of newly
synthesised ATP (see Chapter 6). Other arguments against an
electrogenic exchange were based on claiming that energisation
changes KM rather than Vmax [73] and a conformational change of the
AAC by ΔμH+ was invoked.
Direct measurements of the electrical charge transfer became
important to further ascertain the electrical nature of the exchange.
In mitochondria permeabilised for K+ by valinomycin, the uptake or
efﬂux of K+ or H+ was measured parallel with ATP or ADP uptake [89].
Experiments were performed to determine the electro-neutral share
of transport by measuring the H+ movement which would accom-Fig. 3. The inﬂuence on the partitioning of the total exchange transport capacity into the
four exchange modes: productive De–Ti (ADPex–ATPint), unproductive De–Di, Te–Ti,
counter-productive Te–Di modes. Energised (~) and de-energised state (FCCP) of
mitochondria, and of the equivalentΔψ variation in reconstituted AAC proteoliposomes.
Strong preference of the productive mode in energised state and at +180 mV and near
equal mode distribution on uncoupling and Δψ=0. The data in mitochondria are given
without and with correction for endogenous Mg++. The corrected values are to be
compared to those of the reconstituted Mg++-free system. From [81,64].pany an ADP3−/ATPH3− exchange, and to determine the share of
electrical ADP3−/ATP4− exchange by measuring the parallel H+ or K+
transport in mitochondria which are permeabilised for H+ (uncou-
pler) or for K+ (valinomycin) [89]. The electro-neutral share
amounted to about 0.2 H+/ATP and the electrical share to 0.6 to
0.8 K+/ATP. In other experiments, by inducing ATP uptake by K+ or H+
additions, the ratios H+/ATP or K+/ATP reached 0.8 to 0.9 [90]. Since
due to back leakages some of those values may be underestimated,
with Occam's razor one negative charge per ATP has been
extrapolated and thus a fully electrical ADP3−/ATP4− exchange
postulated [90]. However, a fractional charge, corresponding to a
partial ATPH3−-transport cannot be ruled out andmay serve to adjust
the energy share used in the exchange in dependence on Δψ and
ΔpH. At any rate, the ADP–ATP exchange is a primarily “electro-
phoretic” ATP export, and can be classiﬁed as a “secondary active”
transport. In another work [91] using a ﬂuorescent indicator, the
change of Δψwas recorded during the import of ATP into ADP loaded
SMP from BHM, showing that the reversed exchange is electrogenic.
Applying valinomycin and nigericin the changes of ΔpH were
attributed to other side reactions rather than to ATPH3− transport,
substantiating a fully electric ATP4−–ADP3− exchange.
4.2. Electrophoretic control of the reconstituted AAC
In the reconstituted system, without interference by other
mitochondrial components, Δψ and separately ΔpH can be set
arbitrarily over a wide range even in the “opposite” direction for
determining their inﬂuence on transport [64]. Internal nucleotides are
not complexed with Mg++ as in mitochondria and the nucleotide
composition can be chosen such that the 4 single modes can be
separately measured. The Δψ is set by the K+-gradient and
valinomycin over a theoretical but actually a somewhat smaller
range of −120 to +180 mV. By varying the Δψ a linear relation
between RT log(VADP→/VATP←) and nFΔψ is obtained with a slope of
n=0.6. Only the hetero-modes ATPe–ADPi and ADPe–ATPi were
markedly inﬂuenced by Δψ, according to the polarity and ATP versus
ADP location. At equal in- and outside concentrations of ATP and ADP
the ratio of uptake rates VATP/VADP is radically changed from 5 to 0.2,
when Δψ was varied from −120 to +180 mV. By double labelling the
efﬂux was also measured and thus the partition of the total exchange
into the 4 modes was determined, showing at Δψ=0 a near equality of
the 4 modes (each 25% of total exchange) and at −120 mV or +180 mV
a preference for the hetero-modes D/T or T/D (60% and 65% of total)
(cf. Fig. 3B). Varying the ΔpH (at Δψ=0) from −1 to +1 decreased the
rate ratio VATP/VADP only 1.5 fold, providing evidence that the electro-
neutral mode ADP3-ATPH3− plays only a minor role as compared to
the electrical mode ADP3-ATP4−.
In a further rigorous study of the reconstituted system the
question was settled [65], in view the different results reported on
mitochondria, of whether the KM (afﬁnity) or the maximal rate Vmax
are changed by the Δψ. The kinetic parameters were analysed by two
different kinetic models according to whether Δψ controls the
afﬁnity (KM) or velocity. The concentrations of external and internal
ADP or ATP were varied for determining the KM and the four uptake
and efﬂux rate constants kD→, kT→, kD←, and kT←. The changes of the
rates by Δψ evaluated according to the KM model were not
compatible with the measured data, but agreed well when calculated
according to the Vmax model. In this model any changes of KM with
Δψ result from an inﬂuence of the velocity, whereas the afﬁnity
(1/KD) remains unchanged. A strong asymmetry of c- versus m-state
distribution of the AAC under the inﬂuence of Δψ emerges from the
evaluation of the kinetic data, caused by the strong asymmetry of the
rates. These results show that Δψ lowers the activation barrier of the
c–m transitions rather than the conformation of the carrier. The data
are supported by results with mitochondria, showing that the
inﬂuence of Δψ on KM is small [2]. Reports by other groups of a
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be conﬁrmed and may be partially explained by experimental
problems.
4.3. Direct measurement of electrical currents of ADP/ATP transport
Electrical currents associated with the electrogenic ATP/ADP
transport could be directly measured [93,94], using a technique [95]
in which the capacity currents across a planar membrane between
two bath electrodes are measured. Reconstituted AAC containing
vesicles were adsorbed at the planar membrane, caged ATP or caged
ADP were added to the medium. These are not transported but are
bound and are competitive inhibitors of ADP/ATP transport. The
exchange was initiated by photolysis liberating ADP or ATP from the
caged compounds. On ﬂash photolysis transients current were
measured which were abolished by combined CAT and BKA. The
currents reﬂect several cycles of ATP–ADP exchange until the external
level of liberated ATP or ADP subside and excess caged ATP or ADP
reclaims the AAC. Opposite currents were measured with caged-
ADPout–ATPin and caged-ATPout-ADPin vesicles. Unexpectedly, cur-
rents were also generated with the homo-exchanges in the mode
caged-ATPout–ATPin. The currents were shorter and weaker and were
visualised to reﬂect the redistribution of carrier sites, initially all
trapped outside by the caged substrates, after the photolytic release of
ATP or ADP. The measurements of the inﬂuence of pH, of K+ gradient,
Δψ and of temperature on these currents [94] all concurred with the
former transport measurements. With excess Mg++ the translocation
currents were suppressed, again underlining that Mg++–nucleotide
complexes are not translocated.
Still smaller but distinct currents were observed with unloaded
vesicles after photolysis of caged ATP and ADP, interpreted as the one
way translocation of carrier sites loaded with ATP or ADP from out-to
inside, to be caused by half cycle translocation of the ATP- or ADP–
AAC complex. The fact that not only with caged ATP but also with
caged ADP currents are measured, although in an opposite direction,
called for a new view of the charge balance at the binding site.
Formerly it was proposed [84] that at the binding center the charge
balance is neutral in the putative ADP3−AAC3+ complex and negative
in the ATP4−AAC3+ complex. The current measurements [96] indi-
cated that ADP–AAC also carries a fractional although positive
charge. While the total charge movement of −1 for ATP4−/ADP3−
exchange is well established, the results call for a fractional charge
distribution at the binding center according to (ATP–AAC)−0.7 and
(ADP–AAC)+0.3. Fractional charge shifts are also observed on binding
of ATR and BKA initiated by photolysis of caged ATP (N. Brustovetsky,
unpublished).
High time resolution measurements revealed the current stages
of the initial in situ conversion of caged ATP3− and caged ADP2−
into ATP4− and ADP3− (1100 s−1) followed by the slower translocation
of the in situ generated ADP or ATP to the inside (ADP, 400 s−1, ATP
160 s−1) [96]. Since caged ATP and caged ADP bind tightly to the AAC,
ADP or ATP are released at the binding site and immediately mobilise
the AAC. The translocation kinetics were independent of the ﬂash
strength, i.e. of how much free ATP and ADP were generated in the
surrounding solution, showing the preferred status of the in situ
released ATP and ADP. This differs from similar experiments with a
typical ATPase [97], such as the Na+/K+-pump where caged ATP and
in situ released ATP are in rapidly equilibrium with the surrounding
photolysed ATP. Probably the binding charge difference, ATP4− in AAC
versus (ATP Mg)2− in the ATPase are responsible for this difference.
In conclusion, the high sensitivity of this method revealed the
detailed working of the AAC such as the forward and back ﬂow of
sites loaded with ADP or ATP as reﬂected in currents with opposite
polarity, the trapping of the carrier outside by caged ATP and ADP
and the competition between external ATP and ADP and the caged
derivatives.4.4. The phosphorylation potential gradient across the mitochondrial
membrane
The electrochemically driven ADP-ATP exchange produces a
gradient of the T/D ratio between the mitochondrial matrix and the
cytosol by elevating external T/D over the internal T/D. This prediction,
which at ﬁrst seemed to be a paradox because ATP is generated in the
mitochondria, was substantiated by a variety of experimental results,
showing that the external ratio (T/D)e can be up to 20 times higher
than (T/D)I [98,99]. In contrast, opposite gradients with a higher (T/D)i
had been reported by Duee and Vignais [62] and were interpreted as a
build up of internal ATP. However this (T/D)i may be in error since it
was calculated as a difference of supernatant and pellet without a
subtraction of the surrounding “sucrose space”, necessary to deter-
mine the matrix space and the T/D ratios therein [98]. Whereas
with phosphorylating mitochondria the (T/D)e/(T/D)i ratio is 5 [1,98],
the (T/D)e/(T/D)i can reach even 20 under conditions where substrate
level and oxidative phosphorylation were halted with oligomycin and
rotenone, allowing equilibration of ADP and ATP across the mem-
brane. Since under these conditions the (T/D)e is “clamped” due to its
large excess, the energisation of the membrane causes primarily a
decrease of (T/D)i by largely depleting the matrix of ATP. It may seem
to be a surprise, that on uncoupling (T/D)i became nearly 3 fold higher
than (T/D)e. However, this can rationalised by noting that the high
internal Mg++ concentration lowers the free (T/D)i as compared to total
(T/D)i approximately 5 fold, because Mg++ binds about 5 times tighter
to ATP than to ADP. Consequently, by adding 2 mM Mg++ the external
and internal T/D become equal [98].
The T/D gradient could be varied over a wide range, under non-
phosphorylating conditions, by imposing a K+ diffusion potential [100]
in the presence of valinomycin, generating Δψ from 50 to 160 mV. The
internal K+ concentrationwasmeasured by radioactive Rb+. At 160 mV
(T/D)i was decreased to 0.01, resulting in (T/D)e/(T/D)i≈100 with (T/
D)e=1.2. The linear relation of log (T/D)e/(T/D)i to the K+ diffusion
potential was determined to follow the relation: log (T/D)e/(T/D)i)=
(0.65 to 1)× log (K+i/K+e)− (0.2 to 0.5). Since this relation was shown to
hold for all energy states of the mitochondria, e.g. uncoupled,
energised or electron transport inhibited states, the Δψ dependent
T/D gradient was concluded to be a function only of the electro-
phoretic ADP/ATP exchange. This ﬁnding again contrasts to the
seemingly evident picture that the T/D gradient across the membrane
with a high internal T/D drives the ATP export [62].
4.5. Oxidative phosphorylation and the free energy of cytosolic ATP
The T/D gradient produces a cytosol/matrix difference of the
phosphorylation potential of ATP Δi− eGATP, which adds to the matrix
ΔGmit.ATP to yield the cytosol potential ΔGATPcyt . The additional “transport
energy” can be calculated by 4 different methods [1,82]. The
calculation has to also include the Pi distribution which depends on
the transmembrane ΔpH since it is transported as “PiH+”. With
ΔpH≤0.5 under most conditions (Pi)i,/(Pi)e is close to 3, thus
inﬂuencing only little Δi− eGATP. With (T/D)e/(T/D)i=20 the difference
of free energies between extra and intramitochondrial space amounts
to Δi − eGATP=2.5 kcal [82]. This corresponds to a typical setting with
isolatedmitochondria in “state 4”. Other values are estimated from the
ATP to ADP ratio of the import and export rates to ΔGi − eATP=3.2 kcal,
from P/O stoichiometry 3.4 kcal, from Δψ and ΔpH 2.9 kcal. ΔGATPtransp.
can reach up to −4.2 kcalwithΔψ=180mV. Given an internal (T/D)i=0.1
and Pi=0.1 mM a matrix ΔGATPmit.=−10.4 kcal and ΔGATPcyt =−14.6 kcal are
calculated. In this extreme “static head” case up to 30% of the free
energy of cytosolic ATP comes from the uphill transport from the
mitochondria. Under most steady state conditions the transport share
will be at 20 to 25%.
The energy distribution can be numerated in terms of the H+
electrochemical energy “units” represented by the H+ pumped by the
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charge transferred by the ATP/ADP exchange, and 1 H+ co-transported
with Pi, (n+1) H+/ATP are required for the supply of cytosolic ATP.With
n=3, the energy needed for the transport amounts to 1/4 of the total
energy. A total of 10 H+/2 e− are assumed [101] to be pumped by the
respiratory chain through the 3 complexes in mammalian mitochon-
dria. With this value, n=3, and one H+ for transport a maximum of 2.5
ATP/2 e− could be accommodated in oxidative phosphorylation for the
ideal case of no leakage and uncoupling. In the reversed reaction, in
ATP hydrolysis of ATP added to mitochondria a ratio of H+/ATP=2 was
measured [102]. Compared to 3 H+/electron transport site, one H+/ATP
was concluded to be consumed by the ATP translocation, correspond-
ing to 1/3 of the total energy.
As predicted by the in vitro results with mitochondria and
reconstituted proteoliposomes, in vivo large phosphorylation poten-
tial differences between mitochondria and cytosol were found. The
most relevant data were obtained by a freeze lyophilisation and non-
aqueous fractionation procedure [103,104]. In perfused rat liver the
maximal difference of Δi −eΔGATP=2.5 kcal was determined. This
gradient was abolished by dinitrophenol to 0.1 kcal, and by CAT to 0.15
[104]. In perfused heart the ΔGATP are deduced from the creatine-P/
creatine ratio asΔi − eΔGATP=1.8 and 3.0 kcal [105]. A summary of these
and further data on the in vivo phosphorylation potential gradient is
given in [106]. These ﬁndings can be summed up in the important
conclusion that in eukaryotes oxidative phosphorylation has evolved
to generate less ATP for the sake of ATPwith a higher energy potential.
4.6. Regulation and rate limitation
For controlling the supply of ATP to the cytosol where a higher
phosphorylation potential reigns, the AAC has developed a simple
“auto-regulation” with a passive response to the factors reﬂecting the
ATP demand, such as the surrounding T/D ratios and the Δψ. Without
membrane potential the AAC can catalyse the 4 exchange combina-
tions of ADP and ATP, two homo-exchange modes T–T, D–D, and two
hetero-exchange modes T–D, D–T at nearly equal rates. Only the D–T
mode (ADP uptake−ATP release) is productive for the ATP delivery
whereas the T–D mode is counter-productive and the homo-modes
D–D and T–T are diverting exchange capacity. The distribution
between the modes should be trivially controlled by the D/T ratiosFig. 4. The H+ transport balance for the synthesis of cytosolic ATP. Out of (n+1) H+
pumped by electron transport, n H+ are used for synthesis of endogenous ATP and 1 H+
for the Δψ driven export of ATP. This H+ is returned by neutralising the Pi− import and
thus compensates the export of one negative charge in the ADP3−–ATP4− exchange. From
[81].on both sides of membranes. The membrane potential skews this
distribution in favour of the D–T mode and suppresses the T–D mode.
In the reconstituted system it was elegantly demonstrated [107] how
themembrane potential redistributes themodes such that at +180mV
the D–Texchange can use 60% of the total capacity under “normalised”
conditions, inwhich the T/D ratios are preset to be equal on both sides
(see Fig. 3). At “static head” the net ATP export will be down regulated
to approach zero when the T/D ratios across the membrane diverge so
much that the D–T mode becomes equal to the T–D mode. The AAC is
constantly exchanging nucleotides, but within its capacity the rate of
various exchangemodesmay strongly vary under the inﬂuences of the
T/D ratios and of Δψ.
The question of whether or towhat extent the ATP transport is rate
limiting in the supply of external ATP has been a contentious issue
[8,108–112]. One problem broadly discussed is how rate limitation by
the AAC is deﬁned in a sequence of reactive steps. Any inﬂuence on
one step will shift the sequence of reactions into a new steady state
and thus spread to other steps by changing the substrate concentra-
tion and electrochemical potential. However, the major issue of how
AAC responds to the varying energy demand is insufﬁciently
accounted for. As pointed out above, the redistribution among the
exchange modes provides an autonomous regulatory response to the
changing demands. The obvious “external” regulatory factor is the Δψ.
But in vivo changes of Δψ are normally conﬁned to a range of 130 to
180mV, and thus the preference of the De–Ti exchangemode is always
supported unless under extreme deranged conditions. Stronger
changes of the ATP export rate are caused by variations of T/D ratios
on both sides of the inner membrane. In particular the cytosolic ADP
level can vary several fold between rest and activity in muscles
[105,113] thus strongly inﬂuencing the exchange mode pattern. As a
result the AAC uses its gateway role for adjusting both the ATP supply
and the phosphorylation potential of ATP in accordance with the
requirements of the cytosol.
4.7. AAC and endosymbiosis
The increase of the free energy of cytosolic ATP by the AAC
exchange can be regarded as a vestige of the prokaryotic origin of
mitochondria. It may be assumed that in the precursor eukaryote cell
ATP operated at a high phosphorylation potential whereas in the
mitochondrial precursor prokaryotes a lowerΔGATP prevailed. The AAC
by virtue of its electrophoretic transport of ATP bridges the energy gap
and thus is a critical factor for the endosymbiosis. The thermodynamic
differences extend also to the redox state represented by the universal
NADH–NAD system. In mitochondria as in the ancestral prokaryotes
the NADH/NAD ratio is linearly related to the ATP/ADP ratio in the
oxidative phosphorylation system, whereas in the cytosol this ratio is
inversely correlated by the substrate level phosphorylation of
glycolysis [114–117]: (NADH/NAD)cyt × (ATP/ADP.P)cyt = const. The
redox potential in the mitochondria is about 100 mV more negative
than in the cytosol, possibly reﬂecting the origin of the mitochondrial
precursor from a more reducing environment. The coupling of the
phosphorylation potentials to the divergent redox potentials of the
NADH/NAD system may be the principal reason for the divergence of
the phosphorylation potentials. The AAC and the aspartate–glutamate
exchanger permit the symbiosis of the different thermodynamic
environments via their electrophoretic mode of transport.
5. Micro-compartmentation?
The ADP/ATP transport was characterised as an exchange of
exogenous with a pool of endogenous nucleotides. On the basis of
comparing the rates of ATP synthesis or of hydrolysis of endogenous
and exogenous nucleotides [20,42,61,62,118], this pool of ATP,
ADP and AMP was shown to be intermediary between transport
and intramitochondrial phosphate transfer reactions, such as ATP
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nate types of the organisation of the ADP/ATP exchange and ATP
synthesis were envisaged [92,87]. As reported by Vignais et al. [92],
addition of 14C-ADP to phosphorylating mitochondria immediately
released endogenous (unlabelled) ADP and ATP and, in agreement
with the pool function, newly synthesised 14C-ATP after a delay.
However, in the intramitochondrial pool, calculated as a difference
between total and exogenous AdN, no 14C-ADP, but only 14C-ATP
appeared without delay. In contrast in non-phosphorylating mito-
chondria added 14C-ADP appeared immediately inside but endogen-
ous ATP was released only as ADP. Both results were interpreted [92]
to show a direct cooperation of ATP synthase and AAC, such that
entering ADP is handed over directly to the ATP synthase and
released as ATP into the endogenous pool. Correspondingly, in non-
phosphorylating conditions endogenous ATP hydrolysed by ATP
synthase is directly exported. As a result a reversible association of
ATP synthase and AAC was postulated with the AAC moving across
the membrane. Kemp and Out reported [87] that on 14C-ADP
addition 14C-ATP is released without time delay bypassing the
endogenous pool. However, in the uncoupled state the added 14C-
ADP seemed to enter the pool. They concluded that entering ADP
passed through the ATP synthase and that, the newly formed ATP is
immediately released, and that the ATP synthase–AAC association is
dependent on the energisation of the membrane. The absence of a
time delay, at variance to Vignais et al. [92] and Klingenberg [83], can
be explained by the 5 times slower rate of 14C-ATP formation than
exchange rate in these experiments which will obscure a time delay.
Probably a not instantaneous quenching of the supernatant lowered
the ATP level. Delayed quenching of the mitochondria may also
explain the failure of Vignais et al. [92] to observe the crucial uptake
of exogenous ADP.
Kinetic experiments using a sophisticated automated rapidmixing,
sampling, separating and quenching apparatus, in which after rapid
pressure ﬁltration both the supernatant and the mitochondria are
immediately quenched, did not conﬁrm [83] those results arguing for
a functional AAC–ATP synthase association. By double labelling in
mitochondria a rapid entry of exogenous 3H-ADP and exit of
endogenous 14C-ATP is measured (Fig. 2). In the external medium
endogenous 14C-ATP appears immediately and exogenous 3H-ATP
after a delay. The steady state rate of 3H-ATP formation is only 1.6 time
slower than the total exchange rate. Similarly, in uncoupled
mitochondria on addition of 3H-ATP, endogenous 14C-ADP exits
immediately and after a delay 3H-ADP is released, again demonstrat-
ing that the endogenous pool is on the main pathway between AAC
and ATPase. These results conﬁrm the previous experiment based
conclusions of a central role of the endogenous pool. They also point
out the importance of fast quenching after separation of mitochondria
[42] to avoid the reported artefacts.
The association of a 29–30 kDa protein with ATP synthase
preparations has been reported [119], but later found to be absent in
better deﬁned detergent solubilised oligomycin sensitive ATPase
preparations [120], conﬁrming in hindsight the suspicion that the
large abundance of AAC amounting to about 2.5 AAC/cytochrome
oxidase based on CAT binding [2], may easily have caused this
contamination. Recently a complex comprising ATP synthase, AAC and
Pi carrier, was described [121,122] as an electron microscopic particle
identiﬁed by antibody staining. Citing the above mentioned, but not
conﬁrmed, kinetic evidence of an association between AAC and ATP-
synthase, a “synthasome” was envisaged to foster the direct
collaboration of the three entities in transport and synthesis of ATP.
Not only the operational evidence but also stoichiometry problems,
such as themolar ratio of AAC/Pi carrier ~4 estimated inmitochondria,
argue against the existence of this entity. At this point one may cite an
evolutionary argument for the independence of AAC from ATP
synthase: in the predecessor bacteria the ATP synthase operated
only with the endogenous AdN pool. Only after the endosymbiotictransition to mitochondria, AAC arose, most probably as independent
entity.
Different from the situation at the matrix side, there is some
evidence for a limited direct cooperation of the AAC in the intra-
membrane space with phosphate transferring enzymes such as with
the mitochondrial creatine kinase (CrK). First proposed on the basis
of a mitochondrial CrK isoform [123], the “creatine phosphate
shuttle” [124] was elaborated and established [125,126] by postulat-
ing a preferred transfer of exported ATP to CrK followed by the
diffusion of creatine phosphate (CrP) to the cytosol. Hereby a
cooperation of the intramembrane CrK with the AAC is implicated
[127,128]. However due to the excess of AAC over CrK only a small
portion of AAC can be physically coupled to octameric CrK. A complex
between AAC, CrK and VDAC (porin) at the contact sites between
inner and outer membrane has been envisaged [129]. Whereas the
CrP-shuttle should be conﬁned to muscle and neuronal cells, in other
cells such as liver the intermembrane adenylate kinase may play a
similar role. In the CrP shuttle the diffusion of a smaller sized CrP
poses an advantage over ATP. This is further underlined by the
ﬁnding that the passage of ADP and ATP through VDAC may be a rate
limiting and regulated step [130]. All these considerations of
functional micro-compartmentation must be viewed on the back-
ground of the physical organisation of the intermembranes space
and the inner membrane into two sections, the inner cristae
membrane surrounding the cristae space and the inner boundary
intermembrane space and inner boundary membrane facing the
outer membrane. The exit from the cristae space into the surround-
ing transmembrane space is provided by small tubular structures
[131,132] whereas the AAC and the respiratory complexes must be
located in the cristae membrane, and the location of the phosphate
transferases is not clear.
6. Inhibitors of transport
Nature has provided the AAC with exceptionally speciﬁc and
effective inhibitors furnishing unique tools for elucidating the
transport mechanism. These natural inhibitors fall into two groups:
those containing atractylogenine and its homologues and bongkrekic
acid (BKA) with the isoform iso-BKA. Both these inhibitor groups are
highly speciﬁc for the AAC and up to date no other transport system
including various other nucleotide transporters have been found to
respond to them [15]. Besides differentiating AAC linked transport,
these inhibitors were also crucially important for isolating the AAC. No
other transporter is known to be endowed by nature with such
selective and high afﬁnity inhibitors which also excel by an
extraordinary opposite membrane side speciﬁcity.
6.1. Atractyloside-group
Atractyloside (ATR) was found to be the toxic principle of the
thistle Atractylis gummifera from the Mediterranean region (see
monography [133]). The inhibitory effect of ATR on oxidative
phosphorylation was early recognised [27,28]. However, its speciﬁc
role of inhibiting the ATP export from mitochondria could only be
identiﬁed after the existence of the ADP/ATP exchange was
established [25]. Erroneously the notion is propagated in the
literature, e.g. [9], that the discovery of the ADP/ATP transport is
due to the inhibition by atractyloside. Bruni [32] found that ATR
inhibits (32P)-ATP “binding” to mitochondria and made the logical
conclusion that ATR binds to the ADP binding site of the ATP
synthase. However, as ﬁrst reported at the IUB congress in 1964, ATR
was shown to inhibit the ADP/ATP transport already previously
established [25]. Similar conclusion were inferred subsequently by
Chappell and Crofts [22] and Kemp and Slater [30] Thus the inhibition
target of ATR was shown to be the transport rather than the ATP
synthesis per se.
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[134], also called gummiferin [135,136], proved to be a very useful
tool for characterising the underlying transporter because of its very
high binding afﬁnity. CAT4− with two glycosidic sulphate groups and
two carboxyls in the aglycone provides one more charge than ATR3−
for binding which may explain the higher binding afﬁnity. However,
the stereo-isomer epi-ATR3− generated by decarboxylation of CAT
and thus carrying only 3 anionic groups [137], has nearly as high
binding afﬁnity as CAT (KD=1×10−9 M for CAT, 1.8×10−9 M for epi-
ATR) [138]. In epi-ATR the carboxyl group is in equatorial [139] and in
ATR in axial position in the kaurine moiety, indicating that the
stereochemistry of the charge groups is equally important as their
number. Elimination of –SO4− group from ATR abolishes binding [140].
The minimum of 3 negative charges is reminiscent of ADP3− and the
exclusion of AMP2− from transport, supporting the notion that ATR
binds to the same site as ADP and ATP. However other atractylogenine
containing glucosides such as wedeloside [141,142] and “coffee-ATR”
[143,144] which carry no sulphate groups, but instead hydrophobic
side chains at the glucose, are also high afﬁnity inhibitors of the ADP/
ATP exchange, indicating a greater complexity of the inhibitor
binding site where hydrophobic interactions can compensate for
the lack of ion bonds.
The inhibition of transport by ATR is quasi competitive with ADP or
ATP [2,140]. For example, a 10 fold increase of the ADP concentration
increases the apparent KI of ATR only 2 fold. A slow dissociation rate of
the ﬁrst bound ATR may prevent equilibrium with ADP added for the
exchange. Fully uncompetitive is the inhibition by CAT, in line with a
high binding afﬁnity (see below) and with epi-ATR [137]. Present both
in epi-ATR and CAT, the equatorial carboxyl seems to bemore effective
for binding [138], perhaps due to greater proximity to the sulfate
groups.
6.2. Bongkrekic acid
A different, very effective transport inhibitor, bongkrekic acid
(BKA), comes from a bacterial source, Pseudomonas cocovenenans
[145–147]. Together with its less effective isomer, iso-BKA, the tri-
carboxylic acid has a complex poly-isoprenoid structure [147]. In iso-
BKA one isoprenoid segment carrying a CO2− group is in trans- instead
of cis-position. It is generated by alkaline treatment of BKA [148] or by
intermediate methyl-ester formation [149,150]. The only common
structural denominator of BKA with ATP and also ADP seems to be
displaying three negative charges. With the hydrophobic backbone
BKA contrasts to themore hydrophilic structure of the ATR group with
their carbohydrate moiety.
In the ﬁrst direct demonstration of BKA as a transport inhibitor
[151] complete inhibition was reached at 0.2 to 0.3 nMol/mg prot. in
liver mitochondria, at the same level as with ATR. The KIb0.2×10−8 M
was lower as for ATR. Whereas the inhibition by BKA is quasi non-
competitive with ADP, inhibition of transport by iso-BKA is
competitive, with a 2 to 4 times higher KI than BKA [148]. Different
from ATR the inhibition by BKA required preincubation at higher
temperature (20°) because of a time delay of the inhibition onset
[151]. A strong pH dependency of BKA inhibition of respiration was
noted [152] and quantitatively investigated [68,153] in conjunction
with other BKA effects such as ADP binding and the contraction of
mitochondria. These and other data reﬂecting the interaction of BKA
with the AAC could be explained [153] by assuming that BKA, before
reaching the AAC, has to diffuse through the inner membrane. Since
the electro-neutral form BKAH3 should by easily permeating, it is
mainly the concentration of BKAH3 which is rate limiting the onset of
inhibition. As a result, in mitochondria, the interaction rate of BKA
with the AAC increases nearly 100 fold from pH 7 to 6.3 [68]. In
accordance in SMP, which aremostly inside-out, nearly no time delay
is observed [78]. Based on this and other types of evidence, it was
concluded that the anion BKA3− is the inhibitory form.6.3. Acyl-CoA
Acyl-CoA, in particular the long chain palmityl- and oleyl-CoA,
were found [154,155] to inhibit the ADP/ATP transport in mitochon-
dria from rat liver and from rat heart with remarkable efﬁciency. The
inhibition could be reversed by ADP [156] or by carnitine addition
[154]. This ﬁnding also explained [155] the early observation [157]
that oleate partially inhibits the ADP–ATP transport in mitochondria
since oleate is converted to oleyl-CoA in the matrix. When CoA is
recruited into succinyl- or acetyl-CoA by addition of ketoglutarate or
pyruvate, oleate is unable to inhibit ADP translocation. As amphipathic
molecules the long chain acyl-CoA absorb at the membrane so that
concentrations are not meaningful and the reported KI of 0.2 μM [158]
and 1 μM [159] are conditional values. Acyl-CoA effects are
competitive with ADP and ATR as shown by binding studies on
mitochondria [160,161] indicating that acyl-CoA bind close to the
carrier binding center. In condensed phase transitions of mitochondria
(see below) palmityl-CoA has the same effect as ATR, emphasising the
similarity to ATR interaction with AAC. However, different from ATR,
acyl-CoA inhibit ADP uptake into SMP [73,78,160] showing that they
also interact from them-side.They do not competewith BKA, probably
because of lower binding afﬁnity. The lack of side speciﬁcity may also
suggest that binding of acyl-CoA to AAC must be weaker than of ATR
and BKA.
Long chain acyl-CoA also inhibits other mitochondrial carriers and
several mitochondrial enzymes, suggesting at least partially an
unspeciﬁc amphipathic effect. An inhibitory role of acyl-CoA on
ADP–ATP transport in starved liver was suggested [162]. However loss
of endogenous nucleotides may have been the main cause of the
observed effects. More conclusive were studies on cardiac ischemia
showing that endogenous nucleotide loss rather than acyl-CoA were
responsible for the impeded ADP/ATP transport [163,164]. For this
reason and the dilemma that the high acyl-CoA levels should inhibit
the AAC during active fatty acid oxidation and ATP generation [8,165],
a physiological regulation by acyl-CoA of the ADP/ATP transport has to
be questioned.
7. The ADP/ATP carrier as a molecular target
7.1. ADP and ATP binding and the inﬂuence of atractyloside
Studies of the underlying carrier AAC of the ADP–ATP exchange can
be divided into two parts: (a) the carrier in the native membrane of
mitochondria, and (b) the isolated carrier in detergent solution, in
reconstituted vesicles and in crystals. Before the AAC protein was
identiﬁed, it was an obvious goal to determine the number and
properties of carrier sites in mitochondria. Bovine heart mitochondria
(BHM) were the favourite target, since they were available in large
amounts and could be expected to have a higher content of carrier
sites than liver mitochondria in analogy to the higher content of
respiratory chain components.
Carrier binding siteswere ﬁrst probedwith their natural substrates
ADP and ATP [166]. For this purpose BHM were depleted of
endogenous ADP and ATP by freeze-thawing and washing with
0.1 M phosphate. In some experiments arsenate was employed to
convert endogenous ADP and ATP into AMP. Speciﬁc carrier related
nucleotide binding was deﬁned as the difference of binding in the
presence of ATR added either before (ATR sensitive portion) or after
the (ATR removable portion) labelled nucleotide. This extensive work
proved to be a gold mine, not only for the ﬁrst determination of the
AAC sites in mitochondria but also unexpectedly providing a ﬁrst
insight into the ﬂexibility of a carrier site concomitant with the
translocation mechanism. The conditions and controls had to be
carefully elaborated to avoid pitfalls as in some parallel work [167]
when using ATR for differentiating and detecting the AAC sites on the
background of other binding sites and the matrix pool. EDTA was
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Mg++ dependent binding sites, whereas Mg++ addition had the
opposite effect. This showed, as to be expected from the transport
studies, that ADP and ATP bind to the carrier sites without Mg++, in
contrast to the universal Mg++ requirement of ATP utilising enzymes.
The concentration dependence of the ATR removable ADP and ATP
binding yielded non-linear relations both with ADP and ATP, which
could be well resolved in terms of two types of binding sites, high
afﬁnity sites with KD=0.1 to 0.5 µM, amounting to 20 to 30%, and low
afﬁnity sites with KD=5 to 12 µM for the rest [166]. Two or more
afﬁnities are not unusual for ligand binding to membrane bound
receptors, and were commonly interpreted as high and low afﬁnity
sites, but the results with membrane bound “mobile” binding sites
called for a more incisive explanation. The high afﬁnity sites were
interpreted to be not in an open equilibration with the added labelled
14C-ADP or 14C-ATP but represent carrier sites which on loading with
external 14C-ADP and 14C-ATP ﬂip into the inner side where the radio-
labelled 14C-ADP or 14C-ATP are mixed with residual endogenous
nucleotides. This “attraction” and “trapping” of 14C-ADP or 14C-ATP
occur at low external concentrations thus mimicking high afﬁnity. The
larger portion of low afﬁnity sites comprise those directed outside
which are in direct binding equilibrium with the external 14C-ADP or
14C-ATP thus exhibiting the “true” afﬁnity. According to this view, the
non-linear binding reﬂects a mobilisation of carrier sites by substrates
to be reoriented to the inner side. With this interpretation [166] the
results visualise for the ﬁrst time the reorientation of carrier binding
sites between the inner and outer site.
Membranes prepared by sonication of mitochondria had low ATR
sensitive binding. This loss of ATR effect was explained by assuming
that ATR binds only from the “c-side” and these vesicles consist largely
of inside-out membrane. In other reports of measuring nucleotide
binding, rat livermitochondria treatedwith the detergent Lubrol were
used [59]. The high values of ADP binding (N1 μM/g prot.) suppressed
by prior ATR addition were reinterpreted [166] to reﬂect in part ADP
uptake rather than binding to carrier sites since the “bound” 14C-ADP
could not be removed by subsequent ATR addition or by “cold” ADP.
7.2. Inﬂuence of BKA on ADP/ATP binding
With the advent of BKA a new dimension in determining ADP
binding to mitochondria emerged. Under the inﬂuence of BKA the
binding patterns were unusually complex but ﬁnally revealed an
underlying simple mechanism of carrier site ﬂexibility, therebyFig. 5. The single site reorientation mechanism and the dual site allosteric mechanism o
atractyloside (ATR) and bongkrekic acid (BKA). AAC (C) in two states (c- and m-state) with d
loaded with ADP or ATP. BKA can diffuse inside and binds only from the m-side. ATR binds o
the AAC. By “allosteric” interactions with the ADP binding site BKA increases binding afﬁnitproviding a more penetrating insight into the “single site reorienting
carrier mechanism” [2]. However, results with BKA were persistently
used as arguments against this mechanism, claiming to show a
separate binding site for BKA [168,169]. As an inhibitor of transport
BKA was expected to remove ADP from the AAC, similar as ATR [166]
but, surprisingly, was found to increase the binding of ATP [170]. These
effects were studied with the same type of depleted bovine heart
mitochondria preparation used for the ADP binding under the
inﬂuence of ATR [153,171].
Themost pertinent results are as follows: (a) Apart from increasing
the binding of ADP, BKA enhances the apparent afﬁnity for ADP [170].
As a result, under the inﬂuence of BKA, the biphasic mass action plots
of ADP binding with an average of KD=2.7 µM were converted into a
mono-phasic plot with single high afﬁnity KD=0.2 μM [171]. (b) More
ADPwas boundwhen BKAwas added after than before ADP. In double
labelling experiments, internal nucleotides labelled with 3H, more 3H-
nucleotides remained bound when BKA was added before 14C-ADP
thanwhen added after 14C-ADP. (c) The BKA induced binding increase
of ADP is strikingly slow, indicating an intervening step. Pre-
incubation with BKA only partially eliminates the slow time course
of ADP binding, indicating that transition to the high afﬁnity state
requires synergism of BKAwith ADP. (d) The rate and the level of BKA
induced ADP binding was strongly pH and temperature dependent.
The pH dependency indicated that the penetration of BKA through the
inner membrane becomes rate limiting due to the low concentration
of themembrane penetrating BKAH3 that is formed in the dissociation
equilibrium BKAH3=BKA3−+3H+ at an average pK=4.5. Thus the
presence of BKA on the matrix side appears to be a pre-requisite for
the ADP binding increase. (e) The BKA induced binding enhancement
of ADP and ATP has strong temperature dependence, reminiscent of
ADP transport, indicating that the translocation is involved in the
binding increase. (f) CAT prevents, ATR only retards the BKA effect. On
the other hand, once BKA has induced binding of ADP, it becomes
resistant, even to the subsequent addition of the high afﬁnity ligand
CAT rendering the binding quasi irreversible.
These and other scrutinising experiments designed to elucidate the
nature of the BKA effect were initially interpreted according to two
different models of BKA interactions (Fig. 5) (a) BKA binds to the same
site as ADP and thus displaces ADP forming a binary complex with
AAC [153,171], and (b) BKA binds to an allosteric site separate from
ADP, forming a ternary complex with AAC, thereby increasing ADP
binding afﬁnity [170]. In the twomodels the state of the tightly bound
ADP is radically different: it is either ﬁxed to the AAC by BKA or freef inhibitor binding to the AAC. A. Single binding site for ADP, ATP and the inhibitors
ifferent afﬁnities for inhibitors. Transition between the two states is possible only when
nly from c-side. B. Dual site mechanism. ADP and the inhibitors bind to different sites of
y and ATR decreases afﬁnity. BKA may bind preferentially from the m-side. From [2].
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allosteric version, to comply with the binding results, in principle BKA
can bind both from out or inside, in the competitive version BKA must
bind exclusively from the inside. As shown above, the results strongly
suggested that BKA acts exclusively from the inside. In the allosteric
model a ternary complex BKA–ADP–AACi is formed with the inside
oriented binding nucleotide site, whereas in the competitive model
BKA occupies the inside oriented ADP binding site, leading to the
following reaction sequence: binding sites are mostly in the external
“c-state”. On receiving added 14C-ADP the sites are “mobilised” and
reorient to the internal “m-state”where BKA, due to its higher afﬁnity,
displaces 14C-ADP into the matrix. Here 14C-ADP is inaccessible to
external ATR, CAT and “cold” ADP because the AAC is trapped by BKA.
The apparent BKA induced binding increase corresponds to the
number of AAC sites transported from the c- to the m-side. The term
“reorienting site mechanism” has been used synonymously with
“single binding center gated pore mechanism” (SBCGP).
As mentioned above, the “single site reorienting mechanism” as an
explanation of the BKA effect was repeatedly criticised [8] based on
several results, for example that much less ADP is bound under
inﬂuence of BKA than to be expected from the reorientation of the
binding sites. This is true only for high concentrations of ADP (50 μM)
which drives most sites inside so that none or few sites are left to be
pulled subsequently by BKA inside. At low ADP (2 μM) nearly all sites
can reorient only with BKA [153]. Other objections will be discussed
below.
Since the state of ADP ﬁxed by BKA is critical for differentiating
between the two models, experiments were designed to elucidate
whether the ADP “bound” by BKA is inert or reacts with intrami-
tochondrial enzymes [172]. 14C-ADP added to mitochondria converted
into a similarly composedmixture of ATP, ADP and AMP as the residual
endogenous nucleotide prior to 14C-ADP addition and this composi-
tion was nearly the same with and without “binding” by BKA. Further
in the presence of BKA the ”bound” 14C-nucleotides reacted freely as
monitored by adding 32P-phosphate under different phosphorylation
conditions, induced by oligomycin or uncouplers. All these results
prove that the added ADP or ATP ﬁxed by BKA in the mitochondria is
in a state similar as the endogenous nucleotide pool, contrary to what
is to be expected for ADP ﬁxed in a ternary BKA–ADP–AAC complex.
7.3. Binding of ATR and CAT
Radio-labelled ATR and CAT were used to identify and characterise
AAC binding sites. By growing seedlings of A. gummifera on 35S-sulfate,
35S-ATR, 35S-CAT, and a third compound identiﬁed as epi-35S-ATR
were extracted from these plants [173,174,137,175]. Higher speciﬁc
activities were later obtained by chemically introducing 3H into ATR
[176] and into CAT (Klingenberg unpublished) [177] or by substituting
14C-acetyl into CAT [178].
In initial binding studies with 35S-ATR on rat liver mitochondria
maximum binding was measured to 0.10 [179] and 0.16 nMol/mg prot
[174]. Higher 35S-ATR binding (1.1 nMol/mg prot.) is observed in
depleted BHM [174]. The KD is increased by ADP from 1.65 to 4.0×10−7
M−1. In sonic particles [180] ATR binding is strongly increased when
added before sonication. Relating the ATR binding to the content of
cytochrome oxidase gives a molar ratio of 2.4, illustrating the high
content of the underlying AAC.
A non-linear concentration dependence of 35S-ATR binding was
observed [179,180] which was converted to linearity by ADP addition.
In depleted mitochondria an inversed non-linearity is seen which
again is rectiﬁed by ADP resulting in decreased afﬁnity for ATR. In
inner membrane preparations [179] ADP lowered afﬁnity more
strongly but increased maximum binding of ATR, whereas in
mitochondria no increase of maximum binding and a smaller afﬁnity
decrease was observed. Vignais et al. [179] interpreted the ADP effects
on ATR binding to show separate, allosterically connected sites for ATRand ADP, Klingenberg et al. [180] maintained that the same site is
competitively shared by ATR and ADP, provided it is in the c-state.
Sites in the m-state can bind ATR only after they have been reoriented
to c-side by ﬁrst binding ADP. In double labelling experiments the
displacement of 3H-ADP by 35S-ATR binding was titrated in depleted
BHM [174] at different given ADP concentrations. The titration with
ATR reaches a ratio of ΔADP/ΔATR of nearly 1, when binding sites are
saturated with 20 μM ADP.
Subsequently, the high afﬁnity 35S-CATwas introduced. In a titration
of rat liver mitochondria a linear correlation between inhibition of
transport and binding was demonstrated [175,181]. At the saturation
point of 35S-CAT binding the inhibition is complete, showing that all CAT
binding sites in mitochondria are identical with the transporter sites.
Identical maximum binding for ATR and CAT was determined in
mitochondria from bovine heart (1.2 to 2.0 µMol/g protein) and from rat
liver (0.3 µM). The concentration dependence of CAT binding showed
complicated convex mass action relations simulating a cooperativity
[175,178,182]. Vignais et al. interpreted the non-linear dissociation plots
as a cooperation of CAT binding sites. However, our observations
indicated that the non-linear relation is due to an incomplete
equilibration artefact caused by very slow residual binding under
conditions of extreme bound/free ratios caused by a very low KD.
Therefore, only a rough evaluation of KD was possible for CAT (b2 nM
[175] or 5 to 10 nM [182]). The dissociation rates of 35S-ATR and 35S-CAT,
induced by excess unlabelled CAT, furnished another indication of the
widely different KD [175]. A more than 100 times lower rate for CAT
dissociationwasmeasured that can be translated into anup to 100 times
higher binding afﬁnity of CAT. Related to the electron transport system,
there are 2.2 to 3 CATsites/Cyt aa3 in heart and 0.6 to 1.5 in rat liver. Thus
the ratio of AAC binding sites to the respiratory chain varies among
different cells, in line with a higher proportion of ATP used in liver
mitochondria than in heart mitochondria which are geared for a nearly
exclusive ATP supply to the myoﬁbrils.
7.4. Binding of bongkrekate
For binding studies BKA was 3H labelled at an allylic position
between two carboxylic groups by 3H+ exchange in alkaline 3H-H2O
yielding 3H-BKA at high speciﬁc activity [149,168]. As a by-product 3H-
iso-BKA was obtained in nearly equal amounts to 3H-BKA [148,149].
Identiﬁcation of BKA binding to the AAC is complicated by the uptake
of BKA into themembranes andmatrix ofmitochondria. Inwork on rat
heart mitochondria saturable high afﬁnity sites (~1/µMol/g prot)
could be segregated from non-saturating BKA binding [168]. The latter
part could be largely eliminated by a pre-treatment of the mitochon-
dria with Mg++ and phosphate. In another work with intact BHM, a
linear non-saturation increase afﬁnity binding of 3H-BKA binding
without a high afﬁnity portion site was measured. Only after
sonication or after freeze-thawing of the BHM or by permeabilisation
with Lubrol WX a saturable high afﬁnity binding was unmasked.
These results show that non-saturating binding corresponds to
internalised BKA which is released on breakage of mitochondria. The
variant results with rat heart mitochondria can be explained by
assuming that the heart mitochondria were partially broken. This is
further supported by using CAT as a tool for discriminating the AAC
speciﬁc 3H-BKA binding. In mitochondria from rat heart CAT
suppressed high afﬁnity binding of 3H-BKA whereas it had no effect
on BHM [150]. Only after damaging the BHM by freeze-thawing or
sonication, 3H-BKA binding became CAT sensitive. In all these cases
3H-BKA binding is strongly increased by addition of ADP, in line with
the synergism between BKA and ADP binding. Double labelling
experiments using 3H-BKA and 14C-ADP showed directly that 3H-BKA
and 14CADP binding are inter-dependent [150]. The synergism
between 14C-ADP and 3H-BKA uptake is more pronounced, when by
prior addition of ATR, 14C-ADP is removed from binding sites. The CAT
sensitive portion of 3H-BKA binding to fragmented BHM was
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has a binding afﬁnity between those of CAT and ATR. IsoBKA exhibits
similar binding characteristics as BKA, however, the afﬁnity of iso-BKA
is about 10 times lower as judged from competitive binding
measurements [150].
These binding results of the inhibitors of the AAC can be
accommodated with the SBCGPmechanism by assuming that in intact
BHM nearly all AAC are in the c-state driven by the endogenous ADP
and ATP and thus in a non-binding state for BKA. By added nucleotides
these carrier sites can switch to them-state where they are trapped by
BKA binding. If CAT is added, the AAC remains in the c-state also after
breakage of mitochondria. This explanation is at variance to the model
proposed by Lauquin and Vignais [168] who postulated that BKA acts
on ADP or ATR froman allosteric site, different from the nucleotide and
from the CAT binding site.
7.5. Interactions between BKA, iso-BKA and CAT, ATR
BKA was early shown to remove 35S-ATR bound to depleted BHM
[180]. This removal was found to require catalytic amounts of ADP
with a surprisingly low KM of only 1.2 μM ADP. This can be explained
according to the single reorienting binding site, where BKA removes
ATR from its binding site only by intervention of ADP which ﬁrst
displaces ATR allowing the site to reorient into the m-state where it is
trapped by BKA. Titrations showed that the removal of ATR by BKA is
uncompetitive. In contrast 35S-CAT binding to depleted BHM was
resistant to BKA [175]. When BKA was added ﬁrst without ADP, 35S-
CAT binding was partially and with ADP nearly total prevented.
Applying 14C-acetyl-CAT and 3H-BKA [178] to rat heat mitochondria,
14C-acetyl-CAT was not removed by BKA although 3H-BKAwas bound.
When ﬁrst added, twice asmuch 3H-BKAwas bound and subsequently
a third 14C-acetyl-CAT was bound without lowering 3H-BKA binding.
These results were interpreted [178] to show that BKA and CAT bind to
different sites. However the interpretation ignores the unspeciﬁc
uptake of BKA into mitochondria [150, 168]. In the depleted BHM
preparation a clear prevention of 3H-BKA binding by 35S-CAT binding
was shown [150]. BKA could remove 35S-ATR but not 35S-CAT [150].
Importantly, both the removal and prevention are strongly dependent
on the presence of ADP. BKA alone prevents only about half and with
ADP more than 90% of 35S-ATR or 35S-CAT binding. In titrations the
activation constant for ADP was about 1 μM. In titrations with 3H-BKA
[150] the replacement of 35S-ATR, amounted to approximately ΔATR/
ΔBKA=−1, providing evidence for an equal number of BKA and ATR
binding sites. Using 3H-iso-BKA the reversed reaction i.e. displace-
ment by 35S-CAT could be demonstrated [150] with a ratio of Δiso-
BKA/ΔCAT=0.7. Probably, some of the displaced iso-BKA was redis-
tributed into the membrane. In both cases the complete replacements
are dependent on ADP. Based on these results the hierarchy of binding
afﬁnity is CATNBKANATRN iso-BKA.
The two crucial results, the mutual displacements and replace-
ments of the inhibitors and the dependence on ADP agree with
postulates of the SBCGP, thus supporting this mechanism. Deviations
from 1:1 stoichiometry can be explained by unspeciﬁc binding of BKA
and of ADP to leaky membranes through which ADP can be recycled.
The results do not support an allosteric ﬁxation of ADP by BKA
[8,168,178]. Further the data are not consistent with the contention
[8,168,178] that BKA and ATR (CAT) bind to different sites. In this
respect the ﬁnding that BKA binds to the AAC only from the m-side
[153] is in agreement with the reported interactions between BKA,
ATR and CAT.
7.6. Binding to the isolated and reconstituted AAC
The isolated and reconstituted AAC provided a platform for
studying ligand binding independently from interferences in mito-
chondria. In the initially isolated CAT–AAC complex the bound 35S-CATcould be slowly replaced by unlabelled CAT [183], indicating that
binding is less tight than in mitochondria. ATR replaced only 30% and
excess BKA required ADP for replacing CAT to 70%. In the isolated 3H-
BKA–AAC complex CAT was able to displace 3H-BKA only when ADP
was added [184]. The speciﬁcity for this catalytic nucleotide effect
agreed with the high speciﬁcity observed for the transport. The
isologous replacement of 3H-BKA by BKA did not require ADP. In the
unliganded carrier isolatedwith LAPAO the amount and afﬁnity of CAT
binding (KD=0.31 µM) and of BKA binding (1.5 µM) was much lower
[185,186]. Binding afﬁnity of ADP and ATP is so low to the soluble AAC
(estimated KDN0.1 mM) that it cannot be measured even at high
protein concentration. More binding results to the isolated AAC using
ﬂuorescent derivatives are reviewed in Chapter 9.2.
On incorporation of AAC into vesicles the amount and the afﬁnity
of 3H-CAT and 3H-BKA binding are dramatically enhanced (KD=13 nM
for CAT, 100 nM for BKA) nearly to the level in mitochondria [186]. In
this system the dependence of the inhibitors binding on ADP or ATP
and their mutual displacements could be most convincingly demon-
strated. Nearly no BKA and little CAT bind unless ADP is added.
Isologous replacements of the inhibitors were complete but hetero-
logous replacements required ADP and reached about 70%. Intricate
combinations of ligands showed that in the reconstituted AAC binding
of BKA and CAT are exclusive and provide no evidence for a ternary
BKA–ADP–AAC complex [186]. CAT and BKA binding indicate the
directionality of incorporated AAC, by showing a variable outside
location of the c- or m-state as to whether ADP is included in the
vesicle formation. Since CAT is not permeating, it can only reach the
AAC portionwith the c-side outside, whereas BKA can bind to bothm-
side populations. More inner sites resist CAT binding on prior BKA
addition, indicating less c-side outside. In both cases maximum
binding requires ADP for the conversion to the c- or m-state. The
interconversion rates are biphasic, the slow portion possibly reﬂecting
imperfect incorporation into unilamellar vesicles, as shown by the
reconstitution. All these results thus support the SBCGP model also in
the reconstituted system [186].
7.7. Non transportable nucleotide derivatives and analogues
Nucleotide analogues may be bound to the carrier sites, without
being transported. But a clear differentiation of binding from a slow
uptake has rarely been made. These compounds may inhibit transport
of ADP or ATP depending on their binding strength. Binding versus
transport activity data can be rationalised within the “ITF”mechanism
[187] reviewed below. The apparent binding strength is the difference
of the intrinsic binding energy and the conformational change energy
in the AAC. If the ligand structure does not permit transport, i.e. is not
tolerated in the transition state, the intrinsic binding energy will
prevail. At variance, with transported substrates such as ADP and ATP
the high intrinsic binding energy is largely consumed by the induction
of the transition state, resulting in low apparent binding strength.
Thus the moderate binding strength of most analogues indicate a
moderate ﬁt to the ground state and a poor or no ﬁt to the transition
state due to disturbance by the substituted groups or conﬁguration
restraint.
In the ﬁrst binding study of analogues based on the displacement
of 14C-ADP [166], binding and exchange were not distinguished.
Derivatives with varied phosphate position or ribose substitution
(ADP-3′P, ADP-ribose) were found to be inactive. ATP-5′-P (“tetra-
ATP”), AMPPCP were also active as a transported substrate. Among
nucleotides with other bases only GDP and ITP were weak binding
competitors. Among the series of derivatives synthesised by the group
of Schlimme and Schafer [188], 1-N-oxides of ADP and ATP were weak
competitors. 8′Br-ATP was the ﬁrst example of an analogue with a
higher binding afﬁnity but no transport activity [189]. Oxidative
cleavage of the ribose ring of ADP and ATP [190] produced weak
inhibitors with KI =10−4 M, but the reported data do not allow to
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inhibit [191]. Dinitro- and trinitrophenol substituted ATP were not
transported [192] but are effective inhibitors [193] of transport with KI
of 2 and 1 μM. 3′O-dimethylamino-naphthoyl-(DAN-) esters of AMP
and ADP bind to AAC in mitochondria but much stronger to SMP
[194,195] with KI of 12 and 8 μM, exhibiting a large ﬂuorescence signal
on binding only to SMP (see Chapter 9.2). The DAN-derivatives are
minimally transported in mitochondria. 3-O′-naphthoyl-ADP and
-ATP (N-ADP, N-ATP) are also good inhibitors binding both from the
c- and m-side and appear not to be transported [196]. Caged
(nitrophenyl-ethyl) ADP or ATP are good ligands to the AAC
[93,96] as shown by the in situ hydrolysis, different from their
binding to ATPases [197]. 1H-NMR measurements show that caged
ATP binds stronger than ATP [198]. In conclusion, the large
substituent size seems to be the reason that most of these derivatives
are non-transportable.
Another factor inﬂuencing binding is the intramolecular mobility
of the nucleotide [8,199]. Anti- and syn-conﬁguration at the glycosidic
bond appear to be relevant for transport and binding. Substitution
with Br or azido at the 8-position of ADP or ATP [189,200] favour the
syn-conformers which are poorly bound and not transported [199].
However, ADP and ATP being preferentially anti-conformers may bind
in this conformation. The anti-conﬁguration can be stabilised in 2-
azido-ADP or -ATP that are good inhibitors of transport (KI =8 µM)
[201] and claimed to be not transported although the evidence is not
entirely convincing. At any rate, the results indicated that ﬂexibility
between anti- and syn-conformers is necessary for transport. Covalent
ﬁxation in the anti-conformation by bridging 2-C with 4-C′ still
allowed binding but was stated to block transport [199].
Interestingly, ATP analogous were generated in vivo from drugs of
the biphosphonate group by converting the phosphate moiety of ATP
to β,γ dichloro-methylene tri-phosphate [202] or by substituting
isopentenyl to the γ-phosphate [203]. These reactions were catalysed
by aminoacyl tRNA synthetase. Both compounds are inhibitors of ADP/
ATP exchange and thus were suggested to enact apoptotic cell death.
Employing 1H-NMR, nucleotide binding to BHM incubated in D2O
was studied [198]. The binding constants were derived from
relaxation times which give the off rates. With the non-hydrolysable
AMPPCP a rapid binding equilibration was demonstrated with an off
ratemore than 1000 times higher than the transport rate. According to
transient nuclear Overhauser effect measurements (TRNOR), the
nucleotide could be shown to adopt the anti-conformation on binding,
in agreement with conclusions from 2-azido-ADP binding [201].
1H-NMR line broadening showed that AMP also binds to the AAC
from the c-side although it is not transported. By comparison with
other nucleotide monophosphates the relative binding strengths
were evaluated to show that GMP, dAMP, FOMP and IMP also
exhibit some binding strength, pyrimidine nucleotides are virtually
non-binding.
8. Physical and chemical probes of AAC structure
8.1. Fluorescent nucleotides and derivatives
The high selectivity of the AAC for the adenine nucleotides is
reﬂected also in the limited choice of ﬂuorescent nucleotide
derivatives to be used as probes for monitoring binding and possibly
reorientation of binding sites. Well propagated highly ﬂuorescent
derivatives of nucleotides such as etheno-adenine nucleotides do not
bind to the AAC [204]. Formycin nucleotides (FoDP, FoTP), with a base
very similar to adenine, are weakly ﬂuorescent. They are transported
by AAC with 15% of the ADP rate [2]. Apart from the low ﬂuorescence
yield, a disadvantage is the overlap with the ﬂuorescence of
endogenous tryptophane, which allows only approximate measure-
ments formycin nucleotide ﬂuorescence in mitochondria [204],
whereas with the isolated AAC, FoDP could be directly used [205].To overcome the obstacles in mitochondria, secondary high yield
ﬂuorescence probes were introduced which received and enhanced
the signal from FoDP by resonance transfer [204]. For this purpose,
anthracene derivatives (vinyl-anthracene (VA) and anthracene
maleimide (AM)) were absorbed into the mitochondrial membrane
or covalently attached to SH groups. Thus a convenient ﬂuorescent
recording of FoDP binding was possible. The ﬂuorescence is
quenched by ADP at concentrations which differ widely according
to whether ADP is added before or after FoDP (KI =0.2 µM versus
40 µM). This can be explained by the reorienting carrier mechanism
assuming that the ﬂuorescence indicates m-side location of FoDP:
external ADP added before FoDP, even in small amounts, are
sufﬁcient to switch AAC sites to the matrix side rendering them
unavailable to the 5 times slower FoDP, whereas when ﬁrst FoDP is
allowed to go inside, higher amounts of external ADP are required to
remove FoDP by exchange. The m-side localisation of the ﬂuorescent
FoDP is compatible with the probable attachment of anthracene
maleimide to a matrix oriented-SH (C56) group. The complete
quenching of FoDP ﬂuorescence by BKA shows that BKA displaces
FoDP from the AAC in the matrix, supporting the view that BKA binds
to the same site as ADP [153]. Particular attention was paid to
measure the ﬂuorescence decay time which on binding was pro-
longed from 0.95 to 1.95 ns indicating an unpolar environment of the
formycin binding pocket. A depolarisation decay time N15 ns shows
that the bound FoDP is immobile at this time period.
Introducing ﬂuorescent groups to the ribose of adenine nucleo-
tides provided some very useful probes for the AAC as ﬁrst noted by
Schäfer and Onur [194]. From the comparison of various substituants
carrying naphthoyl- and benzyl-groups, 1,5-dimethylamino-
naphthoyl-3′O-AMP, -ADP and -ATP (DAN-AMP, -ADP and -ATP)
emerged as the most useful ﬂuorescent probes to monitor binding to
the AAC [192, 206]. Being largely quenched in solution, on binding
they emitted a large and conveniently located ﬂuorescence with a
maximumat 520 nm [192,206]. Naphtoyl-3′O-ADP and -ATPwere also
extensively used [196], however opposite to the DAN-AdN, the
relatively weak ﬂuorescence of the free probe was partially quenched
on binding and thus could only be monitored as a ﬂuorescence
difference.
DAN-AdN ﬂuorescence depended on binding to the inner (m-) side
of themembrane: on addition tomitochondria from heart only a small
or from liver no ﬂuorescence signal was observed [192], whereas with
sonicated patricles (SMP) the DAN-derivatives rapidly displayed a
strong ﬂuorescence signal which was totally reversed by BKA [195],
indicating that the ﬂuorescence reﬂects speciﬁc binding to the AAC.
The apparent afﬁnity was high with KD=2 µM for DAN-AMP and
1.5 µM for DAN-ADP. CAT could reverse ﬂuorescence slowly and not
more than by half and only when ADP or ATP was present. ADP or ATP
alone could only partially inhibit or reverse the ﬂuorescence requiring
surprisingly high concentration of N2 mM. In conclusion, the ﬂuo-
rescence of the DAN-nucleotides corresponds to m-side speciﬁc
binding and permits recording the reorientation of binding sites
under the inﬂuence of ADP and the inhibitors BKA and CAT between
the c- and m-states.
DAN-nucleotides are competitive inhibitors of the ADP transport
both in mitochondria with a KI =12 µM and in SMP with KI =2 µM,
indicating that DAN-nucleotides also bind from the c-side to the
AAC [192]. By introducing radio-labelled DAN-nucleotides, binding
was measured parallel to ﬂuorescence [195]. In SMP a total of
2.8 µMol/g protein 3H-DAN-ADP were bound and 1.6 µMol/g prot.
were removed by BKA which should represent binding to the AAC
sites. The difference of 1.2 µMol/g of non-ﬂuorescent binding is
probably to the ATP synthase. The same base level was obtained in
SMP prepared from CAT loaded mitochondria. The parallel determi-
nation of CAT sensitive binding of 3H-BKA gave the same value
(1.6 µMol/g protein), showing a 1:1 binding capacity for BKA and
DAN-nucleotides.
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ADP could be measured, however, without a ﬂuorescence response.
The KD≈15 µM was close to the KI. From the total binding of 0.8 μM/g
prot. CAT could remove only about 25%, but when added before 3H-
DAN-ADP, CAT decreased binding by 70% and BKA by 75%. Obviously
a small portion (20%) of 3H-DAN-AMP is bound to the c-side
and the larger portion is translocated inside where it is mostly re-
placed at the AAC by endogenous ADP and ATP leaving DAN-AMP in
the free non-ﬂuorescent state. This is supported by the same
experiments with liver mitochondria. ADP addition reduced binding
not only to AAC but also by driving out 3H-DAN-ADP from mito-
chondria by exchange.
The different interactions of DAN-ADP with the c- and m-state of
the AAC can be explained with a single but ﬂexible binding site. On
binding to the m-state the DAN group contributes to the afﬁnity by
binding to a partially hydrophobic niche signalled by the strong
ﬂuorescence, whereas in the c-state by the same criteria the DAN
moiety seems not to participate in binding. In the case of DAN-AMP
the additional binding energy even overrides the usually poor
binding of AMP as compared to ADP or ATP. Thus DAN-nucleotides
provided the most persuasive illustration for the difference of the
binding center interfaces between the in and out state, as postulated
in the original concept of the single site reorienting carrier [2,3].
Further DAN-nucleotides allowed to visualise the distribution and
the transition of the AAC between the c- and m-state in accordance
with the reorienting (alternating) carrier mechanism [206,207].
The more easily synthesised ﬂuorescent 3-O′-naphthoyl (N-)
derivatives show a different interaction pattern with the AAC
[192,196,208]. Opposite to DAN-nucleotides, free N-ADP and N-ATP
have exhibit ﬂuorescence in solution which is decreased on bind-
ing. Probably due to the stronger hydrophobicity of the unsubstituted
N- as compared to the DAN-group, N-ADP and N-ATP ﬂuoresce
without binding. Therefore not the binding but only the displace-
ment of bound N-AdN by CAT or BKA producing a ﬂuorescence
increase can be recorded [196,208]. Further the low ﬂuorescence
yield results in a lower signal to noise ratio as compared to DAN-
nucleotides. N-ADP was found to bind to AAC both in mitochondria
and in SMP as monitored by the ﬂuorescence increase by CAT and
BKA [208]. In mitochondria CAT alone seemed to release most of N-
ADP whereas the BKA induced release depended largely on ADP. In
SMP the ﬂuorescence increase, reﬂecting N-ADP displacement,
reached maximum at 2.0 µMol BKA/g prot., but was small with
CAT. Thus the responses of N-ADP binding to inhibitors were similar
as with DAN-nucleotides but, at variance, N-ADP appeared to have
the same afﬁnity to mitochondria and to SMP, i.e. to c- and m-state.
Using radio-labelled 14C–N-ADP maximum displacement of N-ADP
binding by CAT was determined at 1.3 µMol CAT/g protein in
mitochondria which agrees with the parallel measured value of 14C-
acetyl-CAT binding [196]. In SMP the AAC attributable 14C–N-ADP
binding was 1.2 μMol/g prot.
These results were interpreted [208] in terms of the “CATR”- and
“BA”-state of the binding site, including an ADP requirement for the
transition between these states. Thus the authors [208] essentially
implement and support the c- and m-state binding site change and
their catalysis by ADP [153,209], however with the speciﬁcation that
the binding sites for CAT and BKA are not shared with the
nucleotide site. As an inconsistency with the single site model the
removal of internal N-ADP in the presence of CAT by external ADP
and vice versa in SMP in the presence of BKA was quoted [208].
Instead two anti-cooperative sites in AAC were envisaged which are
out- and inside located in line with the simultaneous kinetic
mechanism, reviewed in Chapter 4.4. However, it may be argued
that the partially leaky membranes permit ADP to diffuse inside and
thus to switch the carrier sites to the outside. Another explanation
would be that, similarly to DAN-ADP, N-ADP may catalyse a slow c-
to m-transition.A ﬂuorescent derivative of ATR, 6-O-dansyl-aminobutyryl-ATR
supplements these results [210]. High ﬂuorescence appears on
binding and can be largely suppressed by CAT or by BKA only in
conjunction with ADP. Opposite to the DAN-nucleotides, this
compound provides a sensitive ﬂuorescent probe speciﬁc for the c-
state of the AAC.
8.2. Fluorescent ligands for the isolated AAC
Binding of DAN-AMP, -ADP, -ATP to the solubilised AAC produced
ﬂuorescence, similar as in SMP, only in the m-state [207]. The
absorption of DAN-nucleotides to the detergents induced a ﬂuores-
cence which was subtracted from the signal due to AAC binding, after
a careful calibration of the ﬂuorescence yield. The ﬂuorescence
changes of DAN-AMP, -ADP, -ATP in response to ADP, CAT and BKA
additions were recorded and combined with binding measurements
of 3H-DAN-AdN, 3H-BKA and 3H-CAT. The decrease of 3H-DAN-AMP
binding corresponded approximately 1:1 to the replacement by 3H-
BKA or 3H-CAT in conjunction with ADP. The equal binding level is in
agreement with the assumption that these diverse ligands bind to the
same adaptive site. An additional application of DAN-nucleotides is
the convenient determination of the a priori distribution of the
solubilised AAC between the c- andm-state, based on the ﬂuorescence
response. Thus, for example, salts (Na-sulfate, NaCl) were found to
shift the AAC more to the m-state.
The ﬂuorescence response of N-ATP binding was also probed with
the solubilised AAC [211]. A total of two, one high and one low afﬁnity
sites for N-ATP per one CAT binding site was extrapolated from the
titrations whereas the BKA sensitive N-ATP binding has only low
afﬁnity sites. However, these ﬂuorescence titrations seem less reliable
than the binding measurement with 14C–N-ATP in mitochondria,
where a displacement ratio N-ATP/CAT=1.2 was directly measured
[196]. The different afﬁnities were interpreted to reﬂect anti-
cooperativity between two binding sites. No correction for the
ﬂuorescence of N-ATP absorbed to the detergent is reported although
it may strongly inﬂuence the calibrations. Another factor for the
discrepancies of binding numbers might be that analogues to DAN-
AdN N-AdN also have a different ﬂuorescence yield on binding to the
c-state or m-state and the two afﬁnities may reﬂect binding to the c-
and m-states.
The binding of 3H-DAN-AdN to the isolated AAC has some
peculiarities seemingly at odds with the AAC binding site [207].
DAN-AMP binding is highly sensitive to BKA but its displacement does
not conform to the hierarchy of transportable substrate. High
concentrations (N5 mM) of ADP and ATP are required for the removal
of DAN-AMP, in contrast to the μM concentration needed to activate
the ﬂuorescence by shifting the AAC from the c- to m-state. ATP is
more effective in the removal whereas ADP is more effective in the
activation. Poorly transported GDP and GTP and salts, such as Na2SO4,
pyrophosphate are effective competitors with DAN nucleotide bind-
ing. These ﬁndings and that DAN-AMP has even a higher afﬁnity than
DAN-ATP and DAN-ADP argue that the binding site assumes a state
close to the abortive m′-state induced by BKA with little afﬁnity for
ADP and ATP [212] (see Chapter 16.1).
It can be concluded that the various models based on the work of
N-ATP binding to the AAC [196,205,211,8], such as high and low
afﬁnity sites, separate sites for the inhibitors and nucleotides,
tetrameric AAC, are not sufﬁciently founded to revise the reorienting
single site (SBCGP) model. Similar reservations can be applied to the
conclusions drawn from FTP binding to the isolated AAC [205], where
4 classes of binding sites for FTP are claimed. Here binding is further
complicated by the ability of FTP as a transportable substrate to
catalyse switching between the c- to m-states although less efﬁciently
than ATP. This may explain the biphasic binding competition between
FTP and ATP and would argue against the proposed model [205] that
employs different sites for inhibitors and nucleotides interacting in
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N-ADP binding are compatible with the SBCGP mechanism.
8.3. Intrinsic ﬂuorescence of AAC
Intrinsic ﬂuorescence based on constituent tryptophanes was
extensively used to probe the interaction of ligands with the AAC
[213–215]. Fluorescence decreased on addition of ATP and CAT and
increased by BKA. Based on titrations only about 4 nMol/CAT/mg
protein bind (as compared to 14 for pure AAC), similar as with N- and
DAN-AdN, reﬂecting the low yield on isolation of “free” AAC. In the eye
of the reviewer, the response of intrinsic ﬂuorescence to CAT, BKA and
ATP basically supports the SBCGP model. A biphasic kinetic response
to ATP at low temperature is interpreted to show segregated rapid
binding and slower translocation. The fact that sub-stoichiometric
amounts of ATP can convert all AAC into the high ﬂuorescence form
shows that the conformations can exist independent of ATP binding,
in agreement with c–m-state model. Also in studies on yeast AAC2
mutants [216] with single eliminations of Trp for elucidating the
individual contributions of the three Trp, the ﬂuorescence response to
the various ligands could be rationalised within the framework of the
c–m-state mechanism (called here C–C⁎). Based on the intrinsic
ﬂuorescence change, an inﬂuence of the detergent type on the initial
state of the isolated free AAC was noted: in LAPAO the c-state, in
CHAPS the m-state is preferred [213]. In dodecyl-maltoside yAAC2
appears to exist mostly in the c-state [217].
8.4. Probing the AAC in mitochondria with spin labels
Spin labels (SL) attached to ligands of the AAC were primarily used
to explore mobilities. In the ﬁrst applications SL were attached to
various positions at long chain acyl groups linked to ATR and CoA. With
SL-acyl-ATR essentially the mobility of the acyl chain in the lipid
environment of the AAC inmitochondriawere probed [218]. Short chain
SL-acyl-ATR was less mobile on binding to the AAC in mitochondria
than long chain acyl-ATR. The long chain acyl groups were less mobile
than free SL fatty acids indicating interactions of the acyl chains with
the AAC similar as previously seenwith SL-acyl-CoA [219]. However the
immobilisation of long chain acyl appears to be too small for protein
interaction and thus a model was invoked where the AAC in the center
of the membrane has a lipid niche or is divided into two subunits in
tandem across the membrane in the ATR-state.
Positioning the spin label at the glucose moiety of CAT should give
information on the mobility of CAT on binding to the AAC, or on the
mobility of the CAT–AAC complex in the membrane [220]. Different
from SL-acyl-ATR, with SL-CAT exclusive binding to the AAC was
observedwithout a background asmonitored by the hyperﬁne splitting
(HFS). Two HFS components were found, one major with extreme HFS
and another smaller with lower HFS value. The major component
reﬂects extreme rigidity, with a reorientation time τb107 s−1, and the
other τ≈108 s−1. This surpassed the hyperﬁne splitting measured in
solubilised-frozen SL-CAT–AAC complex, or frozen free SL-CATat −100°.
A highly polar environment of the NO-group was reﬂected in the very
narrow line width. Anisotropic motion of the SL-CAT–AAC complex or
two binding states of SL-CAT were proposed to explain the lower HFS
component. In continuation of these results, saturation transfer ESR
studieswith SL-CATallowed to extend themeasurable time range [221]
and to determine in mitochondria the rotational time τ of the
AAC molecule to 20 µs (0°) and 2 µs (30°). In reconstituted vesicle τ
was 1–5 µswhich can be accommodatedwith a size of the AACN60 kDa
in line with an AAC dimer.
8.5. Covalent modiﬁcations and probes
SH reagents turned out to be most interesting and revealing probes
for the dynamic and structure of the AAC. Initially ADP/ATP exchangeappeared to be insensitive to SH reagents, such as mercurials or
maleimide (NEM), in contrast to the high sensibility of the Pi carrier
towards these reagents [222–225]. This changed with the signiﬁcant
observation that NEM requires the presence of ADP or ATP for becoming
an inhibitor of ADP/ATP transport in mitochondria [69]. ADP enhanced
14C-NEM incorporation into mitochondria and ATR inhibited this effect
[226]. Vice versa once NEM had reacted, 35S-ATR binding was irre-
versibly inhibited [227]. Opposite to ADP, uncoupling counteracted the
inhibition of transport and ATR incorporation by NEM.
The important ﬁnding that ADP induces speciﬁc conﬁguration
changes of the mitochondrial structure which are reversed by ATR
[228] and which are reﬂected in turbidity changes in a suspension of
mitochondria [229], enabled to record the cumulative inﬂuence of
NEM and ADP on the turbidity [69]. These results suggested that the
ADP induced conﬁguration change of the mitochondrial membrane
was involved in unmasking SH groups. The turbidity change was
further explored under the view of AAC involvement [230] and ﬁnally
shown to reﬂect the reorientation of the AAC binding center [68]
(see Chapter 8,7). The kinetics of the NEM induced turbidity increase
was correlated to the increase of 3H-ADP binding and the simulta-
neous decrease of 35S-CAT binding capacity. On this basis the NEM
effect could be consistently integrated in the SBCGP by concluding
that NEM reacts with the AAC only in the m-state and thus required
ADP for catalysing the transition from the c- into m-state [2,231],
rather than explained by an unspeciﬁc ADP induced “allosteric”
change. The unmasking of the SH group in the m-state provided the
ﬁrst evidence for the postulated conformation changes between both
states. This superseded the seemingly obvious conclusion that the
different reactivity toward some amino acid reagents is evidence for
different binding sites for ATR (CAT) and BKA [232]. Interestingly, the
NEM effect, as monitored by the inhibition of 35S-ATR binding, is
inhibited by uncoupling of mitochondria [233]. This agrees with the
evidence from the turbidity changes that transition to the m-state
requires coupled mitochondria [68,230].
Whereas NEM is a penetrating SH reagent, the derivative eosin
maleimide (EMA) is poorly membrane permeable. It was introduced
to measure rotational diffusion of the AAC in mitochondria [234] but
then realized to react with the AAC only after access to the matrix side
in broken mitochondria or sonic particles [235]. Similarly to NEM,
EMA incorporation is inhibited by ATR or CAT. Phenylglyoxal (PheG)
and butanedione were used to probe the involvement of arginines in
binding to the AAC [231,232]. These reagents are membrane perme-
able but require higher concentration than NEM to inhibit the
transport and to inﬂuence CAT and BKA binding. Basically similar to
NEM, PheG was found to inhibit binding of 3H-CAT but not of 3H-BKA
[231], again supporting the concept that the conformation changes
associated with the reorientation unmask residues involved with the
binding center. At variance Block et al. [232] reported that butane-
dione and also PheG inhibit both CAT and BKA binding. At prolonged
incubation time and high concentration, the effect of these re-
agents become less selective andmay affect Arg or other groups also in
the c-state of the AAC. In fact, determination of 14C-PheG incorpora-
tion into the AAC showed that for the inactivation of ATR binding only
1 PheG per AAC dimer but for the inhibition of BKA binding, 2 PheG
were incorporated [237]. Also by UV irradiation a differential inacti-
vation of ATR versus BKA binding was observed [238] which was
enhanced by ADP and interpreted as evidence for segregated sites for
ATR and BKA binding. However, applying the same reasoning as for
the amino acid reagents, the differential inactivation by UV does not
contradict the single site c–m-state conformational activation concept
[231].
8.6. Probing SH group in the isolated AAC
A deﬁnite assignment of the ADP stimulated NEM incorporation to
the AACwas achieved by isolation of the 3H-NEM labelled protein [239].
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of BHM the ADP stimulated 3H-NEM incorporation was concentrated
against a broad background in a 30 kDa fraction and was fully
suppressed by CAT but not by BKA. With CAT or by uncoupling the
incorporation into 30 kDa bandwas largely prevented. Double labelling
permitted [239] to differentiate the ADP or ADP+BKA stimulated 3H-
NEM incorporation from the 14C-NEM labelled background fractions.
By chromatography Triton solubilised AAC was isolated with a low
background and high 3H/14C-NEM ratio and shown to contain about
1 NEM/30 kDa protein.
The reactivity of SH groups of the isolated AAC was studied in the
isolated CAT-, ATR- and BKA–AAC complexes [226]. Although AAC
contains 4 Cys, the incorporation of only one NEMor DTNB/30 kDawas
measured by various methods. The isolated ATR–AAC complex turned
out to bemost useful for studying liganddriven c–m-state conversions,
since it can be isolated in a comparatively stable state protected byATR.
Different from isolated “free”AAC, the ATR–AAC preparation has a high
purity and homogenous c-state population. Because of the lower
afﬁnity, ATR can be displaced and the AAC converted into other states.
Under the premise that DTNB reactingwith the SH group traps the AAC
in the m-state, recording of the absorbance increase of DTNBwas used
as a convenient and precisemethod to elucidate the role of nucleotides
in the c- tom-state transition [226]. Very small concentration of ADPor
ATP, with a KM for ADP of 0.5 µM, for ATP of 3 µM, were able to catalyse
the SH-unmasking, BKA alonewas inactive. Similar as in transport, the
catalytic effectwas highly speciﬁc; GDP, GTP, ITP, etc did not initiate the
reaction but dADP and dATP activated with a KM 10 times higher than
ADP and ATP. The results also excluded a ternary complex of AAC with
BKA and ADP.
Pyrenyl-NEM (PYM) was used as a ﬂuorescent SH reagent to
monitor the inﬂuence of phospholipids (PL) on the access to the SH−
group in the isolated AAC [240]. By competition the hydrophobic
PYM was shown to react with the same site (C56) as NEM. Starting
with the ATR–AAC complex, addition of ADP activated the reaction of
PYM as monitored by ﬂuorescence increase. After phospholipase
treatment the reaction became largely ADP independent. In contrast
cardiolipin addition at N70 mol/mol AAC inhibited completely the
ADP stimulated reaction, evenwhen the AACwas ﬁxed in them-state
by addition of BKA, where otherwise the access to C56 is most
favoured. The effect is quite speciﬁc, other PL inhibiting only up to
70% as compared to 99% inhibition by CL. Obviously CL does not act
by shifting the AAC into the c-state but occludes C56 by virtue of its
speciﬁc structure. Since the isolated ATR–AAC contains bound CL, the
additional CL may bind to additional positive charges thus encasing
the m-side of the AAC.
8.7. The relation of AAC to the macroscopic inner membrane structure
Unique conformation changes of the mitochondrial cristae reticu-
lum between “orthodox” and “condensed” conformation were ﬁrst
attributed to de-energised versus energised states of the inner
membrane [241,242].Weber and Blair [228,243]made the observation
that ADP alone could induce a transition to the condensed conforma-
tion, independently of energy transfer, as judged from the insensitivity
to oligomycin. Features of the condensation such as, requirement of
only µM ADP or inhibition by ATR were evidence for the involvement
of the AAC [229]. These transitions could be conveniently studied by
recording the absorbance increase in a mitochondrial suspension,
reﬂecting the change from the relaxed to the condensed state of the
matrix. Notably, these reconﬁgurations appear not to be accompanied
by matrix volume changes [244,245]. The nucleotide speciﬁcity
coincided with that for transport [230]. In contrast to ATR, BKA was
found to increase the absorbance still further as ADP thus for the ﬁrst
time demonstrating opposite effects of ATR and BKA on the AAC
[246,247]. The absorbance changes were quantitatively correlated [68]
with the binding of 14C-ADP, showing that the absorbance increase isnearly proportioned to the ADP binding, both alone and when
enhanced by BKA. By titrating the absorbance change, KD=4 µM for
ADP, 3 µM for ATP and 0.03 µM for ATR were determined.
Interestingly, BKA added after ADP causes a rapid transient decrease
of absorbance with a half time strongly increasing with pH. No
transient decrease is observed when BKA is added before ADP. 14C-
ADP binding is also transiently decreased indicating that externally
added BKA may transiently and loosely bind to the c-state binding
site. The rate V of absorbance increase by BKA has an extremely
steep pH dependence and was evaluated to follow the relation
ΔlogV/ΔpH=−2.4. This relation provided quantitative evidence that
the concentration of the hydrophobic form BKAH3, required for the
permeation through themembrane, is rate limiting [68], in agreement
with the evidence for BKA binding at the m-side [153]. In accordance,
the transient weak binding of BKA to the c-side, recorded by the rapid
initial absorbance decrease, is largely pH independent.
The role of the AAC in these macroscopic conﬁguration changes is
intriguing. Two groups assumed a general conformation change on
binding ADP and ATR without specifying a mechanism [228,230].
Stoner and Sirak interpreted [247] the pH effect to show accumulation
of BKA in themembrane and changes of the phospholipid organisation
and thus indirectly affecting the AAC. An entirely different interpreta-
tion was based on the reorientation mechanism with the following
postulates [248]: (a) The structural changes reﬂect the distribution of
the AAC between c- and m-state, independently of whether or which
ligand is bound to the AAC. (b) The absorbance increase reﬂects
binding sites accumulation in them-state and vice versa in the c-state.
(c) Mobilising ligands such as ADP and ATP enable redistribution of the
carrier between the c- and m-state. Immobilising ligands (ATR, CAT,
BKA) produce one sided distribution, in either the c- or m-state.
Without added ligands of AAC, mitochondria are in a low
absorbance “relaxed” state, where most binding sites are trapped in
the free form on the c-side after being translocated by the endogenous
ADP or ATP and release of nucleotides. ADP addition partially reorients
the sites to the inside reﬂected in a partial contraction. ATR and CAT ﬁx
the AAC in the extreme c-state with low absorbance and BKA ﬁxes the
AAC in the extremem-state with highest absorbance in the contracted
state. All sites are trapped by BKA only after being mobilised by
external ADP. BKA3− is considered the binding form, as conﬁrmed
by absence of pH dependence of BKA effects on sonic particles
[73,78,150]. Thus the absorbance change of the mitochondrial
suspension provides a unique visualisation of the extent and rate of
the redistribution of the AAC between the c- and m-state.
The molecular basis of these morphologic changes is still a matter
of conjectures. They can be visualised to result from the expansion of
one membrane surface relative to the opposite surface; in the c-state
the outer face is larger than the inner face and in the m-state vice
versa, thus enforcing a more vesicular (relaxed state) or vacuolar
(condensed state) conﬁguration of the matrix [68]. As a possible
driving source, excess surface charges were proposed for the
expansion. On this line the curious initial rapid decrease of the
absorbance on BKA addition [68,249] may be due to the absorption of
BKA3− at the outer membranes surface rather than a weak transient
binding of BKA3− to the c-side of the AAC. It was also discussed [68]
that due to the drastic conformation change of the AAC structure
between c- and m-state, the AAC molecule may occupy more space
either on the c- or on the m-surface of the membrane and, combined
with the high density of AAC corresponding up to 12% the inner
membrane protein, this molecular change translates into macroscopic
changes. This version is supported by the ﬁnding that the AAC is the
major protein exposed at the c-side membranes as shown by to
lactoperoxidase-iodination [250]. The crystal structure of the CAT–
AAC complex with the wide c-side funnel seems further to vindicate
this speculation. Revisiting this discussion on the basis of 3D
tomography of the mitochondrial structure, Mannella [251] suggested
that the surface charge changes are caused by a rearrangement of
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recruits a high amount of cardiolipin molecules [252,253].
9. Isolated AAC
9.1. The solubilisation and isolation of the intact AAC
The AAC from bovine heart mitochondria (bAAC1) was the ﬁrst
membrane transporter to be isolated in a non-denatured form
[77,183,254]. The success was based on the high abundance of the
AAC in these mitochondria and the use of the tightly binding inhibitor
35S-CAT for tagging the AAC. The working hypothesis that CAT binding
stabilises the AAC proved to be a crucial advantage for the isolation of
an intact carrier. Dealing with a deeply embedded transmembrane
protein, the solubilisation of the AAC required full disintegration of the
membrane phospholipid. Whereas with mitochondria cholate had
been the preferred detergent for solubilising membrane proteins, this
and some other popular detergents failed to preserve the CAT binding.
Non-ionic detergents were little used because their removal was
difﬁcult. Among the polyethylglycol (PEG) detergents, only those with
an aromatic moiety such as Triton X100 were found to easily solubilise
mitochondria in conjunction with high ionic strength. Under these
conditions Triton X100 solubilised and preserved the CAT–AAC
complex. In other work the branched alkyl detergent emulphogen
was applied [176]. The more aggressive aminoxide detergents lauryl-
aminoxide (LDAO) and laurylpropyl-aminoxide (LAPAO) were intro-
duced [185] requiring less salt for solubilising the AAC. Attempts to
purify the AAC by afﬁnity chromatography with ADP or with ATR
failed to produce intact AAC [183] or gave only a partially pure protein
[176]. Other reports claiming puriﬁcation without CAT binding,
actually failed to isolate the AAC. In the procedure described by
Egan and Lehninger [255] using the alkyl PEG Brij 56, in fact no
solubilisation of AAC could be achieved [256]. SDS and afﬁnity
chromatography, applied for the isolation [257], abolish CAT binding
and thus the criterion for intactness. Shertzer and Racker [80]
reported puriﬁcation and reconstitution using cholate and ammo-
nium sulfate fractionation. To the contrary, the gel electrophoresis of
this fraction showed a selective decrease of the 30 kDa content.
A great advance was the introduction of hydroxyapatite (HTS) as a
ﬁrst step for separating the AAC from the bulk of mitochondrial
protein [183]. Bound 35S-CAT was the convenient marker for following
the puriﬁcation steps. An important pre-requisite was CAT or ATR
binding for obtaining a high yield of AAC in the initial “break-through”
fraction. Otherwise and particularly with ADP much less or only a
small yield of AAC appeared in the break-through. During the
subsequent further puriﬁcation by sepharose chromatography most
of the detergent and accompanying phospholipid were removed. In
SDS gel a single bandwith aMW=30 kDawas identiﬁed. Starting from
BHM the CAT–bAAC1 complex was puriﬁed about 14 fold as based on
the CAT/protein ratio. The 35S-CAT content of 16 μMol/g prot. in the
puriﬁed protein gives a MW≈60 kDa [137, 256] corresponding to a
dimer. With CAT binding of 2 μMol CAT/g prot. in BHM [3] and with a
MW60 kDa the AAC share amounts to about 12% ofmembrane protein
and thus has the highest content of any BHM membrane protein. The
abundance of the AAC also became evident by the ﬁnding that
lactoperoxidase catalysed radio-iodination of the c-surface of inner
membrane preparation of BHM primarily targeted a 29 kDa protein
[258] estimated at 10% of total membrane protein and later identiﬁed
as the AAC [250].
The AAC was also isolated and puriﬁed as the 3H-BKA–bAAC1
complex [184] until the HTS stage, since the BKA–bAAC1 complex was
too unstable to survive the subsequent sepharose chromatography.
The amino composition of this product was nearly identical to the
isolated CAT–bAAC1 providing direct evidence that CAT and BKA bind
to the same protein. The greater sensitivity of BKA–bAAC1 to
endogenous or exogenous proteases was demonstrated by the nearcomplete (N98%) degradation of the 30 kDa protein by trypsin after
24 h, while CAT–bAAC1 is degraded only by 5%. On solubilisation
without ligands the AAC was degraded in the extracts by endogenous
proteases, to 50%within 3min at 0° asmeasured by CAT binding [256].
The afﬁnity of CAT binding was weaker in the solubilised protein than
in mitochondria as shown by the ability of ADP or ATP to slowly
displace the bound 35S-CAT. As a consequence the isolated CAT–bAAC1
was destabilised by ADP and the protein was degraded with a half
time of 6 hours.
The stability of various ligand–bAAC1 complexes in Triton X100
follows the sequence: CAT–AACNATR–AACNBKA–AACNAACNADP–
AAC [184,185,256,259]. Without inhibitors the AAC stands out in its
instability as compared to other major mitochondrial membrane
proteins, as monitored by the 30 kDa band in SDS gels of Triton X100
solubilised mitochondrial membranes. Whereas the solubilised
major components of cytochrome complexes and of ATP synthase
are stable for hours, the 30 kDa band is rapidly decreased unless
stabilised by prior addition of CAT. The AAC from bovine liver and
kidney (bAAC2) turned out to be still more labile and barely stabilised
by CAT [260].
In the cholate based extraction of mitochondria a major fraction
called “structural protein” containing a 29 kDa band [261] is probable
identical to denatured AAC. N-terminal acetyl-serinewas also found in
the sequence work of authentical AAC [49]. The same band was
regarded as a constituent of ATP-synthase preparations [119] but was
later eliminated in purer preparations.
Because of its lability, the AAC afforded an early test to grade
detergents according to their efﬁcacy in handling the intact AAC [259].
Weaker solubilisers, requiring high ion strengths, are C12 E8, C13E6–12
(Emulphogen), and dodecyl-maltoside. Good solubilisers requiring
moderate ion strength were in the order of AAC stability: Triton
X100N lauroyl propyl aminoxide (LAPAO)N lauryl-aminoxide (LDAO)N
(unstable) lauryl-betaineNoctylglucosideNcholate. Thus non-ionic
detergents were the least aggressive, and the stronger “dipole”
aminoxide detergents preserved the CAT–AAC complex but were
less tolerable towards BKA–AAC. The need for high ionic strength
(N0.5 M NaCl or N0.1 M Na2SO4) for the solubilisation of the mito-
chondrial membrane was presumably caused by the high content of
charged phospholipids, in particular of N10% cardiolipin in BHM.
9.2. AAC as a dimer
On isolation of the bovine CAT–bAAC1 complex [183] a general
investigation of the composition, size and shape of the protein
detergent micelle was undertaken. Further the question was
addressed of whether AAC forms a dimer [262]. Initially a dimer was
inferred from CAT binding amounting up to 18 μMol/g protein
corresponding to a MW 56000, suggesting that about one molecule
of CAT binds to two AAC monomers. 35S-CAT–bAAC1 complex
detergent micelles labelled with 3H-Triton X100 were separated
from bulk Triton by sucrose gradient or gel ﬁltration. The CAT–bAAC1
complex was monitored by the bound 35S-CAT. 1.5 g Triton X100/g
protein were measured to be associated with the AAC corresponding
to 150 molecules Triton X100 per AAC dimer. The Stokes radius was
determined by gel ﬁltration to 53 Å for the “free” Triton micelles and
65 Å for the protein Triton micelle, equivalent to a diffusion coefﬁcient
D=3.43×10−7 cm2 s−1. The same value was obtained from boundary
broadening in analytical ultracentrifugation. Sedimentation coefﬁ-
cients were determined by two ultracentrifugationmethods to S=3.85
or 3.93×10−13 s. From these data and the speciﬁc weight of 0.85 g/ml a
MW=182 kDa for the AAC micelle was calculated. Independent
sedimentation equilibrium measurements gave a MW=172 kDa. The
speciﬁc volume was determined by centrifugation in H2O/D2O
gradients and agreed with that calculated from the composition of
the mixed micelles. Subtracting the Triton and phospholipids,
MW=67 kDa (sed.-velocity) and 64 kDa (sed.-equilibrium)
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methods error.
Includingmeasurements of the phospholipid content, the AACwas
concluded to form a dimer in the isolated CAT–bAAC1 complex
surrounded by 150molecules Triton X100 and 16 “phosphate units” of
phopholipids [262]. The combination of sedimentation, diffusion
coefﬁcient and MWallowed to determine the frictional ratio f/fo=1.56
indicating a strong deviation from a sphere. These datawere modelled
into an oblate elongated ellipsoid structure with the short axis at the
two fold axis of the dimer surrounded by a detergent shell. Similar
measurements with CAT–bAAC1 isolated using the aminoxide
detergents LAPAO and LDAO gave Stokes radii of 44 Å and 46 Å and
MW of 141 kDa and 130 kDa respectively [263], and for the protein
share MW of 59.5 kDa and 60.4 kDa. The low density of these
detergents leads to a broader error range for the speciﬁc volume and
thus for the MW determination in particular with LDAO. When Triton
X100 was replaced by SDS in the isolated AAC, a MW of 32 kDa was
determined by gel ﬁltration, and 29 kDa and 28.5 kDa by the two
hydrodynamic methods in agreement with the expected monomer
formation in SDS. It might be mentioned that applying the same
hydrodynamic studies to the homologue uncoupling protein (UCP1) a
dimer structure was also assigned to the isolated UCP1 [264]. Small
angle neutron scattering measurements of the CAT–bAAC1 and BKA–
bAAC1 complex isolated in LAPAO were performed [265], again
providing evidence for the dimer structure of the solubilised bAAC.
The detergent micelle contributionwas eliminated by adding 10% D2O
to the solution. Depending on the assumed degree of D to H exchange
in the protein MW 53 to 61 kDa were determined.
The topography of carriers in the membrane had been barely
addressed in the literature, but required attention with the arrival of
the dimer structure of the AAC. In a general essay [266] the principles
governing the orientation of two subunits to each other and to the
membrane were elucidated. Taking into account the protein–lipid
interaction and an asymmetry of the lipid composition between the
inner and outer membrane leaﬂet, simple calculations show that
dimerisation of proteins in the membrane has an energy advantage
over the monomer state and that the twofold axis of a dimer
membrane protein must be perpendicular to the membrane. The
formation of one translocation path at the twofold axis or of two
separate paths in each subunit and the implications for the transport
mechanism were discussed (see chapter 16).
Crosslinking of the isolated AAC with bifunctional lysine reagents
produced protein with MW of 65 kDa in SDS gel [263]. The crosslink
yield of 30% was independent of protein concentrations, showing
intra-dimer crosslinking and providing independent evidence for at
least a dimer state of the isolated CAT–AAC complex. Crosslinking of
bAAC1 in the native membrane by Cu++-phenanthroline forming S–S
bridges [267] or by using bifunctional maleimides [268] leading to a
covalent dimer involving the C56–C56 bridge are reviewed in Chapter
14.5. These results provide evidence for the existence of AAC as a
dimer in mitochondria. Other members of the mitochondrial carrier
family were also crosslinked showing their dimer state. Isolated UCP1
can be easily crosslinked by forming an S–S link between C304 near
the C-terminal. The yield is 90% and independent of protein
concentration. The isolated oxoglutarate carrier (OGC) could also be
oxidatively crosslinked between C184 located in TMH4, indicating
their proximity at the dimer interface [269].
Using native gel electrophoresis of mitochondria a dimer state of
yeast yAAC2 was demonstrated [270]. Interestingly the MW was
80 kDa whereas a slightly lower MW was found for yAAC2 from a
cardiolipin (CL) deﬁcient mutant [271]. The difference probably
reﬂected the retention of tightly bound CL in isolated yAAC2 from
wt yeast, supporting the NMR data [272]. With this method the
dimerisation of the oxoglutarate carrier (OGC) after import into
mitochondria membrane was also shown [273]. A monomer–dimer
dissociation equilibrium of OGC in the membrane is proposed withabout 2% monomer for accepting newly imported OGC molecules to
form dimers. This equilibrium would indicate that the association of
the dimer is not strong. The dicarboxylate carrier in yeast mitochon-
dria was also reported to form a dimer [274]. For the isolated citrate
carrier from yeast a dimeric state by native and by charge shift
electrophoresis was determined [275].
Recently it has been reported that yAAC2 and yAAC3 isolated in
alkyl-maltosides of various length and in LAPAO exist as monomers
[276]. The Stokes radius determined by gel ﬁltration and extrapolated
to zero alkyl lengths were compatible with a monomer state. Also
equilibrium centrifugation measurements indicate a MW=30 kDa.
Conceivably, the oligomer state depends on the detergent used. No
results are available on the MW of yAAC2 in Triton X100 but bAAC1
isolated in the alkyl-ethylene-oxide detergent emulphogen (tridecyl
E6–14) has a Stokes radius compatible with a dimer [263]. The reason
why the isolated yeast yAAC2 might differ from bAAC1, may reside in
the weaker protein–lipid interaction of the yeast AAC and an easier
dissociation into monomers. A lack of lipids may be suggested in view
of the more stringent requirement for cardiolipin addition in
reconstituting yAAC2 [272] than bAAC1. No data on the lipid content
in the yAAC2 micelles were given in this work [276] although they
may alter the MW calculations. In the bAAC1 micelle PL contribute
about 17% to the weight [262]. Another discussion point is that CAT
binds less tightly to yeast AAC and it would be important to assure that
CAT binding persists in the exclusion chromatography. The two ﬁrst
crystal structures of the bAAC1 did not contain dimers. Also the lattice
of the two-dimensional crystals of yeast yAAC3 did not show
preferred contacts between the single molecules [277]. However, in
a second crystal structure of bAAC1 [278] dimers were discerned in
which CL are located at the interface being probably essential for
mediating the monomer contact.
10. Reconstitution of isolated AAC into vesicles
10.1. Methods of reconstitution
One of the most important applications of carrier isolation is the
reincorporation into PL vesicles. This reductionist approach allows
determination of the various factors inﬂuencing and determining the
transport, free from the complications in the original membrane. A
reconstitution was deemed useful when the carrier was reasonably
pure and the amount of carrier reconstituted was deﬁned [279,280],
since only under these conditions the measured results could be
convincingly assigned. This was not the case in the ﬁrst claims of
reconstitution using cholate extracted “ particles” [80] or cholate
solubilised preparation [281,282]. Without data on the purity,
although called “highly puriﬁed”, the ATR sensitive transport activity
was in the “particle” reconstitution less than 0.2% and in the soluble
fraction 2% of that reconstituted with puriﬁed AAC preparation [283].
Cholate had been found to largely degrade the AAC, explaining the
failure of this approach [254].
In initial reports on a deﬁned reconstitution, LAPAO was intro-
duced besides Triton X100 as a solubiliser [185]. First the reconstitu-
tion efforts focussed on ways to cope with an AAC preparation not
stabilised by CAT. For shortening the steps after solubilisation, the
hydroxylapatite (HTS) column passage was replaced with HTS mixing,
and the 80% pure AAC supernatant was immediately mixed with
sonicated PL. Thus only a few minutes passed before the product was
stabilised by the reincorporation. The identity with the CAT–AAC
complex was assured by immuno cross-precipitation with antibodies
against the CAT complex or unliganded protein [185]. In further work
ATR–bAAC1 and BKA–bAAC1 complexes were used for reconsti-
tution [279]. Different from CAT, these ligands were displaced by the
high ADP or ATP concentration (≈10–20 mM) present for loading the
vesicles. In particles the ATR–AAC complex is stable for several days
and permits puriﬁcation by HTS and sepharose columns before
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were improved (see review [11]), varying the conditions of sonication,
freeze-thawing the phospholipids protein mixture for the incorpora-
tion of protein and the solutes [107]. Later proteoliposomes were
formed by ﬁrst solubilising the phospholipids with excess detergents,
addition of the AAC extract and subsequent stepwise removal of the
detergent by polystyrene beads. Krämer and Heberger [284] elabo-
rated a technique of using a short column of polystyrene beads
throughwhich the phospholipid–detergent–proteinmixture is passed
repeatedly. In this application C12F8 was the preferred detergent for
solubilising the AAC, Triton X100 but not LAPAO could also be handled
by this method if the amounts of detergent, lipid, and protein were
carefully chosen. In another method applied ﬁrst for the reconstitu-
tion of the uncoupling protein, but then also for the AAC, detergent
was removed by additions of polystyrene beads stepwise in 5 to 6
portions [285,286] in 30 min intervals. As with the columnmethod an
excess of beads (Amberlite XAD-2 or Biobeads) were required for the
removal of detergents from the PL and AAC containing mixture.
Vesicles had larger size than in the sonication method but if more
protein was incorporated vesicle size decreased. Finally for removing
the solutes added for loading the vesicles, ﬁltration through ion
exchange column (Dowex) or, with improved yields, short sepharose
column was applied.
An important objective is the elucidation of the phospholipid
requirements. Egg yolk PL proved to be the most suitable basis [280],
whereas asolectin as used by Shertzer and Racker [80,282] failed to
sustain a marked transport activity. Admixture of anionic PL
particularly of cardiolipin (CL), or mitochondrial PL were found to
enhance activity [283]. The activation by CL was conﬁrmed [287] and
the beneﬁcial effect of PE was noted in this [287] and parallel work
[283]. However the maximum rates [287] were 10 times lower than
determined under the optimised composition of PC/PE/CL=58/31/11
(7000 µMol/min/g protein) [283]. CL could be replaced partially by PS
indicating the requirement primarily for anionic PL. All this recon-
stitution work was performed with the standard bAAC1. In later work
onmutants of yAAC2, an absolute requirement for CL was noted [272].
The reconstitution of an isolated AAC provided the opportunity to
study the mechanism of protein insertion into PL vesicles by 31P-NMR
[288]. The method demanded a higher protein/PL ratio than for
transport. The results were interpreted by a mechanism where the
AAC Triton micelle is incorporated into the outer layer of the
multilayer liposome and part of the detergent is released as a mixed
PL–detergent micelle. At a molar ratio of about 200 PL/AAC further
incorporation is stopped. On contact with the detergent absorbing
polystyrene beads, a unilamellar proteoliposome is peeled off the
liposome and a new protein detergent micelle can insert into next PL
layer. Thus a uniform proteoliposome population is generated. By
freeze fracture electron microscopy protein particles were visible on
both aspects of the vesicles providing evidence for their transmem-
brane insertion. These results must be considered on the background
of 1H- and 31P-NMR studies of how detergentmicelles are inserted and
dissolved into PL bilayers [289]. Non-ionic detergent micelles of
LAPAO were found to be readily incorporated into PL vesicles, at ﬁrst
producing a heterogeneous population. This is followed by a slow
uniform distribution of the detergent molecules in all vesicles. Up to a
weight ratio of 0.3 detergent/PL, vesicles remain intact. These results
are also important for understanding the protein solubilisation as a
replacement of PL with detergent molecules.
10.2. Ionic effects
The reconstituted AAC provided a well deﬁned platform for
elucidating ionic effects on the AAC. The inhibition of transport by
divalent cations such as Mg++ is clearly shown [290] to be caused by
the diversion to non-transportable Mg++–nucleotide complexes, as
originally concluded for mitochondria [42]. Besides complexingnucleotides, the Ca++ inﬂuence has more facets some of which are
reviewed in the Chapter 12 on pore formation. In addition to
inhibition, an activation of transport by some divalent cations was
observed [291] in the reconstituted system and also in mitoplasts, but
not in mitochondria. Depending on the conditions, activity could be
stimulated by Ca++ and in particular by divalent organic cations, such
as spermine, as well as by polylysine. The direct interaction of these
cations with the AAC could be excluded, suggesting instead an
interaction with lipid components. CL being tightly bound to the
isolated AAC [252] seems to be a logical target for divalent cations. By
binding to CL they could change the AAC conformation, “loosen” the
carrier “halfway” to the complete opening of the channel, as
hypothesised for the Ca++ effect [292] (see Chapter 12).
Anions were found to both inhibit and activate the reconstituted
AAC [293]. A competition of anionic molecules with ADP and ATP for
the cationic residues of the binding site and thus inhibition of
transport seems feasible. This effect should increase the KM for ADP
and has to be segregated from rate activation by anions. The inhibition
depends strongly on the number of anionic charges, with KI ranging
from 100 mM for Cl− to 0.9 mM for pyrophosphate and 0.015 mM for
ATP. More intriguing and less clearly understood is a strong activation
of reconstituted transport by anions. This effect can bewell segregated
from the activation by divalent cations and from the inhibition by
anions. The activation has a different speciﬁcity, following in part the
lyotropic series; SO4−, ClO4− are strong activators. Judged from Hill plots,
2 anions have to bind to their target for activation. A competition for
the AAC with negatively charged PL was excluded. Since anions
increase the translocation rate constant, it has been suggested that the
anions enhance carrier “mobility” possibly by binding to some of the
excess cationic groups of the AAC.
Surface potential is another factor inﬂuencing the AAC activity [294].
It can be changed by addition of positive or negatively charged acyl
derivatives to be absorbed by the bilayer or by varying the ion double
layer changing the NaCl concentration. Negative surface potential on
the c-side, measured by indicators, increased only little the KM of ADP
and ATP and the KD of CAT, but had a stronger activation effect on the
m-side of the AAC. This is interpreted to indicate that in the c-state the
intruding binding site is more distant from the membrane surface
whereas the m-side is closer to the membrane surface. In conclusion, in
mitochondria negatively charged PL, with CL as the most prominent
one, might inﬂuence the AAC activity via the surface potential.
10.3. Lipid requirements of the AAC
The reconstitution system afforded a ﬁrst insight into the lipid
requirements of the AAC. Egg yolk PC produced tight vesicles but AAC
transport activity required inclusion of acidic PL [295]. Cardiolipin (CL)
was the best activator, as supported by another work [287]. Additional
enhancers are PE and cholesterol [283,287,296]. Both these neutral
lipids were regarded to inﬂuence the AAC activity by modulating the
bilayer structure rather than by interacting with the AAC, at variance
to the interpretation by Brandolin et al. [287] who postulated a
speciﬁc PE interaction with the AAC. In the inner mitochondrial
membrane the PE content is low and cholesterol largely absent, but
the activation by negatively charged PL, most notably by CL, is shown
to be caused by interaction with the AAC (see below). Notably, the
activation of the reconstituted AAC was side speciﬁc [294], the acidic
PL had to be at the m-side of the membrane.
The AAC–Triton micelle contains 16 molecules PL per AAC dimer
[262] in a composition similar to the totalmitochondrial PL. However, in
the analysis of these PL by 32P-NMR a signal for CL was suspiciously low
[252]. Only on denaturation with SDS a marked signal for CL appeared
next to unchanged bands of PE and PC indicating a strong immobility of
CL in the native protein. The size of the CL signal corresponded to 6 CL
molecules per dimer, tightly bound to the isolated AAC. The amount of
CL binding exceeds that reported for other mitochondrial components.
1999M. Klingenberg / Biochimica et Biophysica Acta 1778 (2008) 1978–2021It is the only case known to the reviewer of such extreme 32P-line
broadening of a PL. The unusual excess of 18 positively charged residues
in AAC monomer [49] may be responsible for the CL binding, in
particular at the interface between protein and PL head groups. The
speciﬁc binding of CL to the AAC was vindicated [297] by the crystal
structure of the CAT–bAAC1 complex isolated in LAPAO where 2 CL
molecules/AAC monomer and in a second crystal 3 CL/monomer were
identiﬁed [278].
Using spin labelled PL [253] strong binding of CL and of phosphatidic
acid to soluble AAC was measured but no interaction of PE and PC. In
addition to the endogenous CL, one added molecule CL was bound per
monomer AAC. From these and other data it was concluded that besides
electrostatic also hydrophobic forces contribute to CL binding. Further it
was shown [298] that added 14C-CL did not exchange with the
endogenous CL on an hour scale, marking the unusual binding strength.
Also hydrogenation of bound AAC CL did not loosen the binding as
shown by 31P-NMR, indicating that a speciﬁc acyl chain is not required.
ESR studies of the interaction of various spin labelled PL with AAC
incorporated into lipid vesicles at a high protein/PL ratio showed [299]
that the AAC is surrounded by a shell of 50 PL at the membrane
interface, thus indicating out an unusually large PL binding surface for
the protein size. Acidic PL, PA and CL were preferred ligands measured
at a dissociation time range that does not include the tightly bound CL,
and thus represents additional binding. The surface of a rotational
ellipsoid as deduced for the AAC dimer [262] could accommodate only
34 PL molecules suggesting surface invaginations of the AAC. As
reviewed above (Chapter 8.6), the SH group activated by ADP can be
masked speciﬁcally by addition of CL in the isolated ATR–AAC complex
[240].
Studying mutants of the yAAC2 (e.g.C73S-yAAC2) from S. cerevisiae
an absolute dependence on CL addition was noted [272]. The
speciﬁcity for CL was strict, the acidic PA and PS did not activate
transport, different from the less speciﬁc activation of bovine AAC. The
binding of 3H-CAT to C73S-yAAC2 was unchanged as compared to wt
AAC and was not altered by CL addition. Both mutant and wt AAC
contained nearly equal amounts of CL. However according to 32P NMR
analysis in mutant AAC the tightly bound CL was decreased to 2.9 as
compared to 6.4 CL molecules/AAC dimer in wt AAC. These results
show that the complete set of tightly bound CL is necessary for
transport. On reconstitution of recombinant AAC from Neurospora
crassa (ncAAC) expressed in E. coli the dependence of transport on CL
had a threshold dependency on CL [300] starting at 4% with a
maximum of 12% CL whereas in the reconstitution of the yeast mutant
AAC the dependence was linear with a maximum at 8% CL. Obviously,
because of the total absence of endogenous CL in the ncAAC expressed
in E. coli inclusion bodies, a minimum level of CL is required for any
transport activity. In a S. cerevisiae mutant devoid of CL by disruption
of CL synthesis, this defect could be partially compensated by
increased levels of other acidic PL in particular PG, enforced by
growth on non-fermentable substrate [301]. Despite a near normal
level of AAC and cytochromes, oxidative phosphorylationwas reduced
in isolated mitochondria indicating that PG can only partially
compensate the lack of CL. In isolated and reconstituted AAC from
this CL deﬁcient yeast transport is virtually inactive but can be
stimulated to half the activity of wt by 8% CL.
11. Pore functions of AAC
11.1. The role of AAC in mitochondrial pore transition
Apart from the 1:1 exchange, in isolated mitochondria the AAC can
mediate an efﬂuxof nucleotides. Leakage of nucleotides induced by Ca++
and Pi additions had been early reported [302–306]. In rat liver
mitochondria AdN efﬂux induced by Mg++ and Pi [307] was speciﬁcally
associated with the AAC. ATP was the preferred leakage substrate and
the efﬂux was inhibited by external ADP but not by ATR, which evenprotected against ADP. Similar observations of Mg++ stimulated, ATR
insensitive leakage of ATP were subsequently reported [62]. Although
the Pi+Mg++ driven ATP efﬂux strongly resembles the function of the
Mg++–ATP/Pi exchanger [47,308,309] the role of ADP and ATR argued for
an involvement of the AAC. The role of AAC in leakage was further
strengthened by the advent of BKA. In contrast to ATR, BKA inhibited
theMg+++Pi induced nucleotide efﬂux [246] and also the efﬂux induced
by low Ca++ concentration.
Ca++ induced a less speciﬁc efﬂux frommitochondria comprising all
nucleotides and NAD. At increasing Ca++ concentration the efﬂux
became insensitive to ADP [307]. Large Ca++ induced morphological
changes of the cristae were recorded as a decrease of light scattering
[310, 311]. This membrane transition was associated with the
formation of a leakage pore in the inner membrane. The inhibition of
the transition byADPandBKAand the promotion byATR suggested the
involvement of AAC [311,312,329]. The role of the AACwasmore clearly
discerned by showing that ATR counteracted the inhibition by ADP
plus NEM as well as by BKA [313]. This effect of ATR was interpreted to
show that the c-state of the AAC is required for the pore formation.
Research on the conditions and the factors involved in the
“mitochondrial pore transition” (MPT) also called “permeability transi-
tion pore” was discussed in several reviews [314–319]. A more precise
deﬁnition of the MPT came from the discovery that it can be inhibited
by cyclosporine (CsA) [320,321]. This observationwas then rationalised
by results indicating that binding of mitochondrial cyclophilin-D (CyP-
D) to a component of the pore, possibly the AAC, promotes pore opening
[322–324] and that on CsA binding CyP is released from the pore which
thus becomes closed. The requirement for MPTof CyP is not absolute, as
high matrix Ca++ concentrations and Ca++ in conjunction with
prooxidants can overrule the inhibition of MPT by CsA, thus qualifying
CyP as a conditional modulator of MPT [325–327]. At low sub-μM Ca++
the transition, as monitored by light scattering, can also become CsA
insensitive when PPi is accumulated in the matrix via the AAC during
fatty acid oxidation [322,328]. PPi seems to stimulate K+ inﬂux resulting
in CsA insensitivematrix swelling. In this context an early observation is
to be cited that the leakage of H+ and K+ into mitochondria
accompanying swelling in NH4NO3 medium was controlled by AAC as
judged from inhibition by ADP and its prevention by CAT [330]. By
affecting the SH groups of the AAC with various agents such as NEM,
EMA and by stabilising the c-statewith crosslinking agents diamide and
phenyl arsine oxide, it is further substantiated [331] that the c-state of
the AAC is essential for the MPT. These results overlap with the diverse
oxidation effects on the MPT (see reviews [315,332]) where “proox-
idants” including the SH crosslinkers enhance the sensitivity to Ca++ and
may abolish the sensitivity to CsA. Prooxidants such as oxygen radicals
(ROS) can also affect the AAC by oxidising cardiolipin associated with
AAC as discussed in Chapter 10.3.
A “mega-channel” observed by patch clamp of the inner mito-
chondrial membrane in the presence of Ca++ has been associated with
the MPT [333,334]. However the identity of the components involved
remained unclear. Single channel patch clamp studies with isolated
reconstituted AAC showed Ca++ dependent large channels of up to 600
p-Siemens [292]. The single channels were voltage gated at N150 mV
and closed at pHb5.5, similar as the MPT [335,336]. ADP+BKA closed
the channel, CAT had no effect. Having the same earmarks as MPT, the
patch clamp AAC channel strongly supported the pore forming role of
AAC in MPT. The inability of CsA to inhibit the channel could be
explained by the absence of CyP in the reconstituted system in
agreement with the observation that in MPT high Ca++ can overcome
the inhibition by CsA.
Using recombinant N. crassa AAC (ncAAC) expressed in E. coli, in
patch clamp studies of reconstituted AAC, Ca++ induced channels were
also observed [337]. This preparation was absolutely free of CyP,
arguing against the possibility that traces of CyP may have activated
the reconstituted bAAC1 channels. Interestingly, on addition of CyP
the voltage gating at N150 mV was abolished. When the channel was
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a ﬂickering state. CsA reversed the effect of CyP and ADP closed the
channel. The results show that recombinant AAC devoid of any other
component can form a large pore and that CyP can directly interact
with the AAC. It was concluded that CyP has a modulating rather than
obligatory role in the pore formation of AAC, consistent with evidence
for the MTP. These results suggested that the role of CyP is to regulate
the voltage gating of the MPT.
The prooxidant tert-butylperoxide, known to activate theMPT, was
applied to the patched channel. Interestingly, it also abolished the
voltage gating, and this could be recovered by DTE, indicating the
involvement of SH groups in the gating mechanism. This response of
the AAC channel to tert-butylperoxide is consistent with the enhancer
role of prooxidants for the MPT and the involvement of dithiol groups
[332,338,339]. At this juncture it is important to note that mersalyl
was shown to be an efﬂux inducer [340] in reconstituted AAC vesicles
loaded with ADP or ATP. Mersalyl also increased fatty acid dependent
uncoupling of reconstituted AAC [341]. Similar as EMA [342,343]
mersalyl was thought to target C159 surrounded by basic residues
possibly near the binding center and the m-side gate.
The MPT has been suggested to be a complex of several proteins,
including VDAC (porin), CyP, AAC, hexokinase, creatine kinase, peri-
pheral diazepine receptor [344–346]. A role of the octameric creatine
kinase in MPT was considered [129,347]. These complexes were
thought to be at the contact points between the outer and inner
mitochondrial membrane [348].
Although the central role of the AAC in the MPT has been sup-
ported by various types of evidence [317,319], this role was lately
refuted by showing that mouse liver mitochondria, whose mAAC1
and 2 have been deleted, still exhibit a Ca++ activated MPT, sensitive
to CsA [349,350]. Based on this and other evidence a regulatory
rather than pore forming role of AAC in MPT was inferred [351]. In
defence of a central role of AAC in “wt” mitochondria one may call
attention to the more than threefold higher threshold of Ca++
concentration required for the MPT in AAC deleted mitochondria
[349], suggesting that this MPT may involve another mitochondrial
carrier [350]. It might be speculated that the MPT is comparatively
unselective in also employing other mitochondrial carriers but has a
a normal preponderance of the AAC. The pore formation under the
inﬂuence of mercurials of the reconstituted carriers for aspartate/
glutamate and for Pi as well as of AAC [340,352,353] may support this
view. The role of MPT and thus of AAC in cell death such as apoptosis
and necrosis has been abundantly reviewed [317,319,344]. Important
pathologic roles of MPT are well documented in the ischemia
reperfusion damage in heart cells [317,319] and the excito-toxicity
in neuronal cells [354–356].
11.2. Basal uncoupling and fatty acids
Another class of “leakage” inducers, by which the AAC can be
taken hostage to be diverted from its proper function, are long chain
fatty acids. Endogenous FA were early known to be a major cause of
uncoupling in isolated mitochondria, as reﬂected in the recoupling
by serum albumin (see review [357]). Added FA, e.g. oleate, stimu-
lated a H+ leakage, as reﬂected in uncoupling, that wasmuch stronger
than could be explained [358] by a slow FA−/FAH cycle across lipid
bilayers [359–361]. It was concluded [358] that a membrane com-
ponent catalyses the cycle, by accelerating the rate limiting FA−
transfer. The ﬁnding, that CAT partially inhibited the FA induced
uncoupling [362,63], pointed out an involvement of the AAC. The
effect is weak in liver and stronger in muscle mitochondria [363,364]
which have a higher AAC content [174]. Similarly, enhanced levels of
AAC in hyperthyroid livers increase the FA mediated uncoupling
[365].
The AACwas envisaged to translocate the FA− anion by virtue of its
role as a transporter of anionic substrates [366]. A similar mechanismwas proposed for the FA dependent H+ translocation by uncoupling
protein (UCP) [366] which reaches, however, two orders of mag-
nitude higher rates than the AAC dependent H+ translocation. Besides
AAC, other carriers such as for aspartate/glutamate [367] and for
dicarboxylates [368] also seem to contribute to the FA dependent
uncoupling. Thus the FA induced uncoupling in mitochondria is the
sum of contributions from various carriers and possibly other
membrane components, with the AAC having a major share. To
complicate the picture further, under certain conditions, such as low
Ca++ loading, the uncoupling by FA assumes properties of MPT as
deﬁned by the sensitivity towards CsA [369,370]. AMP is reported to
activate the basal metabolic rate by 15% in skeletal muscle
mitochondria [371]. Similarily as with FA, the effect is largely
abolished by CAT. A possible involvement of FA is not tested. AMP,
althogh not transported, can bind to AAC [372] but in vivowould be in
competition with ATP and ADP.
It should be stressed that the FA inducedH+ conductance is weak as
compared to uncouplers or as compared to UCP and might play, if any,
only a minor role in cell metabolism. A role in thermogenesis of
muscles has been proposed. However, only few muscles, e.g. heart,
have a sufﬁciently high content of mitochondria and the constantly
working heart does not need generation of heat in addition to that
produced by myoﬁbril contraction. An alternative or additional role of
the FA linked uncoupling is to lower ROS production [373] as
discussed in a broader context also for the uncoupling by UCP.
In vesicles, co-reconstituted with isolated AAC and cytochrome
oxidase for generating a H+ electrochemical gradient, a clear assign-
ment of FA mediated uncoupling to AAC could be made, free of any
possible cofactors [341]. H+ efﬂuxwas only about 30% inhibited by CAT
as compared to inhibition by albumin (BSA) and further inhibited by
BKA, indicating that a large portion of AAC is incorporated with c-side
inside. The Δψ recordings with vesicle containing COX only and COX+
AAC, showed the critical role of AAC in partial uncoupling by FA, even if
theweak uncoupling amounts to only aminor fraction (5%) of totalΔψ.
Interestingly, mersalyl known for generating a small pore in AAC,
markedly potentiated the FA effect. It sensitised the uncoupling against
nucleotides, even allowingGDP tobecome inhibitoryand restitutes the
sensitivity towards ATR. Also in mitochondria the partial inhibition by
GDP of uncoupling by FA was recently reported [374]. The skewed
inhibitor speciﬁcities of the AAC mediated uncoupling attest to the
different translocation mechanism in the FA effect.
A possible role of AAC mediated FA uncoupling in kidney tubular
cell reperfusion damage was reported [375]. By ablating AAC1 in
murine muscle mitochondria and in insect cells, basal uncoupling was
decreased by half and elevated by overexpression of AAC1 [376]. These
changes were observed both for the CAT sensitive and insensitive
portions, indicating that more than half of basal uncoupling, although
dependent on AAC presence, was not associated with CAT sensitive FA
induced uncoupling. Instead a H+ conductance by polyunsaturated PL
acyl chains at the AAC interface was suggested [376]. Tightly andmore
loosely bound CL with their high degree of unsaturation [298]
surrounding the AAC [252,253] may be responsible for the H+
conductance.
11.3. Side effects of AAC in mitochondria result from its principal function
In summary, the AAC is obviously involved in a wide variety of
leakage phenomena of the mitochondrial inner membrane. These may
be categorised (a) by the size of the underlying channel and the
selectivity of the leaked solutes and (b) by the sensitivity and speciﬁcity
towards speciﬁc AAC ligands. Under the provision that inmost cases the
AAC constitutes the pore (channel) forming component, it seems that
the AAC is highly ﬂexible in response to the pore inducing factors,
ranging fromapartially “native” statewithATP speciﬁc leakage to a state
with a wide pore of ~20 Å under the inﬂuence of Ca++ that allows
unselective solute passage and becomes irreversible with additional
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center, is still rudimentary at the ﬁrst leakage stage and abolished at the
stage ofMPT. Typically in this category, ADP and BKA are pore inhibitors,
but CAT and ATR are pore promoters by preventing ADP and BKA
binding, indicating that the pore state resembles the c-state of AAC but
with an openedm-gate. With CAT bound, the pore opening requires the
existence of a channel around the binding site which is difﬁcult to
visualise. In a functional AAC dimermodel acting in “half site reactivity”
with only one subunit occupied by CAT, the “free” subunit might form a
pore. The FA induced weak, partially CAT sensitive, H+ leakage may be
due to a H+ diffusion facilitated at the AAC surface layer by virtue of its
highCL content. Someof theeffects reﬂect the abundance ofAAC, others,
like the MPT, a strategic localisations of selected AAC at the peripheral
inner membrane.
Why would the AAC have these side roles, besides its primary
function necessary for the existence of the eukaryotic cell, featuring
some roles endangering and executing the demise of these cells? It
seems reasonable to argue that the secondary roles are a conse-
quence of the primary function and that, to make the best of this
situation, negative side effects of the AAC function have been evolved
to be exploited to some extent for useful purposes. In other words, on
the basis of its role in ADP/ATP transport the AAC is captive of
forming pores in mitochondria. The reasoning is as follows. The AAC
handles large substrates and thus must have a wide translocation
path with wide gates requiring large conformation changes on
opening and closing. These large rearrangements involve high
energy barriers which require unusual measures to be surmounted.
The strong interactions of AAC with cardiolipin [252,272] have been
proposed to involve “collar” lysines at the m-side of AAC at the
membrane surface [292] which may be one reason for the high
content of lysines in AAC. The binding energy of CL is thought to
provide catalytic energy in addition to the intrinsic ATP or ADP
binding energy needed for facilitating the large gating rearrange-
ments. With a high afﬁnity for CL [377] Ca++ can derange the CL–AAC
interaction by sequestering CL (Fig. 6). The released excess positive
charges should enforce the opening of the m-side gate. Inherited
from the primary function, AAC has the potential for a large pore that
manifests itself, when the coordinating gating is disturbed. Thus
with the evolution of the precursor prokaryotes into mitochondria,
eukaryotic cells acquired with AAC an “Achilles heel”. Another weak
spot caused by the high CL requirement is the unusually high degree
of acyl chain unsaturation, rendering CL most vulnerable to oxygen
radicals. ROS affect CL bound to the AAC forming aggressive
aldehydes such as malondialdehyde and hexenal [378, 379]. These
react in situ with lysines of the AAC to form Schiff base adducts. This
was demonstrated by exposing isolated mitochondria to tert butyl-
OOH. The only major protein detected to change the MW was the
AAC [379] illustrating the exceptional vulnerability of this membrane
component.Fig. 6.Mechanism of pore formation in the AAC under the inﬂuence of Ca++. At the matrix sid
bound to positive charged residues from the AAC at the m-side. The liberated positive char12. The structure of the AAC
12.1. The sequence of the AAC and its structural highlights
The primary structure (amino acid sequence) of the AAC was ﬁrst
establishedwith the standard bovine heart AAC (bAAC1) [49,380]. The
ability to isolate large quantities of the AAC protein as the stable AAC–
CAT complex enabled amino acid sequencing with technologies of the
1970–80 ties when c-DNA cloning of mammalian proteins was still in
its infancy. The amino acid sequence was the ﬁrst primary structure of
any transporter, preceded by the c-DNA sequence at the bacterial
lactose permease [381]. Adverse conditions made sequencing difﬁ-
cult: unfavourable positioning of standard CNBr cleavage sites,
acetylation of the N-terminus (acetyl-ser), the necessity for citraco-
nylation etc. of the hydrophobic peptides to facilitate peptidases work.
The peptides were separated by gel chromatography with formic acid
and other solvent mixtures and sequenced by the liquid phase Edman
procedure.
The sequence comprising 297 amino acids surprised [49] by
consisting of more than 20% (total of f56 acidic and 39 basic) charged
residues, which was unexpected for an integral membrane protein.
Due to the excess of 18 basic residues, bAAC1 has a high isoelectric
point pKiN9. In 8 positions positive and negative residues are ad-
jacent suggesting charge pairs. The scattering of numerous charged
residues over the sequence gave mixed results in algorithms
searching for hydrophobic transmembrane segments. In the ﬁrst
report [49] three candidate transmembrane helix segments were
noted, W111-L133, G 171-Y195, and I209-F230. In particular the
region to become TMH2 barely qualiﬁed for intramembrane regions
showing too low hydrophobicity coefﬁcients. Only by using internal
homology plots, segmentation into 3 similar domains, each featur-
ing 2 helices with a total of 6 transmembrane helices, were pre-
dicted [382] (Fig. 7).
The striking sequence RRRMMM regarded as an AAC signa-
ture [383] was present in all forthcoming AAC sequences, such as
of N. crassa [384], S. cerevisiae [385], Zea mays [386], now all based on
c-DNA sequencing, and in the ﬁrst forthcoming mammalian cDNAs
[387–390]. The conservation in the three domains of helix breaking
prolines and glycines was emphasized [49]. In addition acidic and
basic residues fully or partially are conserved in putative TMH
terminating positions. The subsequently elucidated [391] amino acid
sequence of uncoupling protein (UCP1) turned out to be similar to
AAC also featuring a three repeat domain structure. The comparison
of the two structures and the search for conserved residues
facilitated to discern essential elements. Both sequences of AAC
and UCP were aligned in a 3 repeat arrangement, by allowing for
insertions or deletions, for ﬁnding maximum of conserved residues
in the combined six repeat domains. Six fold conserved prolines were
found and placed as helix breakers at the matrix end of the unevene cardiolipin (CL) is tightly bound to the AAC. Ca++ chelates with CL and thus displaces CL
ges open the m-gate. From [292].
Fig. 7. The 6 transmembrane helix and 3 repeat domain model of AAC exempliﬁed with yeast AAC (yAAC2). The structure accommodates various mapping results. Hairpin loops from
the matrix side intrude the translocation path. Residues involved in site directed mutations and in spontaneous second site mutations are numbered. Modiﬁed from [477].
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the even numbered TMH regions. In three positions acidic or basic
residues were conserved in the repeats domains. Reﬁned hydropathy
analysis searching for amphipathic helices overcame some problems
with the classical hydropathy plots and suggested 6 amphipathic
helical stretches of 20 to 25 residues both in the AAC and UCP. An
apparent amphipathic β-strand appeared to traverse the membrane
between TM1 and TM2, turning the C- and N-terminals to the
opposite side. On the basis of circular dichroismmeasurements 40 to
42% α-helix content was calculated for AAC and UCP [391]. This
amounts to 120 residues in α-helical positions which can accom-
modate 6 average 20 residue long TMH. Applying FTIR spectroscopy
to yAAC2 60 to 70% of the residues were evaluated to be in α-helical
positions [392] which better approximates the helix content of the
crystal structure [297].
In addition to bAAC1 and UCP1, the phosphate carrier (PiC) was
amino acid sequenced and again found to be homologous to the AAC
and UCP [393,394]. The ﬁnding that the primary structures of three
mitochondrial carriers are homologous and all feature three repeat
domains with two transmembrane helices (TMH) allowed for the
ﬁrst time to conclude that the mitochondrial carriers with AAC as a
foremost member form a family [393]. Two sequence motifs were
shown [393] to be conserved in isologues positions in the 3 repeat
domains in all three carriers: at start of the matrix (M) loops PXD/
EXXK/RXK/R and at the end of the M-loops Φ+G (Φ aromatic
residue). The concept of a mitochondrial carrier family (MCF) was
vindicated by the identiﬁcation of numerous more sequences based
on c-DNA screening, the heterologous expression and functional
determination of many carriers of the MCF [12,15,395,13]. This motif,
then more speciﬁcally designated PhD/EXhK/RXK/R (h hydrophobic
residue) [396], was expounded as a marker for a rapidly expanding
mitochondria carrier family.12.2. Isoforms of AAC in mammalians
The occurrence of isoforms of AAC in various organs of mamma-
lians was ﬁrst suggested based on immunological evidence anticipat-
ing the ﬁnding of bovine AAC isoforms [390] and their tissue
distribution. The antiserum against CAT–bAAC1 reacted poorly in
the Ouchterlony assay with isolated CAT–AAC from rat and bovine
liver, bovine kidney [397], later identiﬁed as bAAC2 [390], but reacted
strongly with rat heart AAC. This difference was reciprocally found
with antiserum against bovine kidney CAT–AAC by employing
quantitative immuno-adsorption titrations [260,398]. Bovine liver
AAC reacted at only 20% and kidney AAC at about 50% of the heart AAC.
These results indicate that the immunological difference between
organs is greater than between species.
First in yeast (see below) and then in other organisms, particularly
in mammals, genes of AAC isoform were identiﬁed by mutational
search and later the full inventory of isoforms was determined by
complete genome search. In the following, AAC isoforms of some
“standard” species will be listed such as of mouse, rat, cow and man.
To avoid any confusion – extant in the literature – the isoforms
are given according to the annotations of the Protein Bank. In mouse
mAAC1(P48962) and mAAC2 (P51881) [399,400], in rat rAAC1
(Q05962) and rAAC2 (Q09073) [401], in cow bAAC1 (P02722) [390],
bAAC2 (Q8SQH5) [402], bAAC3 (P32007) [390], bAAC4 (Q2YDD9), in
man hAAC1 (P12235) [388], hAAC2 (P05141) [387], hAAC3 (P12236)
[403], and hAAC4 (Q9H0C2) [404]. Note, there is some ambivalence in
the literature in the assignment of AAC2 and AAC3 (ANT2 and ANT3).
The sequence differences in these isoforms are small, as compared to
those in the yeast, retaining about 85% identity [402], with the
exception of h- and bAAC4 with only 66–68% identity to the other
isoforms [404]. In the two or three isoforms of the cited mammalian
species, the differences were noticed [402] to be concentrated in the
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bAAC1) speciﬁc replacements occur that are conserved in the isoforms
of all these species, e.g. in position 45: Gly in AAC1, Ala in AAC2, Ser in
AAC3. This emphasizes a role of these residues in the still unknown
adaptations of the functional parameters to the particular tissue
needs.
Only a cursory review of AAC isoform expression can be given here,
omitting the literature on the regulatory elements involved in AAC
expression. h- and, bAAC1 occurs exclusively inmuscles [390,402,405],
h- and, bAAC2 in proliferating cells [405,406], hAAC3 in all organs
[389,404,405]. hAAC4 is expressed at low levels and is conﬁned to liver
and testis, marginally to brain [404]. hAAC1 expression is induced
during myoblast differentiation [405]. hAAC2 expression is strongly
stimulated by growth factor in ﬁbroblasts [407] and also increased in
neoplastic cells [408,409] as well in early myoblasts [405]. These
results indicate that the hAAC2 level is related to enhanced glycolysis
in these proliferating cells, and has the role of supplying glycolytic ATP
into the mitochondria, similarly as suggested for yAAC3 in yeast [410].
In fact, substitution of hAAC2 in yeast cells devoid of yAAC3 gene
sustained fermentative yeast cell growth [406]. Thyroid hormone (T3)
was shown [411] to increase selectively the rAAC3-mRNA level 7 to 9
fold in rat liver and rat heart, while not stimulating rAAC1-mRNA.
13. Yeast AAC as a basis for structure/function studies
Yeast (S. cerevisiae) became the platform of convenient genetic
manipulations of the AAC for elucidating structure–function relation-
ships on a broad scale. In S. cerevisiae and Candida utilis the existence of
ATR sensitive ADP/ATP exchange similar to that in rat liver mitochon-
dria was early recognised [412]. A lower temperature dependence and
lower afﬁnity for ATR was noted. AAC mutants resistant to BKA were
claimed by three groups screening the growth of yeast in the presence
of BKA [413–415]. In isolated mitochondria ADP/ATP transport was
reported to be BKA insensitive [414,415]. However these results
remained unconﬁrmed and seemed to be caused by measurement
problems. The ﬁrst “native” AAC mutation was found in the classical
nuclear mutant op1 (p9) [416] showing a decreased translocation rate
and afﬁnity for ADP and ATP. With 35S -CAT binding a lower AAC
content and a 4 times lower afﬁnity for CAT in op1 than in wt was
determined [418]. Also a major afﬁnity decrease for 3H-BKA binding
was reported [419]. In this context attention is drawn to the AAC
in mitochondrial DNA defective ρ− cells. The low ADP/ATP exchange in
ρ− mitochondria was inhibited equally by CAT and BKA [418,419].
Binding of 35S-CAT had the same high afﬁnity as inwt [418]. These and
other [420] results conﬁrmed the nuclear coded biogenesis of AAC and
contradicted the reported absence [421] of an ATR sensitive transport
in ρ− cells. Also in promitochondria isolated from anaerobic yeast a CAT
sensitive ADP/ATP exchange was observed but CAT binding had a
4 times reduced afﬁnity [418]. The reported inhibition of AAC bio-
genesis by erythromycin [421] could not be conﬁrmed [419]. Another
direct proof for nuclear coded AAC came from studying the expression
of AAC in N. crassa [422]. In cells grown on 14C-leucine and chased
with 3H-leucine after addition of chloramphenicol or chlorheximide,
the 3H/14C ratio in the 33 kDa band of AAC clearly established the
nuclear controlled biogenesis of AAC.
13.1. AAC isoforms in yeast
S. cerevisiae contains three genes for isoforms of AAC. yAAC1 was
ﬁrst discovered by sequence homology to bAAC1 [423], but it only
poorly complemented the op1 defect of aerobic growth. Disruption of
the yAAC1 gene revealed the yAAC2 gene which turned out to
represent the op1 gene by fully complementing op1[424]. yAAC2 is
the principal AAC in aerobic yeast, yAAC1 is barely expressed [425].
Disruption of AAC2 alone prevents aerobic non-fermentative growth.
A third transport pathway was postulated [425] based on the ﬁndingthat disruption of both yAAC1 and yAAC2 genes still allowed
fermentative growth. It could be attributed to a third (yAAC3) isoform
[426] that is expressed only under anaeorobic conditions. Exclusively
yAAC3 is obligatory for anaerobic growth as shown by disrupting
the 3 isoforms separately [427]. The role of yAAC3 is suggested [410]
to act in reversed order, supplying ATP from glycolysis to the
mitochondria. Although the expression in anaerobic yeast of yAAC3
can be monitored bymRNA, the level of yAAC1 protein is too low to be
detected in immunoblots [427]. The apparent lack of a leader
sequence lead to the unconﬁrmed speculation that yAAC3 might be
expressed in other intracellular membranes [426]. In particular, the
ﬁnding, that yAAC1 deﬁcient strain produced no phenotype except for
a red colour of adenine precursors accumulated in vacuoles, lead to
suggest a role of yAAC1 in vacuoles [428]. Notably, in the obligate
aerob N. crassa only one ncAAC gene has been found [384].
The yAAC2 became a major vehicle for structure–function studies
by introducing mutations or by searching for spontaneous mutations.
For the functional characterisation mitochondria were used, but for a
more incisive characterisation yAAC2 was isolated and reconstituted.
In an early report the “ATR binding protein” from yeast was isolated
displaying two bands with 37 kDa and 34 kDa [429]. ATR afﬁnity
chromatography produced low yield and according to other experi-
ence [256] a denatured product. For the isolation of intact yAAC2 from
yeast, the HTS procedure was modiﬁed [430] in order to separate the
AAC from porin. In SDS gel yAAC2 was identiﬁed to migrate as 31 kDa
band and yeast porin as 29 kDa. This isolation method was also the
basis for reconstitution. The higher apparent MW of 37 kDa [429] in
the previous work may be caused by calibration problems and the
34 kDa band may be due to porin.
yAAC1 and yAAC2 were isolated from yeast strains constructed to
overexpress these isoforms separately [431]. The reconstituted yAAC1
was still 1/3 as active in transport as yAAC2 and had the same KM for
ADP. Thus the reason, that in yAAC2 defect cells AAC1could not
support aerobic growth, lies in the low expression level. The
conditions and factors involved for the expression of the three
isoforms were shown to be inﬂuenced by the oxygen and heme level
[432–434]. The involved promoters and transcription factors were
characterised and it was shown that the N-terminal extension in
yAAC2 is instrumental for the high expression level [433]. Mammalian
AACs such as bovine bAAC1 could be expressed in yeast only at very
low levels [300,435] even with multicopy vectors. Levels of bAAC1
equivalent to the yAAC2were expressedwhen the unique 5′ extension
of yAAC2 gene was spliced into the expression vector construct [435].
This method was also used for the expression of the three human AAC
isoforms in yeast [436].
13.2. Mutations in yeast AAC
The mutation responsible for pet9 (op1) was identiﬁed as R96H in
AAC2 [385,425]. The overexpressed and reconstituted protein had a
distinct but reduced transport activity [431]. In an extensive broad
study 15 mostly charged residues conserved within the three repeat
structure of the yAAC2 or in the AACmotif were selected formutations
[437]. In the second helix of each repeat the homologous R96, R204,
R294, and in the AAC motif RRRMMM the three Arg were mutated to
neutral residues (Fig. 7). In all these mutated cells non-fermentative
growth was impaired indicating the importance of these charged
residues in AAC function. Direct measurements of ATP synthesis in
cells [438] showed a residual 8% oxidative phosphorylation rate in
R294A and zero activity in the other mutants. In contrast the decrease
of cytochrome content was only small. Obviously in these plasmid
strains oxidative phosphorylation and respiratory capacity are poorly
correlated. Similarly, in the isolated mitochondria respiration and
cytochrome content were reduced to between 25 to 60% of wt [438].
ATP synthesis rates were zero in 5 R→A mutations, but still at 5%
of wt in R96H and 20% in R294A. The AAC content, as measured by
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R204L but retained 70% in R294A and about 25% in R96R, R252A,
R253A, and R254A. Determination of 3H-CAT and 3H-BKA binding in
thesemitochondria revealed a similar pattern. These results show that
the mutations do not affect the binding of BKA and CAT. The ratio of
ATP synthesis to AAC content was reduced to between 20 and 1%.
The mutant AAC was isolated and reconstituted for transport
measurements aimed at elucidating not only changes in the absolute
rates but also in the four exchange modes [66]. Besides stopping
exchange by a CAT+BKA mixture, an automated rapid mixing and
sampling device allowed rapid and precise measurements without
relying on inhibitors which may be disabled in the mutants. With CAT
alone in wt only 10 to 15% of the activity was inhibited indicating that
the majority of AAC is incorporated with the m-side out in the vesicles.
The activity of the basic electro-neutral D/D exchangemodewas zero in
R96A, R204L and at a few % in other mutants, with the exception of
R294A reaching that of wt. This paradox to the poor aerobic growthwas
resolved by measuring the 4 exchange modes. Strikingly, the modes
including ATP in particular the T/T mode, which are normally higher in
wt, were drastically decreased in R294A compared to the D/D mode.
The ratios of the homo-mode rates v(T–T)/v(D–D) inverted from 1.5 in
wt to 0.2 in R294A, and the productive versus counter-productive
hetero-mode rates v(T–D)/v(D–T) from 2.6 in wt to 0.2 in R294A. Since
in the vesicles most of AAC was inserted m-side out, the T–D mode
would be required for ATP delivery in oxidative phosphorylation,
explaining that the AACmutants because of their suppressed T–Dmode
did not sustain sufﬁcient ATP delivery. A similar inversion of modes
although at a lower level was determined in the other Arg mutants.
These and other (Heidkämper et al. unpublished) results indicated that
only the KM of ATP is increased in these mutants indicating the
importance of these Arg, in particular R294, to compensate the extra
negative charge of ATP4− versus ADP3−. R96 and R204, as well as the Arg
triplett (R252-254) seem to be more important for transport activation
in general i.e. for both ADP and ATP, whereas the homologous R294 in
the third repeat controls more speciﬁcally ATP with its extra charge.
Further conspicuous charged residues addressed bymutations [439],
were K38 in the ﬁrst helix,which is conserved in all AACwithin theMCF,
and two other repeat triads largely conserved in the MCF, K48A, R152A
and R252 including a member of AAC signature Arg triplett R252,R253,
R254, and a triad with negatively charged residues E45A, D149S, D249.
These acidic residues, originally proposed to be at the helix terminal at
the matrix membrane surface [437], are according to the crystal
structure [297] located near the matrix surface within the bent helices
(see Fig. 9). Here they form ion bridges with the positive triad residues,
E45-R152, D149-R252, and D249-K48. In all these mutants ATP
synthesis measured in cells and in the isolated mitochondria was
inhibited [439], with the exception of E45G which retained full or in
mitochondria even enhanced activity. According to ELISA the amount of
AAC was reduced to 20 or 50%. 3H-CAT and 3H-BKA binding and
inhibition of exchange were strongly reduced in K48A, D149S, D249S,
indicating a role of these residues in inhibitor binding. The transport
rates of the isolated and reconstituted AAC in the 4 exchange modes
were very low for K48A, D149S, D249S, but nearly normal for all modes
in E45G. Further a strong exchange mode inversion was observed in
K38A and R152A, with little attenuated rate of the basic D–D mode but
strongly decreased rates of the T–T and T–Dmodes. This explained that
these mutants despite their only partially reduced respiratory activity
could not sustain non-fermentative growth.
Taken together, the three residue triads were visualised to form
three charged rings around the translocation path. Most intriguing, in
each triad one residue (E45, R152, R294) is distinctly less important for
transport, spiralling along the threefold axis between the three repeat
domains. This was speculated to cause a rotating substrate movement
along the translocation path [439]. Whereas the triad residues were
regarded to have a more general structural role typical for the MCF,
K38 seems to play a more direct role in ADP/ATP transport.By enforced chemical or irradiative mutagenesis S. cerevisiae was
screened for growth resistance to BKA [169]. Four point mutations in
AAC2 were identiﬁed G30S, Y97C, L14S, G298S which partially
relieved the inhibition of growth on glycerol by BKA. The AAC content
in the isolated mitochondria and exchange activity were normal. The
KI for BKA was only 1.5 to 2 times increased in the mutants. Only ATP
synthesis was recorded as a proxy for transport. All these mutations
generated OH− or SH− groups indicating that conformational changes
rather than lack of binding residues are responsible for the decreased
sensitivity to BKA.
13.3. Mutations in N. crassa AAC and relevance for AAC import
In principle mutational defects can also be caused by defects of
AAC import and folding. To discern this factor, the AAC was
expressed in E. coli. Interestingly, yAAC2 has a partially different
codon usage than other MCF members that does not allow yAAC2 to
be expressed in E. coli. Instead AAC from N. crassa could be well
expressed [300] in E. coli inclusion bodies. Mutations in ncAAC were
introduced in positions isologous to the mutations in yAAC2. Again
the rates of the 4 exchange modes were measured. In general, the
ATP involving modes in particular the T–T mode were more affected
than the basal D–D mode indicating the higher sensitivity of ATP4−
against a loss of a positive charge in the AAC, similarly as observed
with yAAC2. The comparison of the basal transport rates of the
ncAAC mutants isolated from E. coli and from mitochondria (yAAC2)
should indicate whether protein import and folding are impaired by
the mutation. A strong difference was found in the mutants of the
ﬁrst two intrahelical Arg, ncR86A/yR96A, ncR195A/yR204A, which
are inactive in yAAC2 but retained distinct activity in ncAAC,
supporting their importance for AAC processing. In the third repeat
domain the intrahelical Arg (ncR285/yR294) were not impaired in
mitochondria, indicating a different role. These results agree with
the different roles of the three repeat target sequences found in
import studies [440].
13.4. Revertants of yeast AAC2
Starting with selected mutations, spontaneous second site rever-
tantswere searched [441,442] based on the spontaneous conversion of
yeast cells to non-fermentative growth. About 15 revertants were
collected containing second mutations of neutral or charged residues
into neutral residues. In the biochemical characterisation only those
strains, where the ﬁrst and second sites start with charged residues,
showed clear reversions of AAC expression and transport activity.
Further, second site rescues occurred only when the ﬁrst mutation did
not inactivate transport completely. (Heidkämper et al. unpublished).
These were R294A+E45G/Q, R152A+E45Q, D149S+R252T, and K38A
+E45G. Since the spontaneous secondmutations removed an opposite
charge, these residueswere proposed to form salt bridges inwt yAAC2:
R152-E45were visualised to connect TMH1andTMH3, andD149-R252
to connect TMH3and TMH5 [396], both bridges being located at them-
side. This predictionwas conﬁrmed in the crystal structure of the CAT–
AAC complex [9] where these salt bridges form a circular closure.
The replacements of these ion pairs by neutral residues abolished
partially the exchange mode inversion of the primary AAC mutants,
although the absolute transport rates remained low. The results indi-
cate some redundancy in this charge pair network as elimination of
one charge pair still allows sufﬁcient transport to sustain a limited
aerobic growth.
14. Mapping the structure of AAC
A number of topographic methodswere applied for the elucidation
of binding sites, the folding of the peptide chain, and the conformation
changes between the transport states. These included covalently
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antibody interactions, limited proteolysis and mutations. Besides
information on the structure, more importantly, an insight in the
structural changes implicated in transport was obtained. These results
have to be compared and interpreted with the crystal structure of the
AAC, and the crystal structures will also have to be reconciled with the
mapping results. A summary of the mapping studies on the AAC are
assembled in Table 1.
14.1. Mapping of lysine residues
The high content of lysines in bAAC1 made these reactive residues
a favourable target for a broad accessibility investigation [443,444].
Pyridoxal phosphate (PLP) is membrane impermeable and forms
Schiff base conjugates with lysinewhich can be stabilised by reduction
with NaBH4. PLP inhibits ADP/ATP transport with KI =0.8 mM but was
unable to remove CAT or BKA and only partially ATR. 3H-PLP was
synthesised and applied to bovine heart mitochondria to probe c-side
access and to SMP for m-side access. The c- and m-states were
established by loading with CAT, BKA or ATR. Access to the c-side was
probed in mitochondria and to the m-side in SMP. Further, isolated
CAT–AAC and ATR–AACwere probed with PLP. After ﬁxation of 3H-PLP
by NaBH4, the AAC was isolated and fragmented and the peptides
generated by thermolysin were sequenced and analysed for 3H-PLP
incorporation. Among the 18 lysines analysed, the majority could be
accessed from the c-side. Several lysines change their accessibility
between c- and m-state. More were accessible in the m-state (with
BKA) than in the c-state (with CAT or ATR). The interpretation of the
access was based on a 6 TMH folding model. An additional, not
conﬁrmed amphipathic β sheet spanning the membrane after TMH1
placed the N-terminal at the m-side [391] but did not affect the
targeted lysine positions with the exception of K22. K42, K48 in theTable 1
A list of topological studies of the folding of AAC in the mitochondrial membrane
AAC in Probe Sequence region Cond
C-, N-terminals
BHM N-terminal antibody N-terminal positive BKA+
C-terminal antibody C-terminal negative
UCP1 as AAC
analogue
Trypsin C-terminal cleavage (ATP
Yeast-M 2-azido-naphtoyl-ADP C-terminal BKA+
Matrix loops
BHM Azido-ATR C155–M200 –
BHM Pyridoxal-phosphate K162 CAT-
BHM 2-azido-ADP F152-M200 T250-M281 –
Yeast-M 2-azido-ATP, 8-azido-ATP G172 – M210 –
BMH-SMP Trypsin
Lys-protease
Cleavage at K42, K146,
K244
BKA+
CAT−
Yeast-M 2 azido-naphthoyl-ADP S183-R191 I311-K318 –
Yeast-M Trypsin cleavage at K163 CAT+
at K178 BKA+
Eosin maleimide (EMA) access S161C BKA+
BHM-SMP EMA-access C159
BHM C-C crosslinking (Cu-phenanthroline)
(bis-maleimide)
C56–C56 BKA+
CAT−
Cytosol loop
Yeast-M C-scanning by charged SH reagents 106–132 BKA−
CAT+
Transmembrane area
BHM Pyridoxal-phosphate (PLP) K 91, 98, 95 BKA+
K198 CAT-
Yeast-M “Cys scanning” EMA access F98 to F107 BKA+
CAT
BHM Pyridoxal phosphate K42, K48 BKA+
SMP K146 CAT
BHM, bovine heart mitochondria; SMP, submitochondrial particles; Yeast M, yeast mitochond
BKA.ﬁrst matrix loop M1 were exposed to PLP in the presence of BKA and
largely masked in the presence of CAT, whereas K62 was unmasked
by CAT. K146 inM2was exposed to the m-side in both states, but K162
could be accessed only from the c-side. In mitochondria this
access required the m-state but in the isolated AAC it also reacted in
the c-state.
By adhering to the 6 TMH model, the c-side access of K162 led to
the assumption [444] that the segment carrying K162 folds into the
membrane from the m-side into the translocation channel open from
the c-side. The c-side cluster K91, K93, K95 was accessible to PLP from
the c-side in the m-state only and masked with CAT. Originally
assumed to be in the C1 loop, according to the crystal structure [297]
these residues are at the c-side of TMH2. For K91 the masking reﬂects
the linkage in the crystal structure to the SO4− group of CAT. For K93,
K95 the masking agrees with the evidence obtained in yAAC2 that
TMH2 [445] turns 180° from c- to m-state. The analogously positioned
K198 and K 205, originally in C2 but now at the c-end of TMH4, are
accessible in both states from the c-side only. Thus TMH4 can be
visualised to turn between the c- and m-states similarly as TMH2. The
unique AAC speciﬁc K22 in TMH1 is accessible only from the c-side
and masked in the c-state.
14.2. Photoafﬁnity labelling by azido derivatives
Photoafﬁnity labelling of the AAC started with applying 8-azido-
ATP to BHM [200,446]. It was shown to incorporate primarily to a
30 kDa band in SDS gels identiﬁed as AAC by the inhibitionwith ATR.
Also with the more ﬂexible arylazido-ADP, AAC was the preferential
target in BHM, but in yeast mitochondria [447] a 37 kDa band,
probably porin, was the major target. For crosslinking studies a dual
photoafﬁnity label of ATP was synthesised by introducing both the 8-
azido and arylazido group [448]. 2-azido-ADP [449] with a ﬁxeditions Conclusion Reference
N-terminal at c-side [459]
C-terminal masked
) C-terminal at c-side [460]
C-terminal at c-side [454]
Binding site at segment C155–M200 accessible from the c-side [452]
BKA+ M2 loop accessible from c-side by entering the channel [444]
Binding site at loops M2 and M3 accessible from c-side [450]
Access from c-side loop M2 protrudes into channel [453]
Proposal that C-Loops (otherwise M1and M2) intrude channel
from c-side
[461]
M2 loops intrudes channel, additional C-term. contact [454]
Loop M2 protrudes from m-side into membrane [462]
M2 protrudes into channel
M2 loop m-side gated by M1 with CAT [342,343]
Inter-subunit contact indicates large M1 loop mobility [267]
[268]
C1 loop changes on transition m-to c-state [466]
c-side end of TMH2, TMH4 unmasked in m-state [444]
Twisting of TMH2 on transition c→m-state [445]
(−+)
Access from m-side unmasked in m-state,
incorporation only in SMP, not in BHM
[444]
(−+)
ria; TMH, transmembrane helices; CAT, BKA+ stimulated, CAT, BKA− inhibited by CAT or
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preferred anti-conformation, whereas 8-azido derivatives are in the
syn-conformation. As a result 2-azido-ADP has a higher binding
afﬁnity to the AAC than 8-azido-ADP [201]. In BHM 2-azido-ADP
photo-labels againmostly AAC [201], but no incorporation to the AAC
is seen in SMP [450] demonstrating the c-side speciﬁcity of 2-azido-
ADP binding.
After the amino acid sequence of bAAC1 [49] became available the
labelled sites were allocated in the sequence. Mapping of the 2-azido-
ADP 32P-labelled peptides revealed [450] two target sites in the
sequence, the major one at F153-M200 in the second repeat
with incorporation at K162, K65, I183 similarly to azido-ATR (see
below), and the second in Y250-M281which include the last TMH and
C-terminal peptide. Since both labelled segments were accessible
from the c-side a folding patternwas adoptedwith only 5 TMHplacing
these segments at the c-side [450]. In previous studies various azido-
ATR derivatives had been synthesised and their speciﬁc incorporation
to bAAC1 was assigned [451,452] to the segment C159–M200 which
corresponds to the ﬁrst region of 2-azido-ADP incorporation. These
results indicate that ATR and ADP binding sites are not separate as was
suggested by the results with N-ADP binding [8].
Photoafﬁnity labelling of the yeast AAC-2was performedwith both
2- and 8-azido-ATP [453]. Different from 2-azido-ATP, labelling with
8-azido-ATP required isolated AAC because of its lower afﬁnity.
Identiﬁcation of labelled peptides from yAAC2 was easier because
CNBr cleavage sites are more evenly distributed than in b-AAC1. Both
with 2- and 8-azido-ATP all the incorporated label was conﬁned to the
A175-M210 segment, which encompasses matrix loop M2 and the
adjacent TMH4. The absence in yAAC2 of the second site found in
bAAC1 [450] suggests that the secondary site results from a side
reaction of 2-azido-ADP. This interpretation was supported by the
ﬁnding that in yAAC2 with 2-azido-naphtoyl-ADP (azido N-ATP) [454]
only the C-terminal stretch I311-K318 was labelled. The naphtoyl
group may confer less speciﬁcity and derange the binding into a less
precise orientation. This reasoning is at variance to Dianoux et al.
[454] assuming a sort of half site reactivity between the monomers in
the dimer AAC in which the substrate alternates between the two
different sites in step with the transport and the 2-azido-naphthoyl
group reaches out to the C-terminal of the other monomer.
It must be noted that the binding of azido-ADP and ATP to the
central region (A175-M210 in yAAC2, Y153-M200 in bAAC1), seemed
to be at odds with the six TMH folding model where this region is at
the matrix side while the azido-nucleotides as well as azido-ATR bind
from the c-side. At variance to Dalbon et al. [450] these results were
interpreted, by retaining the 6 THM structure, to support the view
[444,453] that this region intrudes into the translocation pathwhere it
can be reached from the c-side [383]. Analogous hairpin structures
were proposed to exist in K+-channels [455] and conﬁrmed in the
crystal structure [456]. The strongmobility of this segment in AACwas
further elucidated by SH-probes (see below):
14.3. Immunochemical properties and mapping of the AAC
Polyclonal antibodies raised against native CAT–AAC (bAAC1)
complex reacted [457] in immuno-precipitation speciﬁcally against
the CAT–AAC and not with the unloaded or the ADP and ADP plus BKA
loaded AAC. Vice versa antiserum against the BKA–AAC complex did
not react with unloaded AAC or CAT–AAC. SDS treated AAC was not
recognised by both antisera. Thus these antibodies display conforma-
tion speciﬁcity reﬂecting the differences in antigen exposure between
the c- and m-state of the AAC. The CAT–AAC antiserum inhibited
transport only weakly in mitochondria but fully in reconstituted
vesicles, probably due to restricted access in mitochondria [260,457].
Interestingly, this antiserum prevented the replacement of 35S-CAT by
BKA (+ADP) but did not inﬂuence the exchange of 35S-CAT against CAT.
Obviously the antibodies did not “cover” and recognise the CAT-sitebut “clamped” the AAC in the c-state conformation. These antibodies
apparently reacted preferentially with the matrix side of the AAC
where most charged residues are located, indicating large structural
rearrangements. Applying quantitative immuno-absorption techni-
ques [260] the cross-reactivity between c- andm-state antibodies was
determined to about 30%.
In another work antiserum against the CAT–bAAC1 [458] were
assigned to react with the C- and N-terminal regions, and antiserum
against SDS–AAC to react with the central region of AAC. Among
antibodies raised against synthesised short peptides of the N- and C-
terminal, only the N-terminal antibody reacted with the AAC in
mitochondria [459] which provided evidence that the N-terminal
extends to the c-side and that the C-terminal is masked. In the
presence of BKA the N-terminal antibody did not react, suggesting a
recessed N-terminal in the m-state.
14.4. Limited proteolysis
First indication for the c-side location of the C-terminal came from
limited proteolysis of the uncoupling protein (UCP1), a homologue of
AAC with the same folding pattern [391]. Limited proteolysis of UCP1 in
mitochondria cleaved a C-terminal peptide of 10 residues without
affecting the function [460]. In limited proteolysis of bAAC1 by trypsin
and C-endoprotease inmitoplasts and SMP [461], cleavagewas observed
only in SMP loaded with BKA at sites identiﬁed as K42 and K244, which
are localised in the intrahelical loops of the ﬁrst and third repeat,
suggesting that both sites face them-side and are retracted in the c-state.
These results seemed to contradict a c-side localisation of these loops
deduced from 2-azido-ADP labelling [450]. To reconcile these results
with a 5 TMH folding model a variable intrusion of the putative c-side
loop into themembranespace becomingaccessibly toproteases fromthe
m-side was discussed [461]. This folding contrasts to the model,
reviewed above, of an intrusion of the matrix loops within a 6 TMH
fold. In yeast mitochondria, exposure to trypsin produced selective
cleavage at two sites in the central loop; K163 with CAT and K178 with
BKA [462]. The reason for this difference between yeast and bovine AAC
inmitochondria is not clear. But the yeast results are consistent with the
accessibility of this loop from the outside, as concluded from 2- and 8-
azido-ADP labelling in yeast mitochondria [453] and in support of the
postulated intrusion of this loop [383].
14.5. SH reagents as conformation probes
Three cysteines occur in conserved three repeat positions in the
intramembrane matrix loops in AAC from mammalian sources [383].
As reviewed above, the ADP dependent inhibition by NEM of transport
andADP stimulatedNEM incorporationwere interpreted to require the
m-state of the AAC [2]. Further work on SH groups in AAC addressed
the identiﬁcation of the targets of the SH reagents in the sequence and
their use in probing conformation changes. NEM was shown [463] to
target C56 located in the ﬁrst repeat of bAAC1. The ﬂuorescent,
membrane impermeable maleimide derivative EMA accesses the AAC
only in SMP [464] and was shown by micro-sequencing to label
primarily C159 [342] located in the secondmatrix loop of bAAC1.While
the reaction of EMAwas rapid, NEM labelled C159 much more slowly.
C128 remained inaccessible for both reagents and C256 was weakly
labelled by EMA. The incorporation of EMA in SMP was inhibited by
high concentration of ADP and by BKA, but by CAT only when added
before sonication [343]. The results suggest that the central loop M2
moves into the translocation path and exposes in the m-state C159 to
EMA. Different from NEM, EMA inhibits transport in SMP, indicating
that it shares with BKA and DAN-AMP an overlapping binding site in
the m-state. The eosin moiety, which has an analogous structure to
adenosine, may bind to the substrate site near C159 and thus enhance
the local concentration for the maleimide moiety to rapidly react with
C159. Further the two anionic charges may increase afﬁnity to the
Fig. 8. The 2.2 Å crystal structure of the CAT–AAC complex (bAAC1) as a ribbon diagram.
A. View from the membrane plane with 6 transmembrane helices (TMH) surrounding
the c-side cavity. The positions of CAT bound in the cavity and of cardiolipin (CL) at the
membrane interface are indicated. B. View vertical to the membrane from the c-side
into the open cavity walled by 6 TMH. CAT bound in the cavity and some surrounding CL
are shown. The TMH converge to close the cavity at the m-side. Adapted from [297].
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without maleimide) is an effective ﬂuorescent ligand for the binding
site in the m-state [465]. The ﬂuorescence response to BKA, CAT and
ADP characterise eosin Yas anm-state ligand in linewith the results for
EMA.
A covalent (AAC)2 dimer of bAAC1 linked by a C56–C56 bridge was
generated by oxidative crosslinking with Cu-phenanthroline [267]. The
crosslinking was only possible in SMP and was inhibited by loading the
mitochondria with CAT before sonication. Using divalent SH group
reagents of various spacer length crosslinking exclusively between C56
was also observed [268]. With these agents the ﬂexibility of C56
between the monomers was estimated [268] to allow a maximum
movement of 12 Å of the M1 loop. Both types of crosslinking inhibited
transport in the SMP [268].
The folding problem of the central loop was further approached
in yAAC2 by the S161C mutation [462]. EMA reacted with this SH
group in mitochondria treated with BKA but not with CAT. The
accessibility of the central loop from the c-side conforms with the
results obtained with the lysine reagent PLP [444]. In another
probing of the translocation path of yAAC2, in 9 positions of TMH2
close to the c-side single Cys were introduced and exposed to EMA
[445]. Whereas in CAT loaded mitochondria nearly all these residues
were protected in accordance with the crystal structure, under ATR
3 Cys positions reacted with EMA and under BKA other 4 Cys
residues. This is interpreted to reﬂect a twisting of TMH2 on the
transition from the c- to m-state. A similar approach [466] was
applied to the ﬁrst external loop C1 consisting of a small coil, ﬂanked
by the TMH2 and TMH3. Differences of EMA labelling between BKA
and CAT loaded mitochondria were more pronounced in the N-
terminal part of C2 and linked to the twisting described for the C-
terminal of TMH2 [445]. By arranging the residues in a helical wheel
the observed EMA access could be shown to be concentrated at one
side. With the exception of K108C, in the BKA induced m-state the
upstream residues were less accessible, whereas in the downstream
region of TMH2 the differences between c- and m-state were minor.
A role of K108 in binding was suggested since K108C was completely
protected by CAT. Further, by attaching positive or negative charges
to the SH groups with MTS reagents, transport became inhibited by
implanting a negative charge at K108Cwhereas the response at other
residues was relatively weak.
15. The crystal structure of AAC
For obtaining the long awaited crystal structure of theAAC [297] the
bovine heart CAT–bAAC1 complex was the most favourable candidate
because of its high stability in non-ionic detergents [254,256,259]. The
early introduced [185] but otherwise little applied LAPAO was
obviously superior to dodecyl-maltoside, the most popular detergent
for crystallisation of membrane proteins. Independently, two-dimen-
sional crystals of yeast ATR–yAAC3 complex have been resolved [277]
to 8 Å by electron diffraction. Both structures agree showing a six helix
barrel fold with no dimer formation. The 2.2 Å structure has been the
principal source for understanding the architecture of the AAC and the
discussion of a possible mechanism.
With the crystal structure some striking features pointed out in the
amino acid sequence [49,383] and modelled into transmembrane
structures [382,391] assume a new more precise and deﬁnite meaning
[9,278,297,467] (Fig. 8A and B). While the structure contains many
featureswhichagreewith the conclusionsdrawn frommapping theAAC
folding by biochemical and physical methods, as reviewed in Chapter 6,
there are a number of features at variance to those predictions. The basic
fold (Fig. 9) of a barrel of 6 transmembrane helices (TMH) consisting of
three repeat domains containing each twoTMH [382] around a pseudo-
threefold axis agrees with the predictions. But the TMH are longer than
modelled by the hydrophobic algorithms and are tilted, thus accom-
modating the long TMH within the membrane area. They form a quiteregular wall surrounding a basket type cavity extending into the center
of the membrane. Near the m-side in each repeat domain, the odd
numbered TMH1, 3 and 5 are bent at the threefold conserved prolines,
interrupting the TMH with a brief coil. The continuing short helix
contains the mitochondrial carrier motif PhD/EXXK/RhK/R (see above)
including the AAC signaturemotif RRRMMMin the third repeat domain.
The following matrix side segments M of each repeat turn the chain
towards the center axis and thus contribute to the closure at the matrix
side. Small, 11 residues long helices in the M segments run nearly
parallel to the membrane. They also contain conserved charge clusters,
forming at the end the second less stringentmotif D/EGXXXXΦK/RG (Φ
aromatic residue) (Fig. 9). A threefold circular salt bridge network of
intrahelical charged residues (E29-R137, D134-R234, and D231-K32)
locks the base of the cavity by tying together the m-sides of the odd
Fig. 9. A. Principle folding diagram of bAAC1 based on the crystal structure of the CAT–AAC complex. Each of the three repeat domains contains a TMHwhich is bent at an intrahelical
proline. The pink areas contain MCF motifs given in part B. The AAC speciﬁc signature in TMH5 is enhanced. The matrix regions contain short helixes. B. Parallel alignment for
similarity of the 3 m-side sequences (M-loop) including two MCF motifs. The AAC speciﬁc signature in M3 is highlighted. Adapted from [9].
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revertants [396]. CAT sits in the cavity with the aglycon carboxy-
atractylogenin near the bottom and the glucose moiety near the c-side.
The two carboxyl groups form salt bridges with R79 of the triad
intrahelical Arg and hydrogen bonds. The two –SO4− groups form salt
bridges to K91 and R187 and hydrogen bonds to N87 in the cavity wall
near the c-side. The numerous positive residues lining the basket may
steerADP3− andATP4− into thebinding site, aswell as stripMg++ fromthe
entering nucleotide complexes. Further a striking ladder of tyrosines on
TMH4 has been suggested [9] contributing to a “non-sticking” steering
of the substrate in the cavity.
16. Mechanism
16.1. Induced transition ﬁt
Before reviewing the mechanism of the AAC mediated transport, a
brief summary of the catalytic principles governing the carrier transport
will be given that are important for the interpretation of function–
structure relations of the AAC. The results obtained with the AAC have
been a prime reason for conceiving a new description of transport
catalysis called the “induced transition ﬁt” (ITF) [187,212,468]. Themost
striking result leading to the single site reorientation mechanism was
the intriguing “mobilisation” of the AAC by the substrate. It comprises
not only the net translocation but a mobilisation of the whole structure
with many intermediate steps. This conformational transition within a
well deﬁned trajectory of the structural coordinates is integrated with
Brownian movements within the AAC, enhanced by ADP or ATP that
might reach a maximum in the transition state.
To illustrate the ITF, the purely catalytic role of the AAC without
external electrical forces as in the homo-exchange modes D–D and T–T
will be considered. Being large hydrophilic substrates, ADP and ATP
require large conformation changes in theAACduring the translocations
entailing high energy barriers which can be compensated only by a
strong substrate–protein binding energy provided by the transportable
substrates ATP and ADP. On binding to the “ground” c- or m-state they
mobilise the carrier to switch into the opposite ground state.Whywould
these substrates activate the translocation process, whereas otheranalogue nucleotides are “stuck” in the carrier? The ITF of transport
catalysis rationalises these observations and is best explained by
comparison to enzyme catalysis. In enzyme catalysis the substrate
changes, in carrier catalysis it is the protein which changes and by this
token uses the substrate as a catalyst. In both cases the substrate–
catalyst interaction must be maximised in the transition state for
efﬁcient catalysis. For this reason the substrates initially should not ﬁt
perfectly to the binding site of the catalyst (Fig.10). For optimising theﬁt
in the transition state, opposite interactions occur for enzymes and
carriers: whereas in enzymes the binding site has evolved to optimally
bind the transition state conﬁguration of the substrate, in carriers the
substrate remains unchanged but induces a conformational change of
the carrier to attain an optimum ﬁt for the substrate. Thus not only is a
maximum ﬁt of the substrate to the binding center attained, but also
global changes in the carrier are facilitated leading to the closure and
openingof the translocation channel at the opposite sides. The increased
binding energy in the transition state drives the transfer of the carrier
complexes (CS)i or (CS)e to the transition state (CS)T. It should be added
that the induction of substrate change in enzymes versus induction of
protein change in carrier, does not exclude in the transition state local
change in enzyme [469,470] and reversible changes in the substrate
conﬁguration during the translocation.
The comparatively loose binding of ADP and ATP (Fig. 10) and the
high selectivity may seem to be a paradox, but actually were an
essential guide to the ITF: the loose ﬁt in the ground state contrasts to
the perfect ﬁt in the transition statewhere a precisematch of substrate
and binding site encompassing all parts of the molecule is required,
explaining the high speciﬁcity. High intrinsic binding energy is needed
to overcome the large conformation energies and facilitate the
translocation. The energetic constraints of the ITF result in a preference
of exchange versus unidirectional transport where the “return” branch
of the carrier cycle is not facilitated by binding energy. Therefore,
dependent on the size of the substrate and concomitant conformation
changes, the obligatory exchange of AAC rationalises the unidirectional
mode of Pi transport in mitochondria handling a small substrate
requiring small conformation changes. In unidirectional transport of
large substrates, the lack of intrinsic binding energy can be compen-
sated by external energy such as in ATP dependent transport [471].
Fig.10. Induced transition ﬁt. The interaction of the carrier binding center with the substrate. A. Poor ﬁt of substrate to the binding site in the ground states Ce and Ci of the carrier. The
transition state is induced by an optimised ﬁt of the substrate producing a high intrinsic binding energy. The changes of the binding center trigger global changes in the carrier leading
to closing and opening of the opposite gate. B. Inhibitors are well adapted to the ground states for tight binding. The different interfaces of the opposite ground states require side
speciﬁc inhibitors. Inhibitors can induce the abortive ground state conformations c′ or m′ to further increase the binding interaction. From [187].
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inhibitors in the transport cycle (Fig.10). In contrast to enzymeswhere
substrate analogues type inhibitors mimic the transition state
conﬁguration for tight binding, in carriers inhibitors must bind to
the ground states and not to the transition state conﬁguration.
Transport inhibitors should be designed to better ﬁt the binding site in
the ground state than transportable substrates and thus produce high
binding energy without an incentive to go into the transition state.
Two types of inhibitors can exist, whether binding to the out- or in-
ground state. For the AAC these inhibitors are represented by some
nucleotide analogues (see above). Inhibitors using an enlarged
binding surface, proposed to induce the ground states into “abortive”
states, are seen to be represented by ATR, CAT and by BKA.
16.2. The single binding center reorienting mechanism of AAC
Transport mechanisms of carriers have relied for many years on
kinetic studies [37]. With the ADP/ATP exchange in mitochondria it
was possible for the ﬁrst time to penetrate to the molecular level and
to deﬁne the carrier sites and their binding dynamics [2]. The reasons
for this paradigm role of the AAC are twofold: the high density of AAC
sites in the inner mitochondrial membrane and the existence of
exclusive high afﬁnity inhibitors for binding to the outer or inner
aspect of the carrier binding site. At ﬁrst the non-linear binding of ADP
and ATP and the effects of ATR on binding to depleted mitochondria
provided an insight into the switching of the AAC binding site
between the out- and inside [166]. This view treated the binding
measurements not as an open equilibrium of the substrates with all
carrier sites but interjected a translocation step by which a part of the
binding sites, once loaded with external substrate, becomes oriented
inside thus establishing an indirect equilibrium with the added
substrates. With the arrival of BKA, the translocation of carrier sites
from the intramembrane (cytosolic) to the matrix side, henceforth
called the c- to the m-state (see [2,3]) could be demonstrated more
directly, by conceiving and experimentally verifying that the BKA
induced binding of ADP or ATP reﬂected in fact trapping of
translocated ADP or ATP inside [153,171] where BKA displaces ADP
and ATP from the binding site [172]. The complex binding phenomena
of ADP and ATP involving ATR and BKA, the cooperative effects, slow
binding kinetics, temperature and pH effects caused by the rate
limiting permeation of BKA could all be reasonably rationalised[3,266,472–474] by the single reorienting binding center-gated pore
mechanism (SBCGP). The possibility to ﬁx all carrier molecules in
mitochondria on the out- or inside or in the c- and m-states gave a
unique insight into the operation of a carrier.
This view implied that the inhibitors ATR, CAT and BKA as well as
ADP and ATP bind to the same site. However in another work the
single site concept was not accepted and separate sites for ADP and
BKA [168] or, on the basis of ATR spin labels, “α and β” subunits on the
outer and inner membrane leaﬂet were proposed [218]. Based on
amino acid probes different binding sites for CAT and BKA and ADP
were postulated in a series of papers [8,237,238]. On the basis of
ﬂuorescent ligands [196,205,208,211] BKA was proposed to act as
“allosteric” effector from a separate site. Further the “BA-state” was
concluded not to represent the inside orientation [208] On the basis of
BKA binding studies the existence of a stable ternary complex was
conceived [168] and based on intrinsic ﬂuorescence studies, a
transitory BKA–ADP–AAC complex was proposed [169,216].
An essential consequence of the single site reorienting mechanism
is the change in the aspect of the binding site between the external
and internal state (for AAC c-state and m-state) engaging partially
different residues [2,473]. Whereas the substrates are bivalent, the
inhibitors are specialised for the c- and m-states. In fact CAT, ATR and
BKA are proposed to engage more residues than the substrates and
induce a conformation change of the “ground” c- or m-states into the
“abortive ground” c′- andm′-states [212,473] (Fig. 10) moving the AAC
structure further away from the transition state. This difference is
monitored by various signals, such as by CAT induced resistance to
proteolysis [184,256], intrinsic ﬂuorescence change [216], spin label
immobilisation [220]. In view of this difference between the abortive
and ground states, the term “CAT-” and “BA-state” for the c- and m-
state can be misleading [8,9].
16.3. Structural changes on c- to m-state transition
The following is a distillate of the various types of evidence
reviewed above for the structural changes involved in the transloca-
tion. With the isolation of the AAC large differences in the stability of
the protein in the detergent micelles towards proteolysis were noted,
indicating an overall more ﬂexible structure in the m- and m′-state
with BKA as compared to the maximally rigid c′-state with CAT
[184,256]. By the same criteria the AAC attains maximum ﬂexibility
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especially high in the three loops, connecting the transmembrane
helix pairs on the matrix side. This was ﬁrst noticed probing lysine
residues [444], showing that thematrix M2 loop is accessible from the
c-side, leading to the proposal that part of this loop intrudes the
translocation channel in the m-state. Further support came from
labelling M2 in BHM with 2-azido-ADP [201] and M2 in yeast
mitochondria with 2- and 8-azido-ATP [453] as well as with azido-
ATR [210,452], although the results were interpreted differently
[201,210,452]. In yAAC2 S161C located in M2 and adjacent to TMH3
was labelled from the c-side in the c-state [462]. The variable
accessibility to three similarly positioned cysteines in M1, M2 and
M3 of each repeat domain in bAAC1 provided strong and speciﬁc
evidence for conﬁguration changes. NEM reacted with M1 C56 only in
the m-state [2,342] whereas the polar EMA reacted with C159 in M2
from the m-side only in the c-state. A gating role was assigned to the
matrix loops: M1 closing in the c-state and M2 closing in the m-state
[343]. Large ﬂuctuations in them-state of M1were deduced fromC56-
C56 crosslinking studies in the bAAC1 dimer [268]. The external N- and
C-terminal segments changed their exposure from c- to m-state as
shown by immuno-assays [459] and proteolysis [462]. All these results
underlined the c- to m-state rearrangement of the M-loops in the
channel. Conﬁguration changes in TMH2 probed in yAAC2 [445] by
“Cys scanning”were interpreted as a 180° twisting of TMH2going from
the c- to m-state. In hindsight the lysine residues access data [444] are
compatible with these changes of both TMH2 and TMH4 in bAAC1.
The homologous repeat helices apparently move in a coordinated
fashion rendering these charged groups inaccessible on transition to
the c-state.
16.4. Crystal structure and mechanism
Any considerations about relating the transport mechanism to the
crystal structure must take into account that according to the ITF the
AAC–CAT complex represents an extreme c-state of the highly mobile
carrier machinery frozen by the binding of CAT [187,383]. In this abortive
c′-state the carrier conﬁguration is probably somewhat distorted to a
more extreme c-side opening than in the “empty” c-state which is the
starting state for the translocation cycle where the cavity may be
narrower with still enough space to permit passage of the substrate and
CAT to the binding center. Without CAT the matrix area appears less
tightly connected as suggested by easier access to proteases and reagents
in the c- than in the c′-state [256]. An important conclusion to be drawn
from the crystal structure is that ADP and ATPmay share the binding site
with CAT, in agreement with the single binding center gated pore
(SBCGP) mechanism [2]. Thus the crystal structure does not support the
tenet [7,8,214,475] as reviewed above, that there are two binding sites
for CAT and for BKA and, according to somemodels, there are segregated
outer and inner binding sites for ADP or ATP [475]. In other versions
inhibitor and nucleotide binding sites overlap so that there remain two
binding sites for simultaneous ADP and BKA binding [7].
When trying to ﬁt the nucleotide into the binding site, a central
issue of the ITF must be considered: a poor binding of the substrates
in the ground state and optimum binding in the transition state.
Candidate residues for ADP, ATP binding are the basic residues
located, according to the derived and the crystal structure, within the
TMH and that are partially involved in CAT binding: R79, R187, R279,
and K22 in bAAC1 and, by analogy, R 96, R204, R294, and K38 in
yAAC2. Whereas the intrahelical Arg are variably conserved in the
MCF, in TMH1 bK22/yK38 are conserved in all AAC known [476]. The
yAAC2 mutants, K38A, R96A have strongly reduced, R204L no
transport activity, whereas R294A is nearly fully active [66,477].
Importantly, in all mutants the transport modes with ATP are
more affected than with ADP, this effect being most dramatic in
R294A on a background of a normal D/D transport. This may suggest
that the γ-phosphate of ATP is close to the discriminating R294 inyAAC2 or homologue R279 in bAAC1. In the CAT–bAAC1 structure
these residues together with Y186 form a “bottleneck” of about 8 Å
diameter above the bottom of the cavity. This structural element was
called a selection ﬁlter [9], a term used for ion channels but less
useful for carriers, unless one may associate this term with the high
selectivity of the transition state required by the ITF. In an “in silico”
study based on the crystal structure [467] this conﬁguration on
omission of CAT is assumed to be a general binding site for MCF
substrates including ADP or ATP. However, it must be cautioned as
emphasised above that according to the ITF, the CAT–AAC structure
may represent a distorted ground state, where binding elementsmay
be moved out of their normal positions by CAT.
Pointing out [159] that the common 3 or 4 negative charges are
segregated in the inhibitors (ATR, CAT, BKA, acyl-CoA) but clustered
in ADP and ATP, it was speculated [159] that inhibitors by pulling the
positive residue apart cause a change in the binding center.
Accordingly in the ligand less ground c-state, K22, R79, R279 may
be in an intermediary position and initially not well adapted to the
di- or tri-phosphate moiety. In in silico extrapolations of the AAC
crystal structure [478], ADP is projected to interact with the three
cationic residues but the distances of the phosphate groups to R79
and K22 are large, allowing for only weak bonding. This seems to
agree with the concept that the CAT–AAC structure represents an
“abortive ground” state where the binding center should be wide
open and offers only a poor ﬁt to the substrate. Without CAT these
residues might be somewhat differently arrange. At any rate, after
initial lose binding of ADP the positive residues might be pulled
closer to the phosphates, and thus the binding center driven into the
transition state. In addition other residues of the AAC contribute to
binding, including the well positioned Y186 [9]. These and further
residues will engulf ADP or ATP in the transition state resulting in a
maximum intrinsic binding energy. The energy released from those
local changes propagates to global shifts of the TMH and the matrix
regions going into the m-state.
Coming from the c-state, the translocation steps require removal of
the barriers constituting the m-gate. One step is pivoting the C-
terminal parts of the kinked helices away from the center. The
intrahelical prolines have been proposed to serve as hinges for that
movement [297]. In the third repeat domain this C-terminal part of
TMH5 is connected to neighbouring TMH6 by a salt bridge R236-E264,
which has to be broken. It is unclear why speciﬁcally ATP with its
additional negative charge, has been suggested to cleave this bridge
[9] as if ADP takes another passage. Another critical step should be the
opening of the three circular salt bridges linking these helices at the
m-side. Here the oscillating charge model [479] may come into play
specifying that the translocation path contains a mobile electrostatic
system that responds to the arriving ADP3− and ATP4−. Strategic
negative residues in salt bridges are assumed to be mobile and weakly
bonded and can be pushed by the negative substrate clusters to ﬁnd
other electrostatic compensation. In this way the substrate may cleave
the salt bridge circle for opening the m-gate. Simultaneously the c-
gate will be closed and a cluster of positive and negative charges at the
C-terminals of the even numbered TMH seems to invite for a similar
circular salt bridge closure. The twist of TMH2 and also of TMH4
between the c- and m-state [445] may contribute to this gating. The
masking of the adjacent upstream half of loop C1 on transition into the
m-state [466] suggests a participation of these loops in the c-gate.
The charged residues K108, D109 and K112 may be involved by
switching their ion bonds. In particular K108may play an active role in
the c-gating.
For comparison it should be noted that in the homologue
oxoglutarate carrier (OGC) the TMH were probed by Cys scanning
[480,481] and the inﬂuence of MTS type SH reagents on transport was
determined. The effects were evaluated on the basis of the OGC
structure extrapolated from the AAC crystal structure. It was pointed
out that in OGC one of three salt brides of AAC is missing and thus, in
Table 2
A list of research highlights on the AAC in chronological order
Year Result Details References
1964–65 Discovery of ADP, ATP exchange. Differentiation of uptake into intermembrane andmatrix space. Identiﬁcation of transport of ADP and ATP
through inner membrane, excluding AMP. 1:1 exchange with endogenous pool.
[20,26,34]
1965–66 Atractyloside (ATR) inhibitor of ADP/ATP
exchange
Direct evidence that ATR inhibits exchange with endogenous pool but not uptake into intermembrane
space.
[26,33]
Indirect evidence: ATR inhibits only phosphorylation of exogenous but not of endogenous pool. [30,22,23]
1966–71 Membrane energisation (ΔμH+) controls ADP/
ATP exchange
In “energised” mitochondria: preferred ADP uptake and ATP release. [34,42]
In de-energised state (uncoupling, K+-valinomycin) no difference between ADP and ATP transport.
1970 Identiﬁcation and dynamics of carrier binding
sites with ADP and ATP.
Titration of ADP and ATP binding to AAC carrier sites in membranes. Differentiation with ATR. Biphasic
concentration dependence explained by ADP, ATP driven reorientation of binding sites.
[166]
1970–72 Electrophoretic ATP4−–ADP3− exchange. Membrane potential Δψ identiﬁed as driving force in ATP4−–ADP3− exchange by ionophores. [89,90]
1970–72 BKA inhibits exchange but has other opposite
effects to ATR
BKA increases apparent ADP, ATP binding. [151,170]
BKA blocks, ATR stimulates efﬂux. [246]
1970–75 Molecular demonstration of a single binding
center gated pore mechanism.
ADP, ATP mobilises the binding site transition between out-(c) and in (m) states: ATR, CAT ﬁx the carrier
sites in the c- and BKA in the m-state.
[153,171]
Experimental deﬁnition of “c and m-state” The apparent BKA induced increase of ADP, ATP binding is explained as trapping of ADP, ATP inside.
1972 (ATP/ADP)cytN (ATP/ADP)mito (ΔGATP)cytN
(ΔGATP)mito.
Δψ driven ATP/ADP gradient causes higher energy level of ATP in cytosol than in mitochondria. [98,99,100]
1972 Decrease of P/O by n /n+1(n=3) Export of ATP lowers yield of oxidative phosphorylation by 25%, by diverting 1 out of 4 H+
pumped by electron transport.
[82,81,89,102]
1972–76 Strategic SH groups. ADP induced NEM unmasking. [69,70]
Indicators of c–m conformation changes. Evidence for NEM unmasking reﬂects m-state transition. [2]
1975 Isolation of CAT–AAC complex. Solubilisation and puriﬁcation of CAT–AAC from bovine heart using Triton X100. First isolation of a
biomembrane transporter in intact state.
[254,183]
1977 Reconstitution of transport with isolated AAC. First reconstitution of transport with an isolated carrier protein. Acidic lipid requirements. [279]
Δψ controls Vmax not KM Demonstration with reconstituted AAC. [107]
1982 Complete amino acid sequence of the AAC. Sequence of AAC from bovine heart. First primary structure of a mammalian transporter. [49]
6 transmembrane helix 3 repeat domain
model
Hydropathy and repeat search evaluations of amino acid sequence. [382]
1982 Dimer structure of isolated AAC. Hydrodynamic measurements of AAC-detergent micelle in Triton X100. [263]
1983 Matrix side (M) loop protrudes into
translocation path accessible from c-side.
Pyridoxal phosphate accesses to lysines, located in matrix (M) loops from the c-side. [444]
8- and 2-azido-ATP incorporation to M-loops from “c” side. [453]
1985 High level tight association of cardiolipin to
AAC.
6 mol CL oer AAC dimer tightly bound and dissociated only by SDS at N30°, as detected by 31P-NMR. [252]
1988 AAC role in mitochondrial pore transition Ca++ induced pore transition has opposite response to CAT and BKA. [313]
Dependence on cyclophilin. [320,321]
1991 “Induced transition ﬁt” of transport catalysis ITF is evident in the mobilisation by of ADP, ATP of AAC transition from c- to m-dtate and the paradox of
low binding afﬁnity and high speciﬁcity, the stabilisation of AAC by CAT or BKA.
[212,187]
1993 Hydrophilic EMA accesses central M2-loop Conversely to M1, the SH group in the central loop M2 is accessed by EMA but blocked by BKA indicating
direct role in translocation path.
[342,343]
1995–98 Charge pair network between odd numbered
TMH at the matrix side of AAC
Spontaneous second site mutations in yAAC2 compensate primary charge defects by opposite charge
deletion at odd numbered TMH.
[396]
1996 Large Ca++ activated channel in isolated AAC. Single channel patch clamp with reconstituted AAC, voltage gated channel closed by BKA not by ATR.
Direct support for role of AAC in “mitochondrial pore transition”.
[292]
1996 Electrical currents measured with ATP4−,
ADP3− in reconstituded AAC
Flash photolysis of caged ATP, ADP with AAC proteoliposomes adsorbed to planar membranes.
Measurement of currents caused by charge movements of ADP and ATP and of the reorienting AAC
binding center
[93,94]
2003 High resolution 2.2 Å crystal structure of
CAT–AAC complex.
c-side open cavity with CAT bound in pseudo 3- fold symmetry. The 6 transmembrane bundle is skewed to
the membrane. Odd numbered TMH are kinked. Evidence for single binding site.
[297,9]
2011M. Klingenberg / Biochimica et Biophysica Acta 1778 (2008) 1978–2021accordance with the ITF [187,212], that the smaller substrate binding
energy requires smaller rearrangement energies.
The unusual high level of cardiolipin (CL) binding to bAAC1 [252] has
been implicated in balancing the high conformation energy require-
ments during the translocation [272,337]. Most notably, CL molecules
are also present in the crystals of the bAAC1–CAT complex [297]. The
special structure of CL sporting two phosphate groups seems to be used
to pull together two TMH between adjacent repeat domains. The
hydrogen bonds of CL extend close to the proline of the neighbouring
uneven TMH. The position of the CL head groups at the region in AAC,
where strong rearrangements are to be expected, suggests a signiﬁcant
role of CL in transport catalysis of AAC. For example, in the transition
state the dual grip of CL on even numbered TMH and them-helixmight
be relieved concomitant with the opening of the m-gate. Thus CL may
change to other binding positions in the m-state.
In a second crystal form C222, generated at low salt concentration,
three CL per monomer are visible [278], showing that all tightly bound
CL molecules [252] are retained. CL is positioned at each repeat
domainwith their head group towards them-side. In the C222 crystals
contacts between two monomers can be discerned. The interface is
prominently ﬁlled with two CL around the twofold dimer axis, whichseems to bond the subunits [278] in addition to contacts between the
C- and N-terminals. At the dimer interface CL forms an additional salt
bridge to K267 in TMH6 of the facing monomer.
16.5. Dimer mechanism
A much discussed issue has been the role of the AAC dimer in
transport. Although the single binding gated pore mechanism and
the overriding induced transition ﬁt mechanism are noncommittal
whether a dimer ormonomer are the functional unit, various types of
evidence and the implication for a functional dimer role are reviewed
here. Originally it was speculated, in view of one CAT molecule
binding per dimer, that the translocation channel passes between the
two monomers [2,472]. However the asymmetry of the binding site
would be incompatible with a channel at the two fold axis [3]. With
the much preferred model of two separate translocation channels in
each subunit, the question arose whether they act independently or
cooperate by inter-subunit contact. Kinetic studies, although they
may be ﬂawed (see above), claimed a simultaneous mechanism
of ADP–ATP transport [71,72], requiring two binding sites which
might operate by a reciprocating exchange between both units in a
2012 M. Klingenberg / Biochimica et Biophysica Acta 1778 (2008) 1978–2021dimer. This mechanism implies that equal numbers of subunits are in
the c- and m-state, contrary to the evidence that all sites can be
trapped in one state.
Based on the results of ﬂuorescent substrate probes and the
stoichiometry of CAT binding the formation of AAC tetramers in the
mitochondria was proposed [7,8,475,482], containing 2 sites for CAT
and for BKA and a total of 4 nucleotide sites, 2 in the c-state and 2 in
the m-state. Whereas a tetramer or dimer may have essentially
compatible mechanisms, the stoichiometry of binding sites differs.
From ﬂuorescence titrations with FTP, two nucleotide sites per CAT
binding site were deduced [205], while with N-ADP and other
nucleotide derivatives approximately 1:1 binding ratio was reported
[482]. Direct measurements with radio-labelled ligands resulted in
about equal amounts of binding sites for DAN-ADP and CAT or BKA
[207]. Binding studies showing equal amounts of high and low
afﬁnity sites were interpreted in terms of negative cooperativity and
functional interdependence in the oligomeric structure [8,450,482].
At variance to the single binding center reorientation (SBCG)
mechanism, the effects of BKA on nucleotide binding, such as
abolishing the non-linearity and negative cooperativity of nucleotide
binding, were taken to show that BKA acts from a separate site
[8,214].
Engineered covalent dimers of the AAC support the existence and
function of a dimer AAC. A tandem dimer with the C-terminal
covalently linked to the N-terminal of yAAC2 was expressed reaching
the same level as wt yAAC2 [483]. The fusion homodimer had similar
transport activity as the wt AAC. In another report on yAAC2 tandem
constructs a slower cell growth was noted [484]. The fact that wt–wt
tandem fusion products are well expressed and show transport
activity equivalent to wt in mitochondria and in proteoliposomes
argues for a functional dimer but does not specify independent or
cooperating channels. A chimer fusion between wt and op1 mutant
[484] had no negative inﬂuence on aerobic growth. The transport rates
of the yAAC2 chimer construct wt-mutants and wt–wt were
compared [485] in mitochondria and reconstituted vesicles. R294A
was chosen for generating the chimerwt-294A, because this mutant is
basically as active as wt but has an opposite preference for ADP versus
ATP (see above). Further wt-R204L was constructed to match wt with
an inactive mutant. With wt–wt and wt-R294A the growth on non-
fermentable source was half as fast as with the control strain, but it
was strongly delayed with wt-R204L. Whereas wt–wt and wt-R294R
were well expressed in isolated mitochondria, wt-R204L was not
expressed but instead only non-fused wt was found in mitochondria.
Obviously genetic splicing to wt-plasmid occurred under the aerobic
growth pressure. After isolation and reconstitution, the tandemwt–wt
had the same pattern of ATP versus ADP selectivity as wt. The wt-
R294A chimer transport modes activities were only slightly dissimilar
to wt, indicating an adaptation to the wt and interpreted as a partial
interdependence. The non-survival of wt-R204L and R204L-wt
seemed to indicate that these chimers are inactive, and that the wt
segment was not able to compensate inactive R204L due to
cooperativity between the units.
For reasons of analogy, a functional dimer interdependence in the
phosphate carrier (PiC) may be quoted [486]. In a sophisticated design
PiC was expressed with two different tags. One formwas inactivated by
NEM and mixed with the active form under various proportions and
conditions. The formation of heterodimers was controlled by the two
different tag signals. Reconstituted transport clearly depended on the
formation of homodimers, while heterodimers were inactive. Recently
this question was again approached [487] by co-expressing in yeast wt
yAAC2 and the Cys-less mutant in various proportions. Before
reconstitution the wt portion was inactivated by the SH reagent
MTSES. The activitywas linearly correlated to the active Cys-less portion
and thus did not show the non-linearity expected from a functional
dimer. However, the transport rates were measured at unusually low
substrate concentration and thus weremuch lower than those reportedin the previous reconstitution work of yAAC2 [66]. It is not clear how
these extreme conditions may have inﬂuenced the results.
17. Conclusion
A summary of research highlights on the ADP/ATP transport and its
carrier is assembled in Table 2. The major perspectives emerging from
the research on the ADP/ATP exchange and its carrier are as follows.
The ADP/ATP transport has to cope with a high and widely varying
demand for ATP in the cytosol of the eukaryotic cell. An elementary
regulation has evolved which tightly couples the ATP export to the
cytosolic energy requirement and the activity of oxidative phosphor-
ylation, via the ΔµH+. Within the transport capacity of the underlying
carrier AAC the “productive” mode is modulated by Δψ creating an
asymmetric activation energy proﬁle which favours export of ATP. No
other regulation by protein contact e.g. with ATP synthase seems to be
involved. Besides this short term regulation the AAC expression levels
can adapt over a wide range to changing cellular circumstances by
regulation mechanisms not covered in this review. Dealing with large
substrates ATP and ADP implicating large conformation changes, the
AAC can be expected to be a “slow” carrier. In fact the turnover of the
AAC is moderate but higher than that of other alternate nucleotide
carriers of the MCF. The exceptional use of the fully charged ATP4− and
ADP3− by the AAC assists in lowering the energy barrier and raising the
transport rate. But still a high expression level is required, making the
AAC the most abundant inner membrane protein of mitochondria or
in some cases of the whole organ.With a comparatively small size and
only 6 TMH, the AAC is obviously reduced to its basic transport
function making it a foremost object for uncovering the essence of
carrier catalysed transport. Passing a large substrate through a small
protein should entail unusually large conformation changes. Therefore
it is not surprising that the general “induced transition ﬁt” of carrier
catalysis has been inspired by the AAC. The elucidation of the
molecular mechanism by various probes, has gained a solid structural
basis in the crystal structure of the CAT–AAC complex, showing the
apparent simplicity of the carrier. However, based on a structure in
one extreme state, extrapolation of the changes during the transloca-
tion and the substrate protein interactions can only be approximate
and the molecular mechanism must await structures which are more
representative of the active AAC.
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